UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934 (Amendment
No. )
Filed by the
Registrant
þ
Filed by a Party other than the
Registrant
o
Check the appropriate box:
o
Preliminary
Proxy Statement
o
Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
þ
Definitive
Proxy Statement
o
Definitive
Additional Materials
o
Soliciting
Material Pursuant to §240.14a-12
ZILA, INC.
(Name of Registrant as Specified In
Its Charter)
(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required.
|
|
o
|
Fee computed below per Exchange Act
Rules 14a-6(i)(1)
and 0-11.
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
1)
|
Amount Previously Paid:
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
ZILA,
INC.
5227
North 7
th
Street
Phoenix,
Arizona
85014-2800
NOTICE OF ANNUAL SHAREHOLDERS
MEETING
November 9,
2007
Phoenix, Arizona
To the Holders of Common Stock of Zila, Inc.:
We will hold the annual shareholders meeting of Zila, Inc.
(ZILA) at the Arizona Biltmore Resort &
Spa, located at 2400 East Missouri, Phoenix, AZ 85016, on
Thursday, December 13, 2007 at 8:00 a.m. Arizona
time. The meeting is being held to:
1. Elect six members to ZILAs Board of Directors;
2. Amend the 1997 Stock Award Plan to increase the total
number of shares authorized for issuance from five million
(5,000,000) shares to eight million (8,000,000) shares;
3. Ratify the appointment of BDO Seidman, LLP as
ZILAs independent registered public accounting firm for
the fiscal year ending July 31, 2008; and
4. Consider any other matters that properly come before the
meeting and any adjournments thereof.
Only shareholders of record of common stock at the close of
business on October 18, 2007 are entitled to receive notice
of and to vote at the meeting or any adjournments thereof.
We have enclosed our 2007 Annual Report to Shareholders, which
includes our Annual Report on
Form 10-K
for our fiscal year ended July 31, 2007, and the Proxy
Statement with this notice of annual meeting.
Your proxy is being solicited by ZILAs Board of Directors.
We urge you to vote as soon as possible whether or not you plan
to attend the annual meeting of shareholders to assure your
representation at such meeting. For your convenience, and to
help reduce expenses, you are encouraged to vote by
telephone
or the internet
, as explained on page 2 of the Proxy
Statement or on the enclosed proxy card. Alternatively, you can
complete, sign and mail the enclosed proxy card. We have
enclosed a return envelope for that purpose, which requires no
postage if mailed in the United States, if you choose to vote by
mail. You may revoke a previously delivered proxy at any time
prior to the meeting. If you decide to attend the meeting and
wish to change your proxy vote, you may do so automatically by
voting in person at the meeting.
David R. Bethune
Executive Chairman
PLEASE
VOTE YOUR VOTE IS IMPORTANT
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
1
|
|
|
|
|
3
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
12
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
22
|
|
|
|
|
22
|
|
|
|
|
22
|
|
|
|
|
22
|
|
|
|
|
22
|
|
|
|
|
22
|
|
|
|
|
23
|
|
|
|
|
23
|
|
|
|
|
24
|
|
|
|
|
27
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
33
|
|
|
|
|
34
|
|
|
|
|
35
|
|
|
|
|
35
|
|
|
|
|
38
|
|
|
|
|
39
|
|
|
|
|
39
|
|
|
|
|
39
|
|
|
|
|
40
|
|
|
|
|
41
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
42
|
|
|
|
|
44
|
|
|
|
|
44
|
|
|
|
|
46
|
|
|
|
|
47
|
|
|
|
|
47
|
|
|
|
|
47
|
|
|
|
|
A-1
|
|
ZILA,
INC.
5227
North
7
th
Street
Phoenix,
Arizona
85014-2800
ANNUAL
SHAREHOLDERS MEETING
PROXY STATEMENT
This summary highlights selected information from this Proxy
Statement and may not contain all of the information that is
important to you. To understand the proposals fully, you should
carefully read this entire Proxy Statement, as well as the other
documents to which we refer you.
GENERAL
MEETING INFORMATION
General
Information
:
|
|
|
Annual Meeting:
|
|
The annual meeting of shareholders will be held on Thursday,
December 13, 2007 at 8:00 a.m. Arizona time at
the Arizona Biltmore Resort & Spa, located at 2400
East Missouri Avenue, Phoenix, AZ 85016.
|
|
Record Date:
|
|
Close of business on October 18, 2007. If you were a
shareholder at that time, you may vote at the meeting. Each
share is entitled to one vote. You may not cumulate votes. At
the record date there were 61,575,879 shares of our common
stock outstanding.
|
|
Agenda:
|
|
1. Elect six members to Zila, Inc.s
(ZILA) Board of Directors (the Board);
|
|
|
|
2. Amend the 1997 Stock Award Plan to increase the total
number of shares of common stock authorized for issuance from
five million (5,000,000) shares to eight million (8,000,000)
shares;
|
|
|
|
3. Ratify the appointment of BDO Seidman, LLP for fiscal
year ending July 31, 2008; and
|
|
|
|
4. Consider any other matters that properly come before the
meeting.
|
|
Proxies Solicited By:
|
|
Georgeson Shareholder
|
|
|
|
ZILA will bear the costs of soliciting proxies for the meeting.
No additional compensation will be paid to directors, officers
or other regular employees in connection with the solicitation
of proxies. ZILA retained Georgeson Shareholder to assist with
the solicitation of proxies for a fee not to exceed $8,000, plus
reimbursement for out-of-pocket expenses. We will reimburse
banks, brokers, custodians, nominees and fiduciaries for
reasonable expenses that they incur in sending these proxy
materials to you if you are a beneficial holder of our shares.
|
|
First Mailing Date:
|
|
We will mail this Proxy Statement on or about November 9,
2007.
|
|
Independent Auditors:
|
|
A representative of our independent registered public accounting
firm, BDO Seidman, LLP, is expected to be present at the meeting
and will be available to respond to appropriate questions from
our shareholders.
|
|
|
|
Voting Information
:
|
|
|
|
How to Vote:
|
|
Shareholders whose shares are registered in their own names may
vote their shares by telephone, the internet, mail or in person
at the meeting.
Voting by telephone or the internet are the
least expensive and fastest methods of voting
. Your proxy
card contains instructions for voting by telephone or the
internet. To vote by mail, complete and sign your proxy card and
return it in the enclosed business reply envelope.
|
|
|
|
If your shares are held not in your name but in the street
name of a bank, broker or other holder of record (a
nominee), then your name will not appear in our
register of shareholders and the nominee will be entitled to
vote your shares. In order to be admitted to the annual meeting
of shareholders, you must bring a letter or account statement
showing that you beneficially own the shares held by the
nominee. Even if you attend the annual meeting of shareholders,
you will not be able to vote the shares that you hold in street
name. Rather, you should instruct your nominee how to vote those
shares on your behalf.
|
|
Proxies:
|
|
The proxies will follow your voting instructions. Unless you
tell us on the proxy card to vote differently, the proxies will
vote proxies that are signed and returned
(i) FOR ZILAs Board nominees;
(ii) FOR the amendment to the 1997 Stock Award
Plan; and (iii) FOR the ratification of the
appointment of BDO Seidman, LLP as ZILAs independent
registered public accounting firm. The proxy holders will use
their discretion on other matters. If a nominee cannot or will
not serve as a member of the Board, the proxy holders will vote
for a substitute nominee proposed by the Board.
|
|
Revoking Your Proxy:
|
|
Proxies may be revoked if you:
|
|
|
|
Deliver a signed, written revocation letter prior to
the annual meeting of shareholders, dated later than the proxy,
to Gary V. Klinefelter, Vice President, General Counsel and
Secretary of Zila, Inc., at 5227 North
7
th
Street, Phoenix, Arizona
85014-2800;
|
|
|
|
Deliver a signed proxy prior to the annual meeting
of shareholders, dated later than the first one, to
Computershare Investor Services, Proxy Unit, 350 Indiana Street,
Suite 800, Golden, CO 80401;
|
|
|
|
Vote your shares by telephone or the internet prior
to the annual meeting of shareholders differently than you did
originally, using the same procedures for those methods; or
|
|
|
|
Attend the annual meeting of shareholders and vote
in person or by proxy. Attending the meeting alone will not
revoke your proxy.
|
|
Quorum:
|
|
The presence in person or by proxy of shareholders entitled to
cast a majority of the votes entitled to be cast at the annual
meeting of shareholders is necessary to constitute a quorum at
the meeting for the election of directors and for the other
proposals. Abstentions and broker non-votes are counted as
present and entitled to vote for purposes of determining whether
a quorum exits.
|
2
|
|
|
The Proposals
:
|
|
|
|
Election of Directors:
|
|
David R. Bethune, J. Steven Garrett, David Goldman, Leslie H.
Green, O.B. Parrish and George J. Vuturo are nominated for
election to ZILAs Board of Directors.
|
|
|
|
The Board recommends a vote FOR each of these
directors. If a quorum is present, the six nominees who receive
a plurality of the votes cast at the annual meeting of
shareholders will be elected. Broker non-votes and votes that
are withheld have no effect on the results of the vote. Please
vote on this matter.
|
|
Amendment to 1997 Stock Award Plan:
|
|
The Board recommends a vote FOR the amendment to the
1997 Stock Award Plan to increase the total number of shares of
common stock authorized for issuance from five million
(5,000,000) shares to eight million (8,000,000) shares.
|
|
|
|
The affirmative vote of the holders of a majority of the shares
present in person or represented by proxy and entitled to vote
at the meeting will be required to approve the proposal.
Abstentions will be counted toward the tabulation of votes cast
on proposals presented to the shareholders and will have the
same effect as negative votes. Broker non-votes will be counted
towards a quorum, but will not be counted for any purpose in
determining whether this matter has been approved.
|
|
Ratification of Auditor:
|
|
Our third proposal asks you to ratify the selection of BDO
Seidman, LLP as ZILAs independent registered public
accounting firm for the fiscal year ending July 31, 2008.
|
|
|
|
The Board recommends a vote FOR this proposal. The
affirmative vote of a majority of the votes cast at the annual
meeting is required to ratify the selection of BDO Seidman, LLP
as ZILAs independent auditor. If the appointment is not
approved by the shareholders, the Audit Committee will
reconsider the appointment of BDO Seidman, LLP. Even if the
selection is ratified, the Audit Committee, in its discretion,
may appoint a different auditor at any time if such appointment
is in the best interests of ZILA and its shareholders.
|
PLEASE VOTE - YOUR VOTE IS IMPORTANT
PROPOSAL ONE:
ELECTION OF DIRECTORS
The Board is comprised of six directors, each of whom is elected
annually. Accordingly, shareholders will elect six directors
this year. Each director is to be elected to hold office until
the next annual meeting of shareholders or until his or her
successor is elected and qualified. If a director resigns or
otherwise is unable to complete his or her term of office, the
Board may elect another director for the remainder of the
resigning directors term.
The Boards nominees are listed below. The Board recommends
that you vote for Mr. Bethune, Dr. Garrett,
Mr. Goldman, Ms. Green, Mr. Parrish and
Dr. Vuturo.
|
|
|
David R. Bethune:
|
|
Mr. Bethune is a member of the boards of directors of
Cambrex Corporation and the Female Health Company. From 1999
until his retirement in 2004, he was Chairman and Chief
Executive Officer of Atrix Laboratories, Inc., a drug delivery
and product development company. Prior to his work at Atrix
Laboratories, Mr. Bethune was President and Chief Operating
Officer of IVAX Corporation, a pharmaceutical company. Before
joining IVAX, Mr. Bethune began a
start-up
pharmaceutical company venture formed by Mayo Medical
|
3
|
|
|
|
|
Ventures, a business unit of Mayo Clinics of Rochester.
Mr. Bethune previously served as group vice president of
American Cyanamid Company and a member of the Executive
Committee where he had executive authority for human
biologicals, consumer health products, pharmaceuticals and
ophthalmics as well as global medical research. He was also
President of the Lederle Laboratories Division of American
Cyanamid Company. Mr. Bethune received a B.A. degree in
accounting and economics from Lenior-Rhyne College, Hickory,
North Carolina and Masters in Business Administration in the
Executive Program from Columbia University Graduate School.
Mr. Bethune has been a member of ZILAs Board since
December 2005 and Chairman of the Board since May, 2007. In
August 2007, Mr. Bethune began serving as ZILAs
Executive Chairman. Age 67.
|
|
J. Steven Garrett:
|
|
Dr. Garrett has more than 30 years of experience in
healthcare. From 1995 to 2005, Dr. Garrett served as Senior
Vice President of Clinical Research for Atrix Laboratories,
Inc., where he managed all of that companys clinical
trials, interfaced with the FDA and coordinated the clinical
portion of regulatory submissions. Dr. Garrett continued in
that position from 2005 to 2007, working for QLT USA, Inc.,
following QLTs merger with Atrix Laboratories. Previously,
Dr. Garrett served as chairman of the department of
periodontics at Loma Linda University as well as director of the
advanced education program in periodontics and implant
dentistry. Dr. Garrett also owned and operated a private
dentistry practice, specializing in periodontics and implant
dentistry. Age 62.
|
|
David Goldman:
|
|
Mr. Goldman is a certified public accountant (CPA) who
spent 35 years with the international accounting firm,
Deloitte & Touche LLP. He specialized in serving SEC
registrants in a variety of industries and held the positions of
partner-in-charge
and senior technical partner of the Arizona Audit Practice.
Mr. Goldman served in a number of the Deloitte &
Touches offices including the Executive Office in New York
and Los Angeles. He retired from Deloitte & Touche as
a senior partner in 2001. Since then, he has operated D. Goldman
Professional Services LLC, a financial services consulting firm.
While at D. Goldman Professional Services, he served as chairman
of the audit committee and a member of other committees of the
board of directors of Swift Transportation Company, Inc. and
advised the Board of Directors of a privately held real estate
services company. Mr. Goldman earned a bachelors
degree in business administration and a masters of accounting
degree from the University of Arizona. Age 63.
|
|
Leslie H. Green
|
|
Since 1998, Ms. Green has been Managing Partner of
Roffe & Green, Inc., which provides interim
management, marketing and business development consulting
services, with particular emphasis on healthcare, consumer
products and services. Since co-founding Roffe & Green
she has served as a consultant or in various full and part-time
interim management positions for several businesses in multiple
industries, including interim Chief Executive Officer and
President of Nydic, Inc., a medical diagnostic imaging company,
from January 1999 to March 2001. Prior to forming her consulting
business she served as VP, Marketing and Corporate Planning at
Swiss Army Brands, Inc. and as a Senior Vice President and head
of The New
|
4
|
|
|
|
|
Products Group, a new product consultancy, at Lowe Marschalk,
Inc., one of the Interpublic Group of Companies. Prior to her
election to the Board of ZILA, she provided consulting services
as interim General Manager and interim National Sales Manager of
Zila Pharmaceuticals, Inc. from July 2003 to March 2004.
Ms. Green currently serves as a member of the Board of
Directors of SSOE, Inc. and Cool Blossom Design, LLC.
Ms. Green has been a member of ZILAs Board since
March 2004. Age 60.
|
|
O.B. Parrish:
|
|
Mr. Parrish is the Chairman and Chief Executive Officer of
The Female Health Company, the developer of the first female
condom. Mr. Parrish has been Chairman of The Female Health
Company since 1987, Chief Executive Officer since 1994, and
acting President since 2006. Mr. Parrish is also the
President of Phoenix Health Care of Illinois, Inc. a private
company which invests in innovative healthcare opportunities. In
addition, Mr. Parrish is the Chairman of Abiant, Inc. of
Chicago, which provides proprietary neuroimaging technology to
the pharmaceutical industry for use in selecting and developing
new drugs.
|
|
|
|
Earlier in his career Mr. Parrish was the President of the
Pharmaceutical Group of G.D. Searle in Chicago where he was
responsible for its global pharmaceutical business. Prior to
joining Searle, Mr. Parrish was Executive Vice President of
the International Division of Pfizer, Inc, in New York. Other
positions held at Pfizer included Executive Vice President of
Pfizer Pharmaceuticals, Division Manager and Vice
President, Marketing of Pfizer Laboratories. Mr. Parrish
holds a B.S. degree from Lawrence University and an M.B.A.
degree from the University of Chicago. Mr. Parrish is also
a trustee of Lawrence University. Age 73.
|
|
George J. Vuturo:
|
|
Dr. Vuturo has over 28 years of experience in the
pharmaceuticals industry and is recognized as a leader in the
field of medical education technology. In 1995, Dr. Vuturo
founded Designing Solutions, L.L.C. and Professional Education
Services Group, L.L.C., both are healthcare services companies
that specialize in providing professional medical education
programs to physicians, pharmacists, dentists, nurses, and other
healthcare providers. Dr. Vuturo has served as managing
partner of both companies since their inception. From 2004 to
2005, Dr. Vuturo was a member of the Board of Directors of
QLT, Inc., a publicly-traded biopharmaceutical company dedicated
to the discovery, development, and commercialization of
innovative therapies. From 2001 to 2004, Dr. Vuturo was a
member of the Board of Directors and, at various times, served
on the Executive, Compensation, Audit and Nominations Committees
of Atrix Laboratories, Inc. In 2005, Atrix Laboratories merged
with QLT, Inc. Dr. Vuturo received his Ph.D. in Health Care
Administration from the University of Florida, where he also
received his Bachelor of Science in Pharmacy. Additionally,
Dr. Vuturo holds a B.S. in Biology from Fairfield
University. Age 57.
|
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE
ELECTION OF THE DIRECTOR NOMINEES.
5
|
|
|
General Information
:
|
|
|
|
Board Meetings:
|
|
In fiscal 2007, the Board held 19 meetings, and a number of
matters were considered by unanimous consent of the Board. None
of our directors attended fewer than 75% of the meetings of the
Board held during the directors service or of any
committee on which the director served during fiscal year 2007.
The Board currently does not have a policy regarding director
attendance at our annual meeting of shareholders, although all
directors are encouraged to attend. All of the directors
attended last years annual meeting of shareholders in
person.
|
|
Independent Directors:
|
|
The Board has affirmatively determined that four of the current
six members of the Board are independent as such
term is defined under NASDAQ Marketplace Rule 4200(a)(15)
and the related rules of the Securities and Exchange Commission
(the SEC), with Dr. Garrett, Mr. Goldman,
Ms. Green and Dr. Vuturo being determined to be
independent. ZILAs independent directors conduct executive
sessions at regularly scheduled meetings as required by NASDAQ
Marketplace Rule 4350(c)(2).
|
|
Shareholder Communications with the Board:
|
|
ZILAs Nominations and Corporate Governance Committee has
established policies and procedures for shareholders to
communicate with the members of the Board. Shareholders wishing
to communicate with the Board should address their
communications to:
c/o Vice
President, General Counsel and Secretary, Zila, Inc.,
5227 N. 7th Street, Phoenix, AZ
85014-2800.
The Vice President, General Counsel and Secretary will forward
all such relevant communication to the Nominations and Corporate
Governance Committee for disposition.
|
|
Board Committees
:
|
|
|
|
Audit Committee:
|
|
The Audit Committee is comprised of Dr. Vuturo (Chair),
Mr. Goldman and Ms. Green, each of whom has been
determined to be financially literate with
accounting or related financial management expertise. The Board
has determined that Dr. Vuturo is an audit committee
financial expert, as defined by the rules and regulations
of the SEC, and qualifies as a financially sophisticated audit
committee member as required under Rule 4350(d)(2)(A) of
the NASDAQ Marketplace Rules. Each of the members is
independent, as defined in NASDAQ Marketplace
Rule 4200(a)(15).
|
|
|
|
Under its charter, the Audit Committee appoints ZILAs
independent registered public accounting firm. It also reviews
audit reports and plans, accounting policies, financial
statements, internal controls, audit fees and certain other
expenses. The Audit Committee held 5 meetings in fiscal year
2007. For more information about the Audit Committee and its
operations, see the Audit Committee charter located on our
website at
www.zila.com
, under the Investor Relations and
Corporate Governance section.
|
|
Compensation Committee:
|
|
The three members of the Compensation Committee are
Mr. Parrish (Chair), Dr. Garrett and Ms. Green.
ZILAs Board has determined that Mr. Garrett and
Ms. Green are independent under NASDAQ
|
6
|
|
|
|
|
Marketplace Rules. Mr. Parrish is the Chief Executive
Officer of The Female Health Company, a company on which David
Bethune, our Executive Chairman, served on the compensation
committee of the board of directors in the past three years.
Therefore, Mr. Parrish is not independent under
NASDAQ Marketplace Rules. However Mr. Parrish remains a
member of the Compensation Committee because, in accordance with
NASDAQ Marketplace Rule 4350(c)(3)(c), the Board has
determined that Mr. Parrishs service on the
Compensation Committee is required by the best interests of ZILA
and its shareholders. Each of the current members of the
Compensation Committee is a non-employee director
under Section 16 of the Exchange Act and an outside
director for purposes of Section 162(m) of the
Internal Revenue Code (the Code).
|
|
|
|
The Compensation Committee held 5 meetings in fiscal year 2007.
For more information about the Compensation Committee and its
operations, see the Compensation Committee Charter located on
our website at
www.zila.com
, under the Investor Relations
and Corporate Governance section. Please also see the
Compensation Committee discussion in the
Compensation Discussion and Analysis located
elsewhere in this Proxy Statement.
|
|
Nominations and Corporate
Governance Committee:
|
|
The three members of the Nominations and Corporate Governance
Committee are Dr. Garrett (Chair), Dr. Vuturo and
Mr. Parrish.
|
|
|
|
The Nominations and Corporate Governance Committee identifies,
interviews and recommends candidates for election or appointment
to ZILAs Board and is responsible for developing and, when
appropriate, updating corporate governance principles applicable
to ZILA. The Nominations and Corporate Governance Committee also
is responsible for developing policies and procedures regarding
all shareholder communications. The Nominations and Corporate
Governance Committee held 3 meetings in fiscal year 2007. For
more information about the Nominations and Corporate Governance
Committee and its operations, see the Nominations and Corporate
Governance Committee Charter located on our website at
www.zila.com
, under the Investor Relations and Corporate
Governance section.
|
DIRECTOR
NOMINATION PROCESS
|
|
|
Director Qualifications
:
|
|
It is the policy of the Nominations and Corporate Governance
Committee that persons nominated to serve as director should
possess the following qualifications:
|
|
|
|
Integrity
. Candidates should be
persons of personal integrity and high ethical character.
|
|
|
|
Absence of Conflicts of
Interest
. Candidates should not have any
interests that would materially impair his or her ability to
exercise independent judgment or otherwise discharge the
fiduciary duties owed by a director to ZILA and its shareholders.
|
|
|
|
Fair Representation
. Candidates
must be able to represent fairly and equally all shareholders of
ZILA without favoring any particular shareholder group or other
constituency of ZILA.
|
7
|
|
|
|
|
Time Commitment
. Candidates must
be prepared to devote adequate time to the Board and its
committees. Board members are expected to attend substantially
all Board and committee meetings.
|
|
|
|
Additional Qualifications
. In
selecting nominees for director, the Committee will assure that:
(i) at least three of the directors satisfy the financial
literacy requirements required for service on the Audit
Committee; and (ii) at least one of the directors qualifies
as an audit committee financial expert under the rules of the
Commission.
|
|
Identifying Director Candidates
:
|
|
The Nominations and Corporate Governance Committee has adopted
the following procedures for identifying and evaluating director
candidates:
|
|
|
|
Incumbent Directors
. The process
shall reflect the practice of re-nominating at least one-half of
the incumbent directors if they continue to satisfy the
Nominations and Corporate Governance Committees criteria
for membership and continue to make important contributions to
the Board and who consent to continue their service on the
Board. Consistent with this policy, when considering candidates
for election at the annual meeting of shareholders, the
Nominations and Corporate Governance Committee will first
determine the incumbent directors who wish to continue their
service on the Board. The Nominations and Corporate Governance
Committee will also consider whether the incumbent director
continues to satisfy the minimum qualifications for director
candidates and review the performance of the director during the
preceding term.
|
|
|
|
Consideration of New
Candidates
. The Nominations and Corporate
Governance Committee will identify and evaluate new candidates
for election to the Board annually and will strive to improve
and optimize the Board while infusing new experience and
perspective on a periodic basis. The Nominations and Corporate
Governance Committee will also evaluate new candidates where
there is no qualified and available incumbent, including for the
purpose of filling vacancies arising by reason of resignation,
retirement, removal, death or disability or a decision of the
Board to expand the size of the Board.
|
|
|
|
Process for Identifying New
Candidates
. The Nominations and Corporate
Governance Committee will solicit recommendations for nominees
from persons the Nominations and Corporate Governance Committee
believes are likely to be familiar with (i) the needs of
ZILA and (ii) qualified candidates. These persons may
include members of the Board and management of ZILA. The
Nominations and Corporate Governance Committee may also engage a
professional search firm to assist in identifying qualified
candidates, provided that the Nominations and Corporate
Governance Committee shall coordinate with management in setting
the firms fees and scope of engagement.
|
|
|
|
Evaluation Process
. For each
recommended candidate that the Nominations and Corporate
Governance Committee believes merits
|
8
|
|
|
|
|
consideration, the Nominations and Corporate Governance
Committee will:
|
|
|
|
ensure the collection of information
concerning the background and qualifications of the candidate,
including information that will be required to be disclosed in
ZILAs proxy statement;
|
|
|
|
determine if the candidate satisfies the
minimum qualifications required by the Nominations and Corporate
Governance Committee for election as director;
|
|
|
|
determine if the candidate possesses any
of the specific skills or qualities that should be possessed by
one or more members of the Board; and
|
|
|
|
consider the contribution that the
candidate can be expected to make to the overall functioning of
the Board.
|
|
|
|
Interviews
. In its discretion, the
Nominations and Corporate Governance Committee may designate one
or more Board members to interview any proposed candidate.
|
|
|
|
Management Input
. The Nominations
and Corporate Governance Committee believes it is appropriate to
solicit the views about the candidates qualifications and
suitability from ZILAs chief executive officer and other
senior members of management.
|
|
|
|
Selection
. The Nominations and
Corporate Governance Committee will make its selections based on
all available information and relevant considerations. The
Nominations and Corporate Governance Committees selection
will be based on who, in the view of the Nominations and
Corporate Governance Committee, will be best suited for
membership on the Board.
|
|
|
|
Shareholder-Nominated
Candidates
. In making its selection, the
Nominations and Corporate Governance Committee will evaluate
candidates proposed by shareholders under criteria similar to
other candidates, except that the Nominations and Corporate
Governance Committee may consider, as one of the factors in
their evaluation, the size, duration and any special interest of
the recommending shareholder or shareholder group in the stock
of ZILA. The Nominations and Corporate Governance Committee may
also consider the extent to which the recommending shareholder
intends to continue to hold its interest in ZILA, including
whether the recommending shareholder intends to continue holding
its interest at least through the time of the meeting at which
the candidate is to be elected.
|
|
Shareholder Nominees
:
|
|
The Nominations and Corporate Governance Committee has adopted
the following procedures for submitting nominating
recommendations:
|
|
|
|
Manner and Address for
Submission
. All shareholder nominating
recommendations must be in writing, addressed to ZILAs
Vice President, General Counsel and Secretary at ZILAs
principal headquarters. Submission must be made by mail or
personal delivery. Email submissions will not be considered.
|
9
|
|
|
|
|
Information Concerning the Recommending
Shareholder
. A nominating recommendation must be
accompanied by the following information concerning each
recommending shareholder:
|
|
|
|
name and address, including telephone
number;
|
|
|
|
the number of shares of ZILAs
common stock owned by the recommending shareholder and the time
period for which such shares have been held;
|
|
|
|
if the recommending shareholder is not a
shareholder of record, a statement from the record holder of the
shares (usually a broker or bank) verifying the holdings of the
shareholder and a statement from the recommending shareholder of
the length of time that the shares have been held
(alternatively, the shareholder may furnish a current
Schedule 13D, Schedule 13G, Form 3, Form 4
or Form 5 filed with the Commission reflecting the holdings
of the shareholder, together with a statement of the length of
time the shares have been held); and
|
|
|
|
a statement from the shareholder as to
whether the shareholder has a good faith intention to continue
to hold the reported shares through the date of ZILAs next
annual meeting of shareholders at which the candidate would be
elected.
|
|
|
|
Information Concerning the Proposed
Nominee
. A nominating recommendation must be
accompanied by the following information about the proposed
nominee:
|
|
|
|
the information required by
Item 401 of the Commissions
Regulation S-K
(generally providing for disclosure of the name, address, any
arrangements or understandings regarding the nomination and the
five year business experience of the proposed nominee, as well
as information about the types of legal proceedings within the
past five years involving the nominee);
|
|
|
|
the information required by
Item 403 of the Commissions
Regulation S-K
(generally providing for disclosure regarding the proposed
nominees ownership of securities of ZILA); and
|
|
|
|
the information required by
Item 404 of the Commissions
Regulation S-K
(generally providing for disclosure of transactions in which
ZILA was or is to be a participant involving more than $120,000
and in which the nominee had or will have any direct or indirect
material interest and certain other types of business
relationships with ZILA).
|
|
|
|
Relationships Between the Proposed Nominee and
the Recommending Shareholder.
The nominating
recommendation must describe all relationships between the
proposed nominee and the recommending shareholder and any
arrangements or understandings between the recommending
shareholder and the nominee regarding the nomination.
|
|
|
|
Other Relationships of the Proposed
Nominee
. The nominating recommendation shall
describe all relationships between the proposed nominee and any
of ZILAs competitors, customers,
|
10
|
|
|
|
|
suppliers, labor unions or other persons with special interests
regarding ZILA.
|
|
|
|
Qualifications of the Proposed
Nominee
. The recommending shareholder must
furnish a statement supporting its view that the proposed
nominee possesses the minimum qualifications prescribed by the
Nominations and Corporate Governance Committee for nominees, and
briefly describing the contributions that the nominee would be
expected to make to the Board and the governance of ZILA.
|
|
|
|
Ability to Represent All
Shareholders
. The recommending shareholder must
state, whether in the view of the shareholder, the nominee, if
elected, would represent all shareholders and not serve for the
purpose of advancing or favoring any particular shareholder or
other constituency of ZILA.
|
|
|
|
Consent to Interview and
Service
. The nominating recommendation must be
accompanied by the consent of the proposed nominee to be
interviewed by the Nominations and Corporate Governance
Committee and other Board members (including the proposed
nominees contact information) and, if elected, to serve as
a director of ZILA.
|
|
|
|
Timing
. A shareholder nomination
must be received by ZILA, as provided above, not later than 120
calendar days prior to the first anniversary of the date of the
proxy statement for the prior annual meeting.
|
|
|
|
Shareholder Groups
. If a
recommendation is submitted by a group of two or more
shareholders, the information regarding the recommending
shareholders must be submitted with respect to each shareholder
in the group (as the term group is defined and interpreted under
Commission regulations).
|
|
|
|
This information contained in this Proxy Statement about our
nominations process is just a summary. A complete copy of the
policies and procedures with respect to shareholder director
nominations can be obtained from ZILA, free of charge, by
writing to our Vice President, General Counsel and Secretary at
the address listed above.
|
11
AMENDMENT
TO 1997 STOCK AWARD PLAN
We are seeking approval of an amendment to the 1997 Stock Award
Plan, as amended and restated as of September 30, 2004 (the
1997 Plan). The amendment will increase the number
of shares available for grant from five million (5,000,000) to
eight million (8,000,000). The affirmative vote of the holders
of a majority of the shares present in person or represented by
proxy and entitled to vote at the meeting will be required to
approve the proposal. Abstentions will be counted toward the
tabulation of votes cast on proposals presented to the
shareholders and will have the same effect as negative votes.
Broker non-votes will be counted towards a quorum, but will not
be counted for any purpose in determining whether this matter
has been approved.
As of September 30, 2007, without taking into account the
proposed increase in the number of shares available under the
1997 Plan, options (net of canceled or expired options) covering
an aggregate of 4,170,000 shares of the our common stock
had been granted under the 1997 Plan, 648,000 shares (net
of forfeited shares) of restricted stock had been granted under
the 1997 Plan and a total of 144,000 shares of our common
stock remained available for future grants under the 1997 Plan,
subject to increase in certain circumstances.
If shareholders approve this amendment to the 1997 Plan,
Section 4(a) of the 1997 Plan will be amended as follows:
(a) Limitation on Overall Number of Shares Subject to
Awards. Subject to adjustment as provided in Section 11(c)
hereof, the total number of shares of Stock reserved and
available for delivery in connection with Awards under the Plan
shall be (i) 8,000,000 plus (ii) any share of Stock
available under the Directors Plan as of the Effective Date of
this Plan. Any shares of Stock delivered under the Plan may
consist, in whole or in part, of authorized and unissued shares
or treasury shares.
Reasons
for Proposed Amendment
The Board believes that we must continue to offer a competitive
equity incentive program if we are to remain competitive in
attracting, and successful in retaining, the most qualified
candidates. We believe that the 1997 Plan is integral to our
compensation strategies and programs. The Board expects that the
1997 Plan will be an important factor in attracting, motivating
and retaining the high-caliber employees, essential to our
future growth and success. In addition, we believe that the 1997
Plan benefits shareholders by continuing to align the interests
of our employees with those of our shareholders through equity
incentives. Grants are used as an alternative to cash bonuses to
reward performance and allow the Board to incentivize and reward
management while directing cash resources to operational goals
and objectives. Failure to approve the amendment to the 1997
Plan will mean that we will be unable to continue to grant stock
options and other equity awards to the extent that the Board
believes that they will be necessary in order to further the
long-term interests of ZILA and its shareholders.
Previous
Board Amendments to the 1997 Plan
The Board, pursuant to its discretion provided in the 1997 Plan,
has made two amendments to the 1997 Plan over the course of the
last year. On November 9, 2006, the Board eliminated
previous Section 8 of the 1997 Plan which provided for
automatic grants of stock options to ZILAs non-employee
directors.
In addition, on November 6, 2007, the Board amended the
1997 Plan to expressly prohibit the repricing
and/or
replacement of outstanding stock options
and/or
stock
appreciation rights granted pursuant to the 1997 Plan. The Board
believes that such action was in the best interests of ZILA and
its shareholders. In connection with this amendment a new
Section 9(b) was added to the 1997 Plan as follows (with
the remaining subsections of Section 9 renumbered
accordingly):
(b) Award Repricing Prohibited. Except in connection
with a Corporate Transaction (for purposes of this
Section 9(b), including, without limitation, any stock
dividend, stock split, extraordinary cash dividend,
recapitalization, reorganization, merger, consolidation,
split-up,
spin-off, combination or exchange of shares), the terms of
outstanding Awards may not be amended to (i) reduce the
exercise price of such Awards or
12
(ii) cancel such Awards in exchange for cash or other
Awards with an exercise price that is less than the exercise
price of the original Awards without shareholder approval.
Attached at
Appendix A
hereto is the full text of
the 1997 Plan, as amended (i) by the Board (as described
directly above) and (ii) by the proposed amendment to be
approved by shareholders at this Annual Meeting. The essential
features of the 1997 Plan are summarized below. This summary is
qualified in its entirety by reference to the complete text of
the 1997 Plan attached as Appendix A.
Background
and Purpose of the Plan
The terms of the 1997 Plan provide for grants of stock options,
stock appreciation rights, restricted stock, stock units, bonus
stock, dividend equivalents, other stock-related awards and
performance awards that may be settled in cash, stock or other
property.
We adopted the 1997 Plan to provide a means by which employees,
directors and consultants of ZILA and those of our subsidiaries
and other designated affiliates, which we refer to together as
our affiliates, may be given an opportunity to purchase our
common stock or receive awards of common stock, to assist in
retaining the services of such persons, to secure and retain the
services of persons capable of filling such positions and to
provide incentives for such persons to contribute to our success
and the success of our affiliates. All of our employees,
directors and various consultants, including persons performing
services for our affiliates, are eligible to participate in the
1997 Plan.
Shares
Available for Awards
Under the 1997 Plan, taking into account the proposed
3 million share increase in the share reserve, the total
number of shares of our common stock that may be subject to
awards under the 1997 Plan is equal to 3,144,000 shares,
plus (i) the number of shares with respect to which awards
previously granted under the 1997 Plan terminate without the
issuance of the shares or where the shares are forfeited or
repurchased; and (ii) the number of shares that are
surrendered or withheld in payment of any awards or any tax
withholding requirements.
Limitations
on Awards
The 1997 Plan imposes individual limitations on certain awards,
in part to comply with Section 162(m) of the Internal
Revenue Code of 1986, as amended (the Code).
However, the 1997 Plan does provide broad discretion to the Plan
Administrator to grant awards thereunder. For instance, each
fiscal year during any part of which the 1997 Plan is in effect,
an eligible person may be granted an award under which up to
1 million shares of common stock could be received. In
addition, the maximum amount that may be earned as a performance
award (payable in cash) or other award (payable or settled in
cash) for a performance period by any one participant can be up
to $5 million. All limitations on the amount of stock to be
issued under the 1997 Plan are subject to adjustment in certain
circumstances.
Adjustments
In the event that a dividend or other distribution (whether in
cash, shares of our common stock or other property),
recapitalization, forward or reverse split, reorganization,
merger, consolidation, spin-off, combination, repurchase, share
exchange, liquidation, dissolution or other similar corporate
transaction or event affects our common stock so that an
adjustment is determined to be appropriate by the administrator
of the 1997 Plan, which is currently our Board of Directors,
then the administrator is authorized to adjust (i) the
shares available under the 1997 Plan, (ii) the limitations
described in the preceding paragraph, and (iii) all
outstanding awards, including adjustments to the number of
shares and the exercise prices of options and other affected
terms of awards. The administrator is authorized to adjust
performance conditions and other terms of awards in response to
unusual or nonrecurring events, or in response to changes in
applicable laws, regulations or accounting principles.
13
Eligibility
The persons eligible to receive awards under the 1997 Plan
consist of our officers, directors, employees and independent
contractors and employees of our affiliates. However, incentive
stock options may be granted under the 1997 Plan only to our
employees, including officers, and those of our affiliates. An
employee on leave of absence may be considered as still in our
employ or in the employ of an affiliate for purposes of
eligibility under the 1997 Plan.
Administration
Our Board administers the 1997 Plan unless it delegates
administration to a committee of our Board. At this time, our
Board has not delegated the authority to administer the 1997
Plan to the Compensation Committee of our Board. Together, our
Board and any committee(s) delegated to administer the 1997 Plan
are referred to as the Plan Administrator. Subject
to the terms of the 1997 Plan, the Plan Administrator is
authorized to select eligible persons to receive awards,
determine the type and number of awards to be granted and the
number of shares of our common stock to which awards will
relate, specify times at which awards will be exercisable or may
be settled (including performance conditions that may be
required as a condition thereof), set other terms and conditions
of awards, prescribe forms of award agreements, interpret and
specify rules and regulations relating to the 1997 Plan, and
make all other determinations that may be necessary or advisable
for the administration of the 1997 Plan.
Stock
Options and Stock Appreciation Rights
The Plan Administrator is authorized to grant stock options,
including both incentive stock options, which we refer to as
ISOs, and non-qualified stock options. In addition, the Plan
Administrator is authorized to grant stock appreciation rights,
which entitle the participant to receive upon exercise the
appreciation in the fair market value of our common stock
between the grant date and the exercise date of the stock
appreciation right. The Plan Administrator determines the
exercise price per share subject to an option and the grant
price of a stock appreciation right. However, the per share
exercise price of an ISO and the per share grant price of a
stock appreciation right must not be less than the fair market
value of a share of our common stock on the grant date. The Plan
Administrator generally will fix the maximum term of each option
or stock appreciation right, the times at which each stock
option or stock appreciation right will be exercisable and
provisions requiring forfeiture of unexercised stock options or
stock appreciation rights at or following termination of
employment or service, except that no ISO may have a term
exceeding 10 years. Stock options may be exercised by
payment of the exercise price in any form of legal consideration
specified by the Plan Administrator, which may include cash,
shares, other awards or other property having a fair market
value equal to the exercise price. The Plan Administrator
determines methods of exercise and settlement and other terms of
the stock appreciation rights.
Restricted
Stock and Stock Units
The Plan Administrator is authorized to grant restricted stock
and stock units. A restricted stock grant is a grant of shares
of our common stock, which is subject to restrictions on
transferability, risk of forfeiture and other restrictions and
which may be forfeited in the event of certain terminations of
employment or service prior to the end of a restricted period
specified by the Plan Administrator. A participant granted
restricted stock generally has all of the rights of one of our
shareholders, unless otherwise determined by the Plan
Administrator. An award of a stock unit confers upon a
participant the right to receive shares of our common stock, or
cash or a combination of both at the end of a specified period,
and may be subject to possible forfeiture of the award in the
event of certain terminations of employment or service prior to
the end of a specified period. Prior to settlement, an award of
a stock unit carries no voting or dividend rights or other
rights associated with share ownership, although dividend
equivalents may be granted, as discussed below.
Dividend
Equivalents
The Plan Administrator is authorized to grant dividend
equivalents conferring on participants the right to receive,
currently or on a deferred basis, cash, shares of our common
stock, other awards or other property equal in value to
dividends paid on a specific number of shares of our common
stock or other periodic payments. Dividend
14
equivalents may be granted alone or in connection with another
award, may be paid currently or be deemed to have been
reinvested in additional shares of our common stock, awards or
otherwise as specified by the Plan Administrator.
Bonus
Stock and Awards in Lieu of Cash Obligations
The Plan Administrator is authorized to grant shares of our
common stock as a bonus, free of restrictions for services
performed for us, or to grant shares of our common stock or
other awards in lieu of our obligations to pay cash under the
1997 Plan or other plans or compensatory arrangements, subject
to such terms as the Plan Administrator may specify.
Other
Stock-Based Awards
The Plan Administrator is authorized to grant awards under the
1997 Plan that are denominated or payable in, valued by
reference to, or otherwise based on or related to shares of our
common stock. Such awards might include, without limitation,
convertible or exchangeable debt securities, other rights
convertible or exchangeable into shares of our common stock,
purchase rights for shares of our common stock, awards with
value and payment contingent upon our performance or any other
factors designated by the Plan Administrator, and awards valued
by reference to the book value of shares of our common stock or
the value of securities of or the performance of specified
subsidiaries or business units. The Plan Administrator
determines the terms and conditions of such awards.
Performance
Awards
The right of a participant to exercise or receive a grant or
settlement of an award, and the timing thereof, may be subject
to such performance conditions, including subjective individual
goals, as may be specified by the Plan Administrator. In
addition, the 1997 Plan authorizes specific performance awards,
which represent a conditional right to receive cash, shares of
our common stock or other awards upon achievement of certain
pre-established performance goals and subjective individual
goals during a specified fiscal year. Performance awards granted
to persons whom the Plan Administrator expects will, for the
year in which a deduction arises, be covered
employees (as defined below) will, if and to the extent
intended by the Plan Administrator, be subject to provisions
that should qualify such awards as performance-based
compensation not subject to the limitation on tax deductibility
by us under Code Section 162(m). For purposes of
Section 162(m), the term covered employee means
our principal executive officer and our three highest
compensated officers as of the end of a taxable year as
disclosed in our filings with the SEC. If and to the extent
required under Section 162(m), any power or authority
relating to a performance award intended to qualify under
Section 162(m) is to be exercised by the Compensation
Committee, and not by our Board.
Subject to the requirements of the 1997 Plan, the Plan
Administrator will determine performance award terms, including
the required levels of performance with respect to specified
business criteria, the corresponding amounts payable upon
achievement of such levels of performance, termination and
forfeiture provisions and the form of settlement. One or more of
the following business criteria, based on our consolidated
financial statements or those of our affiliates, or for our
business units or those of our affiliates (except with respect
to the total shareholder return and earnings per share
criteria), will be used by the Plan Administrator in
establishing performance goals for such performance awards
(including for awards designed to comply with the
performance-based compensation exception to
Section 162(m)): (i) total shareholder return,
(ii) total shareholder return compared to total return (on
a comparable basis) of a publicly available index, such as the
Standard & Poors 500 Stock Index; (iii) net
income; (iv) pretax earnings; (v) earnings before
interest expense, taxes, depreciation and amortization;
(vi) pretax operating earnings after interest expense but
before bonuses, service fees and extraordinary or special items;
(vii) operating margin; (viii) earnings per share;
(ix) return on equity; (x) return on capital;
(xi) return on investment; (xii) operating earnings;
(xiii) working capital or inventory; and (xiv) ratio
of debt to shareholders equity. In granting performance
awards, the Plan Administrator may establish unfunded award
pools, the amounts of which will be based upon the
achievement of a performance goal or goals based on one or more
of certain business criteria described in the 1997 Plan. During
the first 90 days of a performance period, the Plan
Administrator will determine who will potentially receive
performance awards for that performance period, either out of
the pool or otherwise.
15
After the end of each performance period, the Plan Administrator
(which will be the Compensation Committee for awards intended to
qualify as performance-based for purposes of
Section 162(m)) will determine (a) the amount of any
pools and the maximum amount of potential performance awards
payable to each participant in the pools and (b) the amount
of any other potential performance awards payable to
participants in the 1997 Plan. The Plan Administrator may, in
its discretion, determine that the amount payable as a
performance award will be reduced from the amount of any
potential award.
Other
Terms of Awards
Awards may be settled in the form of cash, shares of our common
stock, other awards or other property in the discretion of the
Plan Administrator. Awards under the 1997 Plan are generally
granted without a requirement that the participant pay
consideration in the form of cash or property for the grant (as
distinguished from the exercise), except to the extent required
by law. The Plan Administrator may require or permit
participants to defer the settlement of all or part of an award
in accordance with such terms and conditions as the Plan
Administrator may establish, including payment or crediting of
interest or dividend equivalents on deferred amounts, and the
crediting of earnings, gains and losses based on deemed
investment of deferred amounts in specified investment vehicles.
The Plan Administrator is authorized to place cash, shares of
our common stock or other property in trusts or make other
arrangements to provide for payment of our obligations under the
1997 Plan. The Plan Administrator may condition any payment
relating to an award on the withholding of taxes and may provide
that a portion of any shares of our common stock or other
property to be distributed will be withheld (or previously
acquired shares of our common stock or other property be
surrendered by the participant) to satisfy withholding and other
tax obligations. Awards granted under the 1997 Plan generally
may not be pledged or otherwise encumbered and are not
transferable except by will or by the laws of descent and
distribution, or to a designated beneficiary upon the
participants death, except that the Plan Administrator
may, in its discretion, permit transfers of nonqualified stock
options for estate planning or other purposes subject to any
applicable restrictions under
Rule 16b-3
under the Securities Exchange Act of 1934, as amended (the
Exchange Act).
The Plan Administrator may grant awards in exchange for other
awards under the 1997 Plan or under other of our compensation
plans, or other rights to payment from us, and may grant awards
in addition to or in tandem with such other awards, rights or
other awards. In addition, the Plan Administrator may cancel
awards granted under the 1997 Plan in exchange for a payment of
cash or other property. The terms of any exchange of or purchase
of an award will be determined by the Plan Administrator in its
sole discretion.
Acceleration
of Vesting; Change in Control
The Plan Administrator may, in its discretion, accelerate the
vesting, exercisability, lapsing of restrictions or expiration
of deferral or amend the terms of any award. In addition, the
Plan Administrator may provide in an award agreement that the
performance goals relating to any performance-based award will
be deemed to have been met upon the occurrence of any
change in control. If the participant is terminated
by us or our successor without cause (as defined in
the 1997 Plan) or terminates for good reason (as
defined in the 1997 Plan) within 12 months after a
change in control (as defined in the 1997 Plan),
then the award will become fully vested and, if applicable,
exercisable.
In the event of a corporate transaction (as defined
in the 1997 Plan), the acquiror must assume, continue or
substitute for each outstanding stock option. In addition, the
Plan Administrator may, in its discretion, provide that, in the
event of a corporate transaction (as defined in the
1997 Plan), all repurchase or forfeiture rights will lapse.
Amendment
and Termination
Our Board may amend, alter, suspend, discontinue or terminate
the 1997 Plan or the Plan Administrators authority to
grant awards without further shareholder approval, except
shareholder approval must be obtained for any amendment or
alteration if such approval is required by law or regulation or
under the rules of any stock exchange or quotation system on
which shares of our common stock are then listed or quoted.
Shareholder approval will not be deemed to be required under
laws or regulations, such as those relating to ISOs, that
condition favorable treatment of participants on such approval,
although our Board may, in its discretion, seek shareholder
approval in
16
any circumstance in which it deems such approval advisable.
Unless earlier terminated by our Board, the 1997 Plan will
terminate on the ten year anniversary of the approval of an
increase in the number of shares reserved under the 1997 Plan by
our Board (contingent upon such increase being approved by our
shareholders). If Proposal 2 is not approved by our
shareholders, unless earlier terminated by our Board, the 1997
Plan will terminate upon the earlier of
(i) December 16, 2014 (ten years from the adoption of
the 1997 Plan), or (ii) such time as no shares of our
common stock remain available for issuance under the 1997 Plan
and we have no further rights or obligations with respect to
outstanding awards under the 1997 Plan. Amendments to the 1997
Plan or any award require the consent of the affected
participant if the amendment has a material adverse effect on
the participant.
Federal
Income Tax Consequences of Awards
The information set forth above is a summary only and does not
purport to be complete. In addition, the information is based
upon current federal income tax rules and therefore is subject
to change when those rules change. Moreover, because the tax
consequences to any recipient may depend on his particular
situation, each recipient should consult the recipients
tax adviser regarding the federal, state, local and other tax
consequences of the grant or exercise of an award or the
disposition of stock acquired as a result of an award. The 1997
Plan is not qualified under the provisions of
Section 401(a) of the Code and is not subject to any of the
provisions of the Employee Retirement Income Security Act of
1974.
Nonqualified
Stock Options
Generally, there is no taxation upon the grant of a nonqualified
stock option. On exercise, an optionee will recognize ordinary
income equal to the excess, if any, of the fair market value on
the date of exercise of the stock over the exercise price. If
the optionee is our employee or an employee of an affiliate,
that income will be subject to withholding tax. The
optionees tax basis in those shares will be equal to their
fair market value on the date of exercise of the option, and the
optionees capital gain holding period for those shares
will begin on that date.
Subject to the requirement of reasonableness, the provisions of
Section 162(m) and the satisfaction of a tax reporting
obligation, we will generally be entitled to a tax deduction
equal to the taxable ordinary income realized by the optionee.
Incentive
Stock Options
The 1997 Plan provides for the grant of stock options that
qualify as incentive stock options, which we refer
to as ISOs, as defined in Section 422 of the Code. Under
the Code, an optionee generally is not subject to ordinary
income tax upon the grant or exercise of an ISO. In addition, if
the optionee holds a share received on exercise of an ISO for at
least two years from the date the option was granted and at
least one year from the date the option was exercised, which we
refer to as the Required Holding Period, the
difference, if any, between the amount realized on a sale or
other taxable disposition of that share and the holders
tax basis in that share will be long-term capital gain or loss.
If, however, an optionee disposes of a share acquired on
exercise of an ISO before the end of the Required Holding
Period, which we refer to as a Disqualifying
Disposition, the optionee generally will recognize
ordinary income in the year of the Disqualifying Disposition
equal to the excess, if any, of the fair market value of the
share on the date the ISO was exercised over the exercise price.
However, if the sales proceeds are less than the fair market
value of the share on the date of exercise of the option, the
amount of ordinary income recognized by the optionee will not
exceed the gain, if any, realized on the sale. If the amount
realized on a Disqualifying Disposition exceeds the fair market
value of the share on the date of exercise of the option, that
excess will be short-term or long-term capital gain, depending
on whether the holding period for the share exceeds one year.
For purposes of the alternative minimum tax, the amount by which
the fair market value of a share of stock acquired on exercise
of an ISO exceeds the exercise price of that option generally
will be an adjustment included in the optionees
alternative minimum taxable income for the year in which the
option is exercised. If, however, there is a Disqualifying
Disposition of the share in the year in which the option is
exercised, there will be no adjustment for alternative minimum
tax purposes with respect to that share. If there is a
Disqualifying Disposition in a later year, no income with
respect to the Disqualifying Disposition is included in the
optionees alternative minimum
17
taxable income for that year. In computing alternative minimum
taxable income, the tax basis of a share acquired on exercise of
an ISO is increased by the amount of the adjustment taken into
account with respect to that share for alternative minimum tax
purposes in the year the option is exercised.
We are not allowed an income tax deduction with respect to the
grant or exercise of an incentive stock option or the
disposition of a share acquired on exercise of an incentive
stock option after the Required Holding Period. However, if
there is a Disqualifying Disposition of a share, we are allowed
a deduction in an amount equal to the ordinary income includible
in income by the optionee, provided that amount constitutes an
ordinary and necessary business expense for us and is reasonable
in amount, and either the employee includes that amount in
income or we timely satisfy our reporting requirements with
respect to that amount.
Stock
Awards
Generally, the recipient of a stock award will recognize
ordinary compensation income at the time the stock is received
equal to the excess, if any, of the fair market value of the
stock received over any amount paid by the recipient in exchange
for the stock. If, however, the stock is not vested when it is
received (for example, if the employee is required to work for a
period of time in order to have the right to sell the stock),
the recipient generally will not recognize income until the
stock becomes vested, at which time the recipient will recognize
ordinary compensation income equal to the excess, if any, of the
fair market value of the stock on the date it becomes vested
over any amount paid by the recipient in exchange for the stock.
A recipient may, however, file an election with the Internal
Revenue Service, within 30 days of his or her receipt of
the stock award, to recognize ordinary compensation income, as
of the date the recipient receives the award, equal to the
excess, if any, of the fair market value of the stock on the
date the award is granted over any amount paid by the recipient
in exchange for the stock.
The recipients basis for the determination of gain or loss
upon the subsequent disposition of shares acquired as stock
awards will be the amount paid for such shares plus any ordinary
income recognized either when the stock is received or when the
stock becomes vested. Subject to the requirement of
reasonableness, the provisions of Section 162(m) and the
satisfaction of a tax reporting obligation, we will generally be
entitled to a tax deduction equal to the taxable ordinary income
realized by the recipient of the stock award.
Stock
Appreciation Rights
We may grant stock appreciation rights separate from any other
award, which we refer to as stand-alone stock appreciation
rights, or in tandem with options, which we refer to as tandem
stock appreciation rights, under the 1997 Plan.
With respect to stand-alone stock appreciation rights, if the
recipient receives the appreciation inherent in the stock
appreciation rights in cash, the cash will be taxable as
ordinary compensation income to the recipient at the time that
the cash is received. If the recipient receives the appreciation
inherent in the stock appreciation rights in shares of stock,
the recipient will recognize ordinary compensation income equal
to the excess of the fair market value of the stock on the day
it is received over any amounts paid by the recipient for the
stock.
With respect to tandem stock appreciation rights, if the
recipient elects to surrender the underlying option in exchange
for cash or shares of stock equal to the appreciation inherent
in the underlying option, the tax consequences to the recipient
will be the same as discussed above relating to the stand-alone
stock appreciation rights. If the recipient elects to exercise
the underlying option, the holder will be taxed at the time of
exercise as if he or she had exercised a nonqualified stock
option (discussed above).
Subject to the requirement of reasonableness, the provisions of
Section 162(m), and the satisfaction of a tax reporting
obligation, we will generally be entitled to a tax deduction
equal to the taxable ordinary income realized by the recipient
of the stock appreciation right.
18
Dividend
Equivalents
Generally, the recipient of a dividend equivalent award will
recognize ordinary compensation income at the time the dividend
equivalent award is received equal to the fair market value
dividend equivalent award received. Subject to the requirement
of reasonableness, the provisions of Section 162(m) and the
satisfaction of a tax reporting obligation, we will generally be
entitled to a tax deduction equal to the taxable ordinary income
realized by the recipient of the dividend equivalent.
Section 162
Limitations
Section 162(m) denies a deduction to any publicly-held
corporation for compensation paid to certain covered
employees in a taxable year to the extent that
compensation to such covered employee exceeds $1 million.
It is possible that compensation attributable to stock awards,
when combined with all other types of compensation received by a
covered employee from us, may cause this limitation to be
exceeded in any particular year. For purposes of
Section 162(m), the term covered employee means
our principal executive officer and our three highest
compensated officers as of the end of a taxable year as
disclosed in our filings with the SEC. Certain kinds of
compensation, including qualified performance-based
compensation, are disregarded for purposes of the
Section 162(m) deduction limitation. In accordance with
Treasury regulations issued under Section 162(m),
compensation attributable to certain stock awards will qualify
as performance-based compensation if the award is granted by a
committee of the Board of Directors consisting solely of
outside directors and the stock award is granted (or
exercisable) only upon the achievement (as certified in writing
by the committee) of an objective performance goal established
in writing by the committee while the outcome is substantially
uncertain, and the material terms of the plan under which the
award is granted is approved by shareholders. A stock option or
stock appreciation right may be considered
performance-based compensation as described in
previous sentence or by meeting the following requirements: the
incentive compensation plan contains a per-employee limitation
on the number of shares for which stock options and stock
appreciation rights may be granted during a specified period,
the material terms of the plan are approved by the shareholders,
and the exercise price of the option or right is no less than
the fair market value of the stock on the date of grant.
The regulations under Section 162(m) require that the
directors who serve as members of the committee must be
outside directors. The 1997 Plan provides that
directors serving on the committee must be outside
directors within the meaning of Section 162(m). This
limitation would exclude from the committee directors who are
(i) our current employees or those of one of our
affiliates, (ii) our former employees or those of one of
our affiliates who is receiving compensation for past services
(other than benefits under a tax-qualified pension plan),
(iii) our current and former officers or those of one of
our affiliates, (iv) directors currently receiving direct
or indirect remuneration from us or one of our affiliates in any
capacity other than as a director, and (v) any other person
who is not otherwise considered an outside director
for purposes of Section 162(m). The definition of an
outside director under Section 162(m) is
generally narrower than the definition of a non-employee
director under
Rule 16b-3
of the Exchange Act.
New Plan
Benefits
Benefits obtained by our employees under the 1997 Plan are made
on a discretionary basis by the Plan Administrator. Accordingly,
it is not possible to determine the benefits that will be
received by our executive officers and our other employees under
the 1997 Plan in 2008. As of November 9, 2007, no shares
had been issued under the 1997 Plan on the basis of the share
increase subject to this proposal.
19
Stock
Options and Restricted Stock
The table below shows, as to our Named Executive Officers (as
defined under Executive Officer Compensation below)
and the other individuals and groups indicated, the
(i) grants of restricted stock and (ii) number of
shares of common stock subject to option grants made under the
1997 Plan, for our 2007 fiscal year, together with the weighted
average exercise price payable per share in the case of the
stock options. In fiscal 2007, we have not granted any awards
under the 1997 Plan other than the awards listed below.
Plan
Benefits
1997
Stock Award Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock
|
|
|
Number of Shares
|
|
|
Weighted Average
|
|
Name and Position
|
|
Grants
|
|
|
Underlying Options(1)
|
|
|
Exercise Price
|
|
|
Frank J. Bellizzi
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter
|
|
|
50,000
|
|
|
|
100,000
|
|
|
$
|
2.58
|
|
Diane E. Klein
|
|
|
|
|
|
|
50,000
|
|
|
$
|
2.58
|
|
All Executive Officers as a Group(2)
|
|
|
275,000
|
|
|
|
500,000
|
|
|
$
|
2.41
|
|
All Non-Executive Directors as a Group(3)
|
|
|
|
|
|
|
180,000
|
|
|
$
|
2.53
|
|
All Non-Executive Officer Employees as a Group
|
|
|
|
|
|
|
491,026
|
|
|
$
|
2.55
|
|
|
|
|
(1)
|
|
This table does not include certain grants of options for a
total of 128,000 shares of common stock to ZILAs
medical and dental advisory boards and to consultants in fiscal
2007.
|
|
(2)
|
|
Includes grants of restricted stock and options for shares of
common stock to former executive officers.
|
|
(3)
|
|
Includes grants of options for shares of common stock to former
non-executive directors.
|
THE BOARD
OF DIRECTORS RECOMMENDS A VOTE
FOR THE ADOPTION OF THE AMENDEMENT TO
THE 1997 STOCK AWARD PLAN TO INCREASE THE
NUMBER OF AUTHORIZED SHARES TO EIGHT MILLION.
PROPOSAL THREE:
RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
|
|
|
General:
|
|
ZILA is asking the shareholders to ratify the Audit
Committees appointment of BDO Seidman, LLP as ZILAs
independent registered public accounting firm for the fiscal
year ending July 31, 2008. In the event the shareholders
fail to ratify the appointment, the Audit Committee will
reconsider this appointment. Even if the appointment is
ratified, the Audit Committee, in its discretion, may direct the
appointment of a different independent registered public
accounting firm at any time during the year if the Audit
Committee determines that such a change would be in ZILAs
and its shareholders best interests.
|
|
Annual Meeting:
|
|
BDO Seidman, LLP has been ZILAs independent registered
public accounting firm since November 12, 2004.
Representatives of BDO Seidman, LLP are expected to be present
at the meeting and will have the opportunity to make a statement
if they desire to do so. It is also expected that they will be
available to respond to appropriate questions. Shareholder
ratification of this selection of BDO Seidman, LLP as
ZILAs independent registered public accounting firm is not
required by the ZILAs Bylaws or otherwise. However, the
Board has elected to seek such ratification as a matter of good
corporate governance practice.
|
THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE
FOR
RATIFICATION OF THE APPOINTMENT OF BDO SEIDMAN, LLP AS
ZILAS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.
20
|
|
|
|
|
|
|
Name
|
|
Age
|
|
|
Position and Background
|
|
Frank J. Bellizzi
|
|
|
41
|
|
|
Dr. Bellizzi has served as ZILAs Executive Vice
President and as President of Zila Pharmaceuticals, Inc. since
May 2006. From March 2004 to July 2006, Dr. Bellizzi was
Managing Director of Indalo Ventures, a specialty advisory and
investment firm he founded to incubate and launch emerging, high
growth businesses. Before starting Indalo Ventures,
Dr. Bellizzi was Director of Crest Advisors, a firm
providing strategic advice to similar businesses, from January
2002 to February 2004. Dr. Bellizzi served as Chief
Financial Officer and Chief Operating Officer of Ten-TV, a media
software company, from May 1997 to December 2001.
Dr. Bellizzi has also held positions in private equity
investing and consulting firms, including Booz, Allen &
Hamilton and has been an independent consultant, advising the
American Hospital Association, Merck, Schering-Plough, the Czech
Republics Ministry of Health, and the United States
Department of Health & Human Services. Dr. Bellizzi
holds an MBA from The Wharton School at the University of
Pennsylvania, a Doctorate in Dental Medicine from The University
of Pennsylvania, and a Bachelor of Science degree from
Georgetown University.
|
|
|
|
|
|
|
|
Gary V. Klinefelter
|
|
|
59
|
|
|
Mr. Klinefelter has served as ZILAs Vice President and
General Counsel since December 2004. Mr. Klinefelter was
appointed ZILAs Secretary in October 2005. From
1988-2004, he was Secretary and General Counsel of AMERCO, a
holding company whose principal operating subsidiaries are
U-Haul International, Inc., Republic Western Insurance Company
and Oxford Life Insurance Company. Mr. Klinefelter is licensed
as an attorney in Arizona. On June 20, 2003, AMERCO filed a
voluntary petition for relief under Chapter 11 of the United
States Bankruptcy Code. On March 15, 2004, AMERCO emerged from
Chapter 11 with full payment to its creditors.
|
|
|
|
|
|
|
|
Diane E. Klein
|
|
|
59
|
|
|
Ms. Klein has served as ZILAs Vice President - Finance and
Treasurer (principal financial officer) since August 1, 2007 and
Vice President and Treasurer from June 2004 through July 2007.
Ms. Klein joined ZILA in August 2003 as Director of Finance. Ms.
Klein was Vice President-Finance for Bay Area Foods, Inc., a
privately held grocery chain, from 1998 to 2003. Prior to Bay
Area Foods, Ms. Klein held progressively responsible
financial/accounting positions at Southwest Supermarkets, LLC,
MegaFoods Stores, Inc. and the Circle K Corporation. She was
previously a senior manager in the audit practice of Arthur
Andersen & Co. in Phoenix, Arizona.
|
21
COMPENSATION
DISCUSSION AND ANALYSIS
The following compensation discussion and analysis
(CD&A) should be read in conjunction with the
Summary Compensation Table and related tables that
are presented elsewhere in this Proxy Statement.
The purpose of this CD&A is to provide information about
each material element of compensation that we pay or award to,
or that is earned by, our named executive officers and to
explain the numerical and related information contained in the
tables located below. For our 2007 fiscal year, our named
executive officers were:
|
|
|
|
|
Frank J. Bellizzi, our Executive Vice President and the
President of Zila Pharmaceuticals, Inc., our wholly-owned
subsidiary;
|
|
|
|
Gary V. Klinefelter, our Vice President, General Counsel and
Secretary; and
|
|
|
|
Diane E. Klein, our Vice President of Finance and Treasurer.
|
Douglas D. Burkett, our former Chief Executive Officer, Andrew
A. Stevens, our former Vice President and Chief Financial
Officer and Lawrence A. Gyenes, our former Chief Financial
Officer, are also named executive officers because each served
in their respective positions during our 2007 fiscal year.
The
Compensation Committee
The three members of the Compensation Committee are O.B. Parrish
(Chair), J. Steven Garrett and Leslie H. Green. ZILAs
Board has determined that Mr. Garrett and Ms. Green
are independent under NASDAQ Marketplace Rules.
Additional information regarding our Compensation Committee can
be found under the Board Committee heading in the
Board Information section of this Proxy Statement.
Role
of Executives in Determining Executive Compensation
In the past, the Compensation Committee acts on behalf of the
Board to establish ZILAs general compensation policies for
its executive officers. The Board determines whether the
Compensation Committee will make determinations as a committee
or will make recommendations to the Board. In fiscal 2007, the
Compensation Committee determined the compensation of the
ZILAs executive officers and delegated compensation
determinations for other employees to ZILAs former Chief
Executive Officer, Dr. Burkett. Beginning in fiscal 2008,
which generally coincided with the appointment of
Mr. Bethune as Executive Chairman, the Board determined it
would make all executive officer compensation decisions, based
upon recommendations of the Compensation Committee.
Significant
Compensation Events in Fiscal 2007
Each of Douglas D. Burkett, our former Chief Executive Officer,
Andrew A. Stevens, our former Vice President and Chief Financial
Officer, and Lawrence A. Gyenes, our former Chief Financial
Officer resigned during the 2007 fiscal year and received
certain severance payments and other benefits in connection with
each of their respective resignations. Please see the All
Other Compensation column in the Summary Compensation
Table for the severance payments made to these officers.
In addition, in December 2006, the Company agreed in principle
to changes in the compensation packages and related letter
agreements with each of Frank J. Bellizzi, Gary V. Klinefelter,
Diane E. Klein and Douglas D. Burkett, and entered into amended
letter agreements with Mr. Klinefelter and Ms. Klein.
Please see the Employment Agreement discussion below
the Summary Compensation Table for additional information on
these arrangements and agreements.
Significant
Compensation Events in Fiscal 2008
Subsequent to the end of our 2007 fiscal year, in connection
with the restructuring of our management team, David R. Bethune,
a member of our Board since 2005 and Chairman of our Board since
May 21, 2007, accepted an offer letter to become the
Executive Chairman of the Board. Please see the discussion
following the Director Compensation section below
for information on Mr. Bethunes compensation received
in fiscal 2007 as a director and received in fiscal 2008 in his
role as Executive Chairman.
22
In September 2007, as part of its annual equity grant process,
the Board issued options to purchase shares our common stock to
our named executive officers as follows:
(i) Mr. Bellizzi received 120,000 options to purchase
common stock, (ii) Mr. Klinefelter received 40,000
options to purchase common stock, and (iii) Ms. Klein
received 40,000 options to purchase common stock. The Board also
granted stock options to other executives and a significant
number of key employees. The Board was unable to fully implement
its long-term equity incentive plans for fiscal 2008 related to
these named executive officers and other executives because of
the lack of available authorized shares. In the event that
Proposal 2 is approved by ZILAs shareholders, and
ZILAs authorized shares are increased, the Board plans to
issue additional options to its named executive officers.
Compensation
Philosophy and Objectives
ZILA has developed a compensation program for executives and
employees designed to meet the following goals:
|
|
|
|
|
align compensation with the business objectives and performance
of ZILA, thereby promoting shareholder value;
|
|
|
|
reward performance and further the long-term interests of its
shareholders;
|
|
|
|
attract, motivate and retain executives and employees with
competitive compensation for ZILAs industry, its stage of
growth and the labor markets in which it operates;
|
|
|
|
build and encourage ownership of ZILAs shares; and
|
|
|
|
balance short-term and long-term strategic goals.
|
To meet these objectives, the Compensation Committee did utilize
competitive compensation data to implement the programs
discussed below.
In setting compensation for fiscal 2007, the Compensation
Committee reviewed companies similar to ZILA in terms of
industry (pharmaceutical, biotech/clinical trial phase III
companies, and dental companies), revenue and market
capitalization. While this market data is an important factor
considered by the Compensation Committee when setting
compensation, it is only one of multiple factors considered by
the Compensation Committee, including individual performance and
responsibilities, the executives ability to meet current
and future challenges and objectives, ZILAs expectation of
the executives contribution to its future success, and
ZILAs cash position.
ZILA engaged Pearl Meyer & Partners at the end of the
2006 fiscal year to review the competitiveness of cash
compensation and equity ownership levels for selected executive
and senior management positions, which included
Messrs. Bellizzi, Klinefelter and Ms. Klein.
ZILAs total cash compensation for its named executive
officers ranged below the
25
th
percentile
for its identified peer group, with Mr. Bellizzis
total cash compensation falling between the
25
th
and
50
th
percentiles.
The equity ownership of the named executive officers (as a
percentage of total shares outstanding) averaged between the
25
th
and
50
th
percentiles
when compared to its ZILAs identified peer group.
ZILAs peer group, as determined by Pearl Meyer, consisted
of the following companies:
|
|
|
|
|
Pharmaceutical Companies
|
|
Biotech or Phase III Companies
|
|
Dental Companies
|
|
Bentley Pharmaceuticals, Inc.
|
|
Accentia Biopharmaceuticals, Inc.
|
|
AFP Imaging Corporation
|
Bradley Pharmaceuticals, Inc.
|
|
ArQule, Inc.
|
|
Align Technology, Inc.
|
Collagenex Pharmaceuticals, Inc.
|
|
Barrier Therapeutics, Inc.
|
|
BioLase Technology, Inc.
|
Lannett Co., Inc.
|
|
Cell Genesys, Inc.
|
|
Lifecore Biomedical, Inc.
|
SciClone Pharmaceuticals, Inc.
|
|
GenVec
|
|
National Dentex Corporation
|
|
|
ImmunoGen, Inc.
|
|
Pro-Dex, Inc.
|
|
|
Micromet, Inc.
|
|
Schick Technologies, Inc.
|
|
|
Rigel Pharmaceuticals, Inc.
|
|
Young Innovations, Inc.
|
|
|
Valera Pharmaceuticals, Inc.
|
|
|
|
|
XOMA, Ltd.
|
|
|
23
Compensation
Programs Design and Discussion
ZILAs executive compensation program is composed of
cash-based compensation, in the form of base salaries and
discretionary bonuses, and equity-based compensation that
currently takes the form of stock option and restricted stock
grants. In addition, our named executive officers have the
opportunity to participate in our company-wide 401(k) plan and
our company-wide Employee Stock Purchase Plan (the
ESPP).
The table below lists each material element of our executive
compensation program, the compensation objective or objectives
that each element is designed to achieve and the characteristics
of each compensation element.
|
|
|
|
|
Element
|
|
Purpose
|
|
Characteristics
|
|
Base Salary
|
|
To attract and retain qualified executives; fixed rate of pay
for an individuals skills, experience and performance
|
|
Not at risk; normally eligible for annual merit increases and
adjustment for changes in job scope
|
Incentive Bonuses
|
|
To attract and retain qualified executives; to motivate and
reward achievement of annual ZILA goals
|
|
At risk; performance-based cash award; amount earned will vary
based on actual results achieved relative to target results
|
Equity Based Compensation
|
|
To align interests of executives with shareholders; to reward
stock price appreciation over time
|
|
Majority is performance-based; amount realized will depend upon
stock price performance.
|
Other Compensation
|
|
To attract and retain qualified executives
|
|
Not at risk; costs generally fixed
|
Change in Control (COC)
|
|
To attract and retain qualified executives; to provide
continuity of leadership team leading up to and after a change
in control
|
|
Contingent compensation; provides for continued employment upon
a COC and severance benefits if an executives employment
is terminated following a COC
|
During fiscal 2007 and the beginning of fiscal 2008, the Board
determined that given ZILAs current cash position and
operational goals and objectives for its business, the Board
would maintain base salaries for its management at their current
amounts and would not distribute cash bonuses to management for
fiscal 2007. The Board has instead focused on long-term equity
awards to incentivize its management, as evidenced by grants
provided to management in September 2007. The Board believes
that this approach further aligns managements interests
with ZILAs shareholders and is also consistent with
ZILAs current goals and objective.
Base
Salary
Base salary, which is designed to attract and retain qualified
executives, provides a fixed amount of cash to our named
executive officers. Base salaries for named executive officers
are generally determined on an individual basis by evaluating
each executives scope of responsibility, performance,
prior experience and salary history and are set forth in letter
agreements that allow for discretionary adjustment to base
salaries from time to time. In setting fiscal 2007 base
salaries, the Compensation Committee considered executive
compensation for the peer companies listed above, as these
companies are most likely to compete with us for the services of
our executives. As compared to our compensation peer group, we
target our named executive salaries to be in the
25th 50th percentile, although according to the
Pearl Meyer study (as discussed above) we were generally below
that range for all our named executive officers in fiscal 2007,
except Mr. Bellizzi.
24
2007
The approved fiscal 2007 salaries, as compared to fiscal 2006
salaries, include the following for our continuing named
executive officers:
|
|
|
|
|
Frank J. Bellizzi, Executive Vice President and President of
Zila Pharmaceuticals, Inc. $334,600 ($56,846 in
2006(1));
|
|
|
|
Gary V. Klinefelter, Vice President, General Counsel and
Secretary $236,062 ($216,062 in 2006); and
|
|
|
|
Diane E. Klein, Vice President of Finance and
Treasurer(2) $159,939 ($143,725 in 2006).
|
|
|
(1)
|
Mr. Bellizzi was appointed as President of Zila
Pharmaceuticals, Inc. and Executive Vice President of ZILA on
May 23, 2006. Fiscal 2006 compensation includes only that
portion actually paid in fiscal 2006. In fiscal 2006, Zila paid
consulting fees of $377,188 to Mr. Bellizzis
consulting practice, Indalo Ventures.
|
|
(2)
|
Effective August 1, 2007, Ms. Klein, the former Vice
President and Treasurer, was promoted to Vice President of
Finance and Treasurer and has assumed the duties of the
principal financial officer of the Company.
|
Douglas D. Burkett, our former Chief Executive Officer, was paid
a base salary of $347,524 in fiscal 2007, as compared to
$356,688 in fiscal 2006. Andrew A. Stevens, our former Vice
President and Chief Financial Officer, was paid a base salary of
$101,662 in fiscal 2007, as compared to $215,965 in fiscal 2006.
Lawrence A. Gyenes, our former Chief Financial Officer, was not
employed by ZILA during fiscal 2006 and was paid $113,308 in
base salary in fiscal 2007.
Incentive
Bonuses
As part of ZILAs compensation program, employees may be
eligible to participate in its Employee Incentive Bonus Plan
(the Bonus Plan). The parameters of the Bonus Plan
are set, in part, based on publicly available information from
comparable companies in our industry, as these companies are
most likely to compete with us for the services of our
executives. The Compensation Committee has historically viewed
cash incentive compensation as a means of closely tying a
portion of the total potential annual cash compensation for
executives to the financial performance of ZILA.
As described below, the letter agreements with each of
Mr. Bellizzi, Mr. Klinefelter and, formerly,
Mr. Gyenes, provide each with a maximum incentive bonus of
50% of base salary. The letter agreements for Ms. Klein,
Mr. Stevens and Mr. Burkett did not specify an
incentive bonus, but did provide that each is or was eligible to
participate in the Bonus Plan.
2007
In fiscal 2007, ZILAs executive officers were eligible for
cash bonuses for their performance to the extent that ZILA met
certain EBITDA (earnings before interest, taxes, depreciation
and amortization) and revenue growth targets at the corporate or
business unit level compared with the operating plan for that
year. In addition, performances were to be measured against the
achievement of certain specified corporate, division and
personal performance goals.
As discussed above, the Board determined to that it would not
award any cash bonus awards for fiscal 2007 in connection with
ZILAs efforts to direct its cash resources toward
activities in support of its operational goals and objectives.
However, on July 24, 2007, the Board approved a one-time
$20,000 cash bonus for Ms. Klein as a reward for her for
serving as the ZILAs Chief Financial Officer between
December 22, 2006 and March 12, 2007.
Equity-Based
Compensation
The purpose of the equity-based compensation component is to
instill the economic incentives of ownership in our named
executive officers and to create long-term incentives for
management to increase shareholder value. ZILA frequently uses
vesting periods in its awards to encourage executives to remain
with it and to focus on longer-term results.
25
Equity-based compensation is awarded pursuant to our 1997 Stock
Award Plan, as amended and restated, (the 1997
Plan), which is described in greater detail in
Proposal Two of this Proxy Statement. Although the 1997
Plan allows the Compensation Committee to make a variety of
awards, typically the Compensation Committee will award stock
options and shares of restricted stock under the 1997 Plan.
The Compensation Committee recommends, on a discretionary basis,
whether to grant stock options or restricted stock, as well as
the amount of shares of common stock subject to, and the terms
of, the grants. The Compensation Committee does not adhere to a
policy in recommending the mix between stock options and
restricted stock, but prefers a flexible approach to permit
awards to be tailored to the needs and motivations of each
recipient. In making these discretionary recommendations, the
Compensation Committee takes into account eligibility and
participation in the Bonus Plan and the executives
responsibilities and position. In addition, based on publicly
available information, the Compensation Committee considers
option grants by comparable companies in our industry, as these
companies are most likely to compete with ZILA for the services
of our executives. The Compensation Committee also seeks the
recommendation of senior management with respect to awards
granted to all employees.
Stock
Options
Stock options align executives interests with those of
shareholders, as options only have realizable value if the share
price of ZILA stock increases relative to the grant, or
exercise, price. The exercise price of options granted under the
1997 Plan is never less than the fair market value of
ZILAs common stock on the grant date.
Traditionally, in connection with the first Board meeting of the
fiscal year in September the Board makes grants of option awards
to ZILAs employees, including its named executive
officers. The grant date and exercise price of such option
awards are set as of the date of such Board meeting. Quarterly
grants are made if special circumstances demand and generally
coincide with the date of a regularly planned meeting, with
grant dates and exercise price set as of the date of such
meeting.
2007
In fiscal 2007, we granted to our named executive officers
options to purchase shares of ZILA common stock, as compared to
the number of options in fiscal 2006, as follows:
|
|
|
|
|
Frank J. Bellizzi, Executive Vice President and President of
Zila Pharmaceuticals, Inc. no options to purchase
shares of common stock in 2007 (500,000 in 2006(1));
|
|
|
|
Gary V. Klinefelter, Vice President, General Counsel and
Secretary options to purchase 100,000 shares of
common stock in 2007 (100,000 in 2006); and
|
|
|
|
Diane E. Klein, Vice President of Finance and
Treasurer options to purchase 50,000 shares of
common stock in 2007 (24,000 in 2006).
|
|
|
(1)
|
Mr. Bellizzi was appointed as President of Zila
Pharmaceuticals, Inc. and Executive Vice President of ZILA on
May 23, 2006.
|
Douglas D. Burkett, our former Chief Executive Officer, was
granted options to purchase 150,000 shares of common stock
in fiscal 2007, as compared to 100,000 options in fiscal 2006.
Andrew A. Stevens, our former Vice President and Chief Financial
Officer, was granted no options to purchase shares of common
stock in fiscal 2007, as compared to 50,000 options in fiscal
2006. Lawrence A. Gyenes, our former Chief Financial Officer,
was not employed by ZILA during fiscal 2006 and was granted
options to purchase 200,000 shares of common stock in
fiscal 2007. All of the 2007 and 2006 option grants were
forfeited by such executive officer in connection with their
departures.
Restricted
Stock
Restricted stock is granted to executives to facilitate
retention and, for newly hired executives, recruitment. The
restrictions on the restricted stock awards granted to
executives typically lapse periodically over the course of three
years. The restrictions generally provide that, unless the
Compensation Committee in its discretion determines
26
otherwise, during the term of the restrictions the shares may
not be sold or otherwise transferred, and the shares will be
immediately forfeited in the event of the executives
termination of employment for any reason other than death,
disability or retirement. The grant price of restricted stock
granted under the 1997 Plan is never less than the fair market
value of ZILAs common stock on the grant date.
2007
In fiscal 2007, we granted to our named executive officers
shares of restricted stock, as compared to the number of shares
of restricted stock in fiscal 2006, as follows:
|
|
|
|
|
Frank J. Bellizzi, Executive Vice President and President of
Zila Pharmaceuticals, Inc. 75,000 shares of
restricted common stock (none in 2006(1));
|
|
|
|
Gary V. Klinefelter, Vice President, General Counsel and
Secretary 50,000 shares of restricted common
stock (none in 2006); and
|
|
|
|
Diane E. Klein, Vice President of Finance and
Treasurer no shares of restricted common stock in
fiscal 2007 (none in 2006).
|
|
|
(1)
|
Mr. Bellizzi was appointed as President of Zila
Pharmaceuticals, Inc. and Executive Vice President of ZILA on
May 23, 2006.
|
Douglas D. Burkett, our former Chief Executive Officer, was
granted 100,000 shares of restricted common stock in fiscal
2007, as compared to none in fiscal 2006. Andrew A. Stevens, our
former Vice President and Chief Financial Officer, was granted
no shares of restricted common stock in fiscal 2007 and fiscal
2006. Lawrence A. Gyenes, our former Chief Financial Officer,
was not employed by ZILA during fiscal 2006 and was granted
50,000 shares of restricted common stock in fiscal 2007.
Other
Compensation
Our named executive officers also either participate or are
eligible to participate in our other benefit plans and programs
on the same terms as other employees, including a 401(k) plan,
the ESPP, medical and dental insurance, term life insurance,
short-term disability insurance, long-term disability insurance
and paid time-off plan.
Severance
and Change in Control Payments
We also provide certain of our named executive officers with
severance and change in control benefits. We believe these
arrangements are a fair reward for hard work and value creation,
assist us in retaining our named executive officers, and provide
incentives to our named executive officers to remain with us
during periods of uncertainty at the end of which such
executives may not be retained. Generally, the Compensation
Committee does not provide benefits if employment is terminated
for cause, death or disability or if employment is voluntarily
terminated by the named executive officer.
In general, severance payments, other than those made in
connection with a change in control, are only payable upon
termination of a named executive officer without cause because
the Compensation Committee does not believe named executive
officers should be rewarded for failing to perform their
respective jobs.
With respect to payments upon changes of control, the
Compensation Committee requires a double trigger
prior to any payment in that both a change in control and a
termination of employment must occur. The letter agreements for
Mr. Klinefelter and Ms. Klein establish a presumption
that a termination was because of a change in control if the
termination occurs within 18 months following the change in
control. Mr. Bellizzis agreement does not establish
any such presumption. Similar to severance payments made for
termination without cause, payments made following a termination
upon a change in control are only payable if the named executive
officer provides a release of claims to ZILA and the named
executive officer does not violate any other contractual
obligations to ZILA or solicit additional employees to leave
ZILA following the departure.
27
Please see the Employment Agreement discussion below
the Summary Compensation Table for additional information on
these arrangements and agreements.
Other
Compensation Policies and Considerations
Tax
Code Considerations
Section 162(m) of the Internal Revenue Code disallows a
corporate income tax deduction for executive compensation paid
to its chief executive officer or any of its four other highest
compensated covered employees in excess of
$1 million per year unless it is performance-based and is
paid under a plan satisfying the requirements of
Section 162(m). Qualifying performance-based compensation
is not subject to the deduction limit if certain requirements
are met. The Compensation Committee believes that the
compensation arrangements with ZILAs executive officers
will not exceed the limits on deductibility during the current
fiscal year. The Compensation Committee currently intends to
structure the performance-based portion of the compensation of
executive officers in a manner that complies with
Section 162(m).
Accounting
Considerations
The Board and Compensation Committee generally consider
accounting considerations related to forms and amounts of
compensation of our named executive officers, although this has
not typically been a significant factor in compensation
decisions for ZILA.
SUMMARY
COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-
|
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name and Principal Position
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)
|
|
|
($)(4)
|
|
|
($)
|
|
|
($)
|
|
|
Frank J. Bellizzi,
|
|
|
2007
|
|
|
|
334,600
|
|
|
|
|
|
|
|
101,786
|
|
|
|
319,355
|
|
|
|
|
|
|
|
|
|
|
|
31,116
|
(5)
|
|
|
786,857
|
|
Executive Vice President and President of Zila Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter,
|
|
|
2007
|
|
|
|
236,062
|
|
|
|
|
|
|
|
67,859
|
|
|
|
163,350
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
467,271
|
|
Vice President, General Counsel and Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diane E. Klein,
|
|
|
2007
|
|
|
|
159,939
|
|
|
|
27,000
|
(3)
|
|
|
|
|
|
|
62,197
|
|
|
|
|
|
|
|
|
|
|
|
5,008
|
(6)
|
|
|
254,144
|
|
Vice President of Finance and Treasurer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Former Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas D. Burkett,
|
|
|
2007
|
|
|
|
347,524
|
|
|
|
|
|
|
|
258,000
|
|
|
|
207,837
|
|
|
|
|
|
|
|
|
|
|
|
90,000
|
(7)
|
|
|
903,361
|
|
former Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andrew A. Stevens,
|
|
|
2007
|
|
|
|
101,662
|
|
|
|
|
|
|
|
|
|
|
|
37,944
|
|
|
|
|
|
|
|
|
|
|
|
107,549
|
(8)
|
|
|
247,155
|
|
former Vice President and Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence A. Gyenes,
|
|
|
2007
|
|
|
|
113,308
|
|
|
|
25,000
|
(4)
|
|
|
108,000
|
|
|
|
32,653.61
|
|
|
|
|
|
|
|
|
|
|
|
170,552
|
(9)
|
|
|
449,514
|
|
former Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
The amounts reflect the dollar amount recognized for financial
statement reporting purposes for the fiscal year ended
July 31, 2007, in accordance with Financial Accounting
Standards Board Statement 123(R), or SFAS No. 123(R), of
restricted stock awards issued pursuant to the 1997 Stock Award
Plan (i.e., grant date fair value amortized over the requisite
service period, but disregarding any estimate of forfeitures
relating to service based vesting conditions). For restricted
stock awards, fair value is calculated using the closing price
on the grant date
|
28
|
|
|
|
|
as if these awards were vested and issued on the grant date.
These amounts reflect ZILAs accounting expense for these
awards, and do not correspond to the actual value that may be
recognized by the named executive officers.
|
|
(2)
|
|
The amounts reflect the dollar amount recognized for financial
statement reporting purposes for the fiscal year ended
July 31, 2007, in accordance with SFAS No. 123(R)
of stock option awards issued pursuant to the 1997 Stock Award
Plan (i.e., grant date fair value amortized over the requisite
service period, but disregarding any estimate of forfeitures
relating to service based vesting conditions) and predecessor
stock option plans and thus includes amounts from outstanding
stock option awards granted during and prior to fiscal 2007.
Assumptions used in the calculation of these amounts are
included in the notes to ZILAs audited consolidated
financial statements for the fiscal year ended July 31,
2007.
|
|
(3)
|
|
Represents discretionary bonuses paid to Ms. Klein for
services rendered during fiscal 2007. In July 2007,
Ms. Klein received $20,000 for serving as interim Chief
Financial Officer between December 2006 and March 2007. In
December 2006, Ms. Klein received a $7,000 discretionary
bonus related to performance of her duties.
|
|
(4)
|
|
Represents bonus paid to Mr. Gyenes under this employment
agreement dated March 12, 2007.
|
|
(5)
|
|
Represents relocation costs of $30,086 paid to Mr. Bellizzi
under his employment agreement dated May 22, 2006 and
matching contributions totaling $1,030 that ZILA made to its
401(k) plan during fiscal 2007.
|
|
(6)
|
|
Represents matching contributions that ZILA made to its 401(k)
plan during fiscal 2007.
|
|
(7)
|
|
Represents severance paid to Mr. Burkett under his
separation agreement dated June 13, 2007.
|
|
(8)
|
|
Represents severance payments of $104,000 paid to
Mr. Stevens under his separation agreement dated
December 22, 2006 and matching contributions totaling
$3,549 that ZILA made to its 401(k) plan during fiscal 2007.
|
|
(9)
|
|
Represents relocation payments of $19,552 paid to
Mr. Gyenes under this employment agreement dated
March 12, 2007, and severance of $151,000 paid under his
severance agreement dated July 31, 2007.
|
Named
Executive Officers
Frank
J. Bellizzi
We entered into a letter agreement, effective as of May 22,
2006, with Frank J. Bellizzi setting forth the terms of his
employment as President of Zila Pharmaceuticals, Inc. and
Executive Vice President of ZILA. The agreement provides for an
initial annual base salary of $325,000 and an automobile
allowance of $800 per month, in addition to various other
customary benefits. It provides for an initial grant of options
to purchase 500,000 shares of common stock, vesting in
thirteen equal amounts, with the first tranche vesting on
Mr. Bellizzis start date and the remaining tranches
vesting on a quarterly basis thereafter. The letter agreement
does not obligate us to employ Mr. Bellizzi for any period
of time, but provides for severance payments in connection with
an actual or constructive termination without cause, or upon a
change in control, equal to the greater of $650,000 or two years
of base salary at the time of the triggering event, if certain
other conditions are satisfied.
Gary
V. Klinefelter
We entered into a letter agreement, effective as of
December 15, 2004, with Gary V. Klinefelter setting forth
the terms of his employment as Vice President and General
Counsel. The agreement provides for an initial annual base
salary of $200,000 and an automobile allowance of $800 per
month. It also provides for an initial grant of options to
purchase 100,000 shares of common stock, vesting in two
equal increments on the second and third anniversary of the
grant. Also included was an additional grant of options to
purchase 50,000 shares of common stock on the first
anniversary of the date of hire, with such options vesting
equally on the first, second and third anniversary of the grant.
The letter agreement does not obligate us to employ
Mr. Klinefelter for any period of time, but provides for
severance payments equivalent to his then-current base salary
for (i) twelve months in the event of a change in control
and (ii) six months under certain other circumstances. In
connection with the execution of the letter agreement,
Mr. Klinefelter received a $25,000 signing bonus.
29
On December 14, 2006, the Compensation Committee approved
changes to Mr. Klinefelters letter agreement,
increasing his base salary, effective January 1, 2007, to
$240,000 and providing Mr. Klinefelter with a severance
payment equal to two years base salary plus bonuses if
Mr. Klinefelter is terminated upon a change in control of
ZILA. Any such severance payment will be in the form of a lump
sum on the six-month anniversary of termination of employment.
These arrangements were memorialized in an amended letter
agreement on March 30, 2007. For additional information
regarding severance and change in control payments that could
become due to Mr. Klinefelter, please see the
Severance and Change in Control Payments section
below and in the Compensation Programs Design and
Discussion section above.
Diane
E. Klein
We entered into a letter agreement, effective as of
March 4, 2005, with Diane E. Klein setting forth the terms
of her employment as Vice President and Treasurer. The agreement
does not provide for an annual base salary. The letter agreement
provides that Ms. Klein is eligible for future awards of
stock options. The letter agreement does not obligate us to
employ Ms. Klein for any period of time, but provides for
severance payments equivalent to her then-current base salary
for (i) twelve months in the event of a change in control
and (ii) six months under certain other circumstances.
On December 14, 2006, the Compensation Committee granted to
Mr. Klein a cash bonus award of $7,000 and increased her
then current annual base salary to $160,000, effective
January 1, 2007. In addition, the Compensation Committee
approved changes to Ms. Kleins letter agreement,
providing her with a severance payment equal to 18 months
base salary plus bonuses if Ms. Klein is terminated upon a
change in control of ZILA. Any such severance payment will be in
the form of a lump sum on the six-month anniversary of
termination of employment. These arrangements were memorialized
in an amended letter agreement on March 30, 2007. Effective
August 1, 2007, Diane E. Klein, Vice President and
Treasurer, was promoted to Vice President of Finance and
Treasurer and has assumed the duties of the principal financial
officer of the Company. On September 27, 2007, the Board
approved an increase in annual base salary for Ms. Klein
from $160,000 to $185,000 related to the assumption of duties as
the ZILAs principal financial officer. For additional
information regarding severance and change in control payments
that could become due to Ms. Klein, please see the
Severance and Change in Control Payments section
below and in the Compensation Programs Design and
Discussion section above.
Former
Executives that are Named Executive Officers
Douglas
D. Burkett
Employment
Agreement
We entered into an employment agreement, effective as of
July 24, 2002, with Douglas D. Burkett, Ph.D.,
pursuant to which Dr. Burkett was employed as our President
and Chief Executive Officer. Pursuant to Board approval,
effective October 21, 2003, we amended
Dr. Burketts employment agreement to: (i) extend
the term of the agreement from January 24, 2004 to
October 20, 2008; (ii) increase his annual base salary
to $310,000; (iii) provide a severance payment of two times
his annual base salary if his employment is terminated other
than for cause; and (iv) provide for a payment of the
balance of the annual base salary due to him for the remaining
term of the agreement, but not less than two years of such
salary, if a change in control and termination other than for
cause occurs, as those terms are defined in the employment
agreements. Effective October 2, 2005
Dr. Burketts base salary was increased to $350,000.
Dr. Burkett was eligible to participate in any of our
applicable bonus plans or programs or stock option plans or
programs. As a result, he was eligible for a performance bonus
of up to 100% of his annual base salary as determined by the
Board or its Compensation Committee at the end of each fiscal
year. In addition to his base salary, Dr. Burkett also
received an automobile allowance of $950 per month,
reimbursement of certain financial, tax and estate planning
expenses up to $5,000 annually and other benefits, including
those generally provided to our other employees.
Severance
Agreement
On June 13, 2007, ZILA accepted the resignation of
Dr. Burkett from his positions as ZILAs President and
Chief Executive Officer and as a member of the Board and entered
into a severance agreement and release of claims
30
with Dr. Burkett. Under the severance agreement,
Dr. Burkett provided a general release of claims against
ZILA and ZILA agreed to pay to Dr. Burkett a $90,000
severance payment, payable in installments on regular Company
paydays, net of applicable withholding, and COBRA coverage for
six months following resignation. All of Dr. Burketts
vested and unvested options to purchase shares of ZILA common
stock terminated upon resignation; provided, however, that
200,000 options that vested prior to the resignation and that
are exercisable at $0.76 per share survived resignation and
remain exercisable for two years. Dr. Burkett was also
permitted to retain 100,000 shares of restricted stock
previously awarded to him.
The severance agreement also contained other customary
provisions, including mutual non-disparagement and cooperation
covenants and a limited release by ZILA of claims it may have
against Dr. Burkett.
Andrew
A. Stevens
Employment
Agreement
We entered into a letter agreement, effective as of
January 22, 2004 and as amended on March 4, 2005, with
Andrew A. Stevens setting forth the terms of his employment as
Vice President and Chief Financial Officer, and at that time,
Treasurer and Secretary. Effective December 22, 2006,
Mr. Stevens resigned from his employment with ZILA.
The agreement provided for an annual base salary of $190,000 and
an automobile allowance of $800 per month. In connection with
the execution of the letter agreement, Mr. Stevens received
a $5,000 signing bonus and an initial grant of options to
purchase 100,000 shares of common stock, vesting in three
equal increments on the first, second and third anniversary of
the grant.
Also included was an additional grant of options to purchase
50,000 shares of common stock on the first anniversary of
the date of hire, with such options also vesting equally on the
first, second and third anniversary of the grant. Effective
October 2, 2005 Mr. Stevens base salary was
increased to $208,000. The agreement did not obligate us to
employ Mr. Stevens for any period of time, but provides for
severance payments equivalent to his then-current base salary
for (i) twelve months in the event of a change in control
and (ii) six months under certain other circumstances.
Separation
Agreement
On December 22, 2006, ZILA accepted the resignation of
Mr. Stevens from his position as ZILAs Vice President
and Chief Financial Officer and entered into a severance
agreement with Mr. Stevens. Under the severance agreement,
ZILA agreed to pay to Mr. Stevens a $104,000 severance
payment, payable in installments on regular company paydays, net
of applicable withholding, and COBRA coverage for six months
following resignation.
Lawrence
A. Gyenes
Offer
Letter
Lawrence A. Gyenes accepted an offer letter from ZILA on
March 7, 2007 to become ZILAs Chief Financial
Officer. Under the offer letter, Mr. Gyenes was entitled to
receive a base salary of $300,000 per year, a one-time $25,000
cash bonus, a performance bonus of up to 50% of his base salary
under ZILAs Bonus Plan and an auto allowance, insurance,
and other benefits consistent with his position as a member of
ZILAs executive management. The offer letter also provided
Mr. Gyenes with (i) options to purchase
200,000 shares of ZILAs common stock under the 1997
Plan, which options were to vest in three equal installments on
the first, second, and third anniversaries of the date on which
Mr. Gyenes begins employment with ZILA,
(ii) additional stock option grants based on individual
performance or as commensurate with grants to other executive
management members, and (iii) a grant of 50,000 shares
of restricted stock, the restrictions on which were to be
removed in equal amounts on the first, second, and third
anniversaries of the date on which Mr. Gyenes begins
employment with ZILA.
Mr. Gyenes also received (i) reasonable out-of-pocket
expenses for trips by Mr. Gyenes or Mr. Gyenes
fiancée from New Jersey to Arizona to transition living
arrangements not to exceed $10,000, (ii) actual costs for
31
professional transportation of belongings from New Jersey to
Arizona, (iii) reasonable out-of-pocket expenses relating
to transportation for Mr. Gyenes and his fiancée from
New Jersey to Arizona, (iv) temporary housing in Phoenix
for up to six months at a maximum of $3,000 per month and
(v) realtor and other closing fees relating to the sale of
Mr. Gyenes home in New Jersey and the purchase of a
home in Arizona not to exceed $50,000. These relocation benefits
must be repaid on a sliding scale by Mr. Gyenes if he
voluntarily terminates his employment with Zila prior to
24 months following the date on which he started his
employment with Zila.
Under the offer letter, and provided that Mr. Gyenes
provides ZILA with a written release of liability,
Mr. Gyenes was also entitled to severance payments if his
employment was terminated because of a change in control or
without cause. If Mr. Gyenes was terminated following a
change in control, he would have been entitled to 18 months
of salary and an amount equal to the maximum cash bonus to which
Mr. Gyenes would have been entitled in the 18 months
following his termination. If Mr. Gyenes was terminated
without cause, he would have been entitled to 18 months
salary. In either case, all options held by Mr. Gyenes
would immediately vest and all restrictions on any restricted
stock held by Mr. Gyenes would lift upon his termination.
Mr. Gyenes rights to these severance payments will
immediately cease if he breaches any contractual obligations he
owes to ZILA or if he breaches standard non-competition and
non-solicitation obligations.
The offer letter was to be effective for three years and renewed
automatically for one year terms at the end of the initial three
year term unless ZILA provided written notice 120 days
prior to any such anniversary of its intent to not extend the
offer letter.
Severance
Agreement
Mr. Gyenes resigned from his employment with ZILA effective
July 31, 2007. In connection with Mr. Gyenes
resignation, on July 30, 2007, ZILA entered into a
severance agreement and release with Mr. Gyenes that
provided for, among other things, the following: (i) ZILA
will pay $150,000, less applicable withholdings, to
Mr. Gyenes over a period of six months according to
ZILAs regular payroll schedule; (ii) ZILA will pay
for COBRA coverage for Mr. Gyenes for 12 months
following resignation; (iii) ZILA will pay the expense of
moving Mr. Gyenes personal property to New Jersey and
reimburse Mr. Gyenes for all relocation expenses properly
submitted for his move to Arizona; (iv) all restrictions on
a prior grant of 50,000 shares of restricted stock will be
lifted and a stock certificate for such shares, less the number
of shares required for applicable withholdings, will be issued
to Mr. Gyenes and (v) Mr. Gyenes offer
letter was terminated. The severance agreement also contained
other customary provisions, including non-disparagement and
cooperation covenants and a mutual release of claims.
32
GRANTS
OF PLAN-BASED AWARDS
The following table sets forth information regarding grants of
plan-based awards made during the year ended July 31, 2007
to the named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
All
|
|
|
|
|
|
Grant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Other
|
|
|
|
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Option
|
|
|
|
|
|
Fair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated Future
|
|
|
Number
|
|
|
Awards:
|
|
|
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payouts Under
|
|
|
of
|
|
|
Number of
|
|
|
Exercise
|
|
|
of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Incentive
|
|
|
Shares
|
|
|
Shares
|
|
|
Price
|
|
|
Option
|
|
|
|
|
|
|
Committee
|
|
|
Estimated Future Payouts Under Non Equity Incentive Plan
Awards(1)
|
|
|
Plan Awards
|
|
|
of Stock
|
|
|
of Stock
|
|
|
of
|
|
|
or
|
|
|
|
Grant
|
|
|
Approval
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
Threshold
|
|
|
Target
|
|
|
Maximum
|
|
|
or Units
|
|
|
or Units
|
|
|
Option
|
|
|
Stock
|
|
Name and Principal Position
|
|
Date
|
|
|
Date
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)
|
|
|
(#)(2)
|
|
|
(#)(3)
|
|
|
Award
|
|
|
Awards
|
|
|
Frank J. Bellizzi,
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
|
|
|
|
|
|
|
$
|
193,500
|
|
Executive Vice President and President of Zila Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter,
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
$
|
129,000
|
|
Vice President, General Counsel and Secretary
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
$
|
2.58
|
|
|
$
|
167,000
|
|
Diane E. Klein,
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
$
|
2.58
|
|
|
$
|
83,500
|
|
Vice President of Finance and Treasurer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Former Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas D. Burkett,
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
$
|
258,000
|
|
former Chief Executive Officer
|
|
|
12/14/06
|
|
|
|
12/14/06
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
$
|
2.58
|
|
|
$
|
250,500
|
|
Andrew A. Stevens,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
|
|
former Vice President and Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence A. Gyenes,
|
|
|
3/12/07
|
|
|
|
3/12/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
$
|
108,000
|
|
former Chief Financial Officer
|
|
|
3/12/07
|
|
|
|
3/12/07
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
$
|
2.16
|
|
|
$
|
254,000
|
|
|
|
|
(1)
|
|
As discussed in our Compensation Discussion and
Analysis, the Board determined to that it would not award
any cash bonus awards for fiscal 2007 in connection with
ZILAs efforts to direct its cash resources toward
activities in support of ZILAs operational goals and
objectives.
|
|
(2)
|
|
The restricted stock grants for Messrs. Bellizzi and
Klinefelter vest in equal shares on January 1 in 2007, 2008 and
2009, subject to vesting conditions. All awards in the column
were granted under the 1997 Stock Award Plan, as amended.
|
|
(3)
|
|
The option grants to Mr. Klinefelter and Ms. Klein
vest in equal shares on January 1 in 2007, 2008 and 2009 and
expire ten years from the date of grant. The option grants to
Messrs. Burkett and Gyenes terminated upon their separation
from ZILA as described above. All awards in the column were
granted under the 1997 Stock Award Plan, as amended.
|
33
OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END
The following table sets forth information regarding outstanding
equity awards at July 31, 2007 for the named executive
officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Plan Awards:
|
|
|
|
Number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Market
|
|
|
|
of
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Market Value
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
|
|
|
|
|
|
Units of
|
|
|
of Shares or
|
|
|
Share or
|
|
|
Shares or
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Option
|
|
|
|
|
|
Stock That
|
|
|
Units of Stock
|
|
|
Units That
|
|
|
Units That
|
|
|
|
Options
|
|
|
Options
|
|
|
Exercise
|
|
|
Option
|
|
|
Have Not
|
|
|
That Have
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
Price
|
|
|
Expiration
|
|
|
Vested
|
|
|
Not Vested
|
|
|
Vested
|
|
|
Vested
|
|
Name and Principal Position
|
|
(#)
|
|
|
(#)
|
|
|
($)
|
|
|
Date
|
|
|
(#)(11)
|
|
|
($)(12)
|
|
|
(#)
|
|
|
($)
|
|
|
Frank J. Bellizzi,
|
|
|
192,308
|
|
|
|
307,692
|
|
|
|
3.41
|
|
|
|
5/23/16
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Vice President and President of Zila Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
65,000
|
(10)
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter,
|
|
|
100,000
|
|
|
|
|
|
|
|
4.43
|
|
|
|
12/16/14
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vice President, General Counsel and
|
|
|
16,667
|
|
|
|
33,333
|
|
|
|
3.74
|
|
|
|
9/8/15
|
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Secretary
|
|
|
16,667
|
|
|
|
33,333
|
|
|
|
3.69
|
|
|
|
12/15/15
|
(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,334
|
|
|
|
66,666
|
|
|
|
2.58
|
|
|
|
12/14/16
|
(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diane E. Klein,
|
|
|
60,000
|
|
|
|
|
|
|
|
5.03
|
|
|
|
6/3/14
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vice President of Finance and
|
|
|
8,000
|
|
|
|
16,000
|
|
|
|
3.74
|
|
|
|
9/8/15
|
(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Treasurer
|
|
|
16,667
|
|
|
|
33,333
|
|
|
|
2.58
|
|
|
|
12/14/16
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33,334
|
|
|
|
43,334
|
(10)
|
|
|
|
|
|
|
|
|
Former Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas D. Burkett,
|
|
|
200,000
|
|
|
|
|
|
|
|
0.76
|
|
|
|
6/13/09
|
(9)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
former Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andrew A. Stevens,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
former Vice President and Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence A. Gyenes,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
former Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Granted on May 23, 2006 and vests quarterly in equal
increments from May 23, 2006 to May 23, 2009
|
|
(2)
|
|
Granted on December 14, 2004 and fully vested on
April 29, 2005.
|
|
(3)
|
|
Granted on September 8, 2005 and vests in three equal
annual increments starting September 8, 2006.
|
|
(4)
|
|
Granted on December 15, 2005 and vests in three equal
annual increments starting on December 15, 2006.
|
|
(5)
|
|
Granted on December 14, 2006 and vests in three equal
increments starting on January 1, 2007.
|
|
(6)
|
|
Granted on June 3, 2004 and vested on April 29, 2005.
|
|
(7)
|
|
Granted on September 8, 2005 and vests in three equal
annual increments starting on September 8, 2006.
|
|
(8)
|
|
Granted on December 14, 2006 and vests in three equal
increments January 1, 2007, January 1, 2008 and
January 1, 2009.
|
|
(9)
|
|
Granted on July 24, 2002 and vested in three equal
increments on July 24, 2002, July 24, 2003 and
July 24, 2004.
|
|
(10)
|
|
Restricted stock granted on December 14, 2006 and vests in
three equal increments January 1, 2007, January 1,
2008 and January 1, 2009.
|
|
(11)
|
|
Amounts represent the unvested portion of restricted common
stock granted on December 14, 2006.
|
|
(12)
|
|
The market value of unvested restricted common stock is
calculated by multiplying the closing stock price at
July 31, 2007 ($1.30 per share) by the number of shares of
restricted stock listed above.
|
34
OPTION
EXERCISES AND STOCK VESTED
The following table sets forth information with respect to
shares of ZILA common stock acquired through exercises of stock
options and vesting of restricted shares and the number of
shares acquired and value realized on exercise or vesting by the
named executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
Option Awards
|
|
|
Number of
|
|
|
Value
|
|
|
|
Number of Shares
|
|
|
|
|
|
Shares
|
|
|
Realized on
|
|
|
|
Acquired on
|
|
|
Value Realized on
|
|
|
Acquired
|
|
|
Vesting
|
|
Name and Principal Position
|
|
Exercise (#)
|
|
|
Exercise ($)
|
|
|
on Vesting (#)
|
|
|
($)(1)
|
|
|
Frank J. Bellizzi,
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
62,500
|
|
Executive Vice President and President of Zila Pharmaceuticals,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gary V. Klinefelter,
|
|
|
|
|
|
|
|
|
|
|
16,666
|
|
|
|
41,665
|
|
Vice President, General Counsel and Secretary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diane E. Klein,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vice President of Finance and Treasurer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Former Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas D. Burkett,
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
184,667
|
|
former Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Andrew A. Stevens,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
former Vice President and Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lawrence A. Gyenes,
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
65,000
|
|
former Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
If the officer executed an exercise and hold transaction, the
value realized equals the difference between the per share base
price of the restricted stock and the fair market value of a
share of our common stock on such date of exercise, multiplied
by the number of shares of restricted stock exercised. If the
officer executed a
same-day-sale
transaction, the value realized equals the difference between
the per share base price of the restricted stock and the per
share sale price upon sale, multiplied by the number of shares
of restricted stock sold. Certain shares of each officer were
repurchased by ZILA to pay for taxes attributable to the vested
shares.
|
SEVERANCE
AND CHANGE IN CONTROL PAYMENTS
As discussed elsewhere in this Proxy Statement, we have letter
agreements with certain of our current named executive officers
that provide severance benefits to the named executive officers
upon termination following a change in control or without cause.
In the table below, we summarize the estimated payments that
will be made to each of our current named executive officers
upon a termination of employment without cause or in connection
with a change in control of ZILA. The major assumptions that we
used in creating the table are set forth directly below. The
table includes an estimate of the compensation that would accrue
for each executive if the triggering event occurred on
July 31, 2007 (ZILAs fiscal year-end) and, unless
otherwise noted, is based on each executives compensation
on that date. Calculations requiring a per share stock price are
made on the basis of the closing price of $1.30 per share of our
common stock on the NASDAQ Global Market on July 31, 2007.
Change in
Control
No cash payment will be made solely because of a Change in
Control. For each current named executive officer, the
cash payments described under the table heading Change in
Control will be triggered upon a termination in connection
with a Change in Control. Cash payments described
under the table heading Without Cause will be
triggered upon a termination without cause as further described
below in Terms of Officer Agreements.
35
Acceleration
upon a Change in Control
Under the 1997 Plan, all outstanding options accelerate upon a
Change in Control, as defined in such plan, if the
option holder is employed by us on the date of the Change
in Control. However, the exercise price for all such
options that would be accelerated for the current named
executive officers is higher than the closing price of our
common stock at July 31, 2007 ($1.30), so our named
executive officers would derive no intrinsic value from the
acceleration of these unvested option awards. Accordingly, for
purposes of the table, we have assumed no value for all
outstanding options accelerated on a Change in Control.
For purpose of the Restricted Stock Award column, we
have assumed the acceleration of the restricted stock awards for
Messrs. Bellizzi and Klinefelter upon a Change in
Control as defined in the 1997 Plan. However, only
Mr. Klinefelters letter agreement provides for
acceleration of restricted stock upon a termination
Without Cause.
Medical
and Other Benefits
The table below does not discuss certain medical, disability or
outplacement services benefits that may be payable on
termination to our current named executive officers. We also do
not include any amounts payable on termination that are
generally available to all employees on a non-discriminatory
basis. In addition, this table does not include specific
treatment of a normal retirement.
Terms of
Officer Agreements
Pursuant to the terms of his letter agreement, Mr. Bellizzi
is entitled to his severance payments if ZILA actually or
constructively terminates his employment without
Cause. For purposes of his agreement,
constructive termination is deemed to have occurred
in the event of a material diminution of compensation or job
responsibilities. Cause means (i) a failure to
correct a specific conduct or job-performance issue or issues
about which Mr. Bellizzi has been informed in writing and
been given an opportunity to correct; or (ii) conduct or
job performance that ZILA believes is sufficiently willful
and/or
egregious for which providing written notice and an opportunity
to correct is an inadvisable business practice, or (iii) an
inability to perform the job (e.g., due to incapacity or death).
If Mr. Bellizzis employment is terminated for any
other reason, including, without limitation, because of a change
in control of ZILA, such termination will be deemed without
Cause.
Mr. Klinefelter and Ms. Klein are entitled to
severance payments upon a termination in connection with either
a change in control event or a termination Without
Cause. For purposes of their letter agreements,
Change in Control is defined and governed by the
definition of change in control contained in the
1997 Plan. By the terms of their letter agreements, if
Mr. Klinefelter or Ms. Klein are terminated within
eighteen (18) months of a Change in Control,
there is a rebuttable presumption that such termination was as a
result of such Change in Control. Without
Cause means (i) a failure to correct a specific
conduct or job-performance issue or issues about which he or she
has been informed in writing and been given an opportunity to
correct; or (ii) conduct or job performance that ZILA
believes is sufficiently willful
and/or
egregious for which providing written notice and an opportunity
to correct is an inadvisable business practice, or (iii) an
inability to perform the job (e.g., due to incapacity or death).
If Mr. Klinefelters or Ms. Kleins
employment is terminated for any other reason, (with the
exception of a Change in Control) such termination will be
deemed Without Cause.
36
In addition, our severance benefits are subject to the current
named executive officers signing a general release acceptable to
ZILA in order for such severance benefits to take effect.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Triggering
|
|
|
Severance
|
|
|
Restricted Stock
|
|
|
Potential/Total
|
|
Name and Title
|
|
Event
|
|
|
Payments ($)
|
|
|
Awards ($)
|
|
|
Value ($)
|
|
|
Frank J. Bellizzi,
|
|
|
Change in Control
|
|
|
|
650,000
|
(1)
|
|
|
65,000
|
(6)
|
|
|
715,000
|
|
Executive Vice President of Zila, Inc. and President of Zila
Pharmaceuticals, Inc.
|
|
|
Without Cause
|
|
|
|
650,000
|
(1)
|
|
|
|
|
|
|
650,000
|
|
Gary V. Klinefelter,
|
|
|
Change in Control
|
|
|
|
480,000
|
(2)
|
|
|
43,334
|
(7)
|
|
|
523,334
|
|
Vice President, General Counsel and Secretary
|
|
|
Without Cause
|
|
|
|
480,000
|
(3)
|
|
|
43,334
|
(7)
|
|
|
523,334
|
|
Diane E. Klein,
|
|
|
Change in Control
|
|
|
|
277,500
|
(4)
|
|
|
|
|
|
|
277,500
|
|
Vice President of Finance and Treasurer
|
|
|
Without Cause
|
|
|
|
277,500
|
(5)
|
|
|
|
|
|
|
277,500
|
|
|
|
|
(1)
|
|
Mr. Bellizzis severance pay would be an amount equal
to the greater of $650,000 or two years current base salary at
the time of the triggering event, less applicable withholdings.
Mr. Bellizzis base salary as of July 31, 2007
was $325,000, which is also his current base salary.
|
|
(2)
|
|
Mr. Klinefelters severance pay upon a change in
control is (i) an amount equal to twenty-four months of his
annual base salary at the time of the triggering event, and
(ii) an amount equivalent to the maximum cash bonus(es) for
which he would have been eligible, during the 2 year period
following the termination of his employment had his employment
not terminated, under any employee bonus plan in effect upon the
date of termination. Mr. Klinefelters base salary as
of July 31, 2007 was $240,000, which is also his current
base salary. Mr. Klinefelter has not received any cash
bonus awards for the past two fiscal years so the amount
reflected does not contemplate a cash bonus figure. For more
discussion on the Boards decisions to refrain from paying
cash bonus awards see Compensation Discussion and
Analysis.
|
|
(3)
|
|
Mr. Klinefelters severance pay upon a termination
Without Cause is an amount equal to twenty-four
months of his annual base salary in effect on the date of his
termination. Mr. Klinefelters base salary as of
July 31, 2007 was $240,000, which is also his current base
salary.
|
|
(4)
|
|
Ms. Kleins severance pay upon a change in control is
(i) an amount equal to eighteen months of her annual base
salary at the time of the triggering event, and (ii) an
amount equivalent to the maximum cash bonus(es) for which she
would have been eligible, during the eighteen-month period
following the termination of her employment had her employment
not terminated, under any employee bonus plan in effect upon the
date of termination. For purposes of this table,
Ms. Kleins current base salary of $185,000 was used
since her base salary increased after July 31, 2007.
Although Ms. Klein did receive some discretionary bonuses
in connection with her recent promotions, she has not received
any cash bonus awards for the past two fiscal years pursuant to
an employee bonus plan, so the amount reflected does not
contemplate a cash bonus figure. For more discussion on the
Boards decisions to refrain from paying cash bonus awards
see Compensation Discussion and Analysis.
|
|
(5)
|
|
Ms Kleins severance pay upon a termination Without
Cause is an amount equal to eighteen months of her annual
base salary in effect on the date of her termination. For
purposes of this table, Ms. Kleins current base
salary of $185,000 was used since her base salary increased
after July 31, 2007.
|
|
(6)
|
|
Mr. Bellizzi has 50,000 shares of unvested restricted
stock.
|
|
(7)
|
|
Mr. Klinefelter has 33,334 shares of unvested
restricted stock.
|
37
Employee directors do not receive any separate compensation for
their Board activities. Non-employee directors each receive a
$10,000 annual retainer. The Audit Committee Chairman receives
an additional $5,000 annual retainer and the Compensation
Committee Chairman and the Nomination Committee Chairman each
receive an additional $2,500 annual retainer. Each non-employee
director also receives $2,000 for each Board meeting attended in
person and $1,000 for each telephonic meeting. Each non-employee
director receives $1,000 for each committee meeting he or she
attends. We reimburse directors for any reasonable expenses
related to their Board service.
On November 9, 2006, ZILAs Board amended the 1997
Stock Award Plan to eliminate the annual automatic grant of
options to non-employee directors.
The following table summarizes compensation paid to our each of
our non-employee directors who served in such capacity during
fiscal 2007. David Goldman was appointed to the Board on
September 27, 2007, and therefore no compensation is
reflected for him in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Earned or
|
|
|
|
|
|
|
|
|
|
|
|
and Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
Paid in
|
|
|
Option
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
Cash
|
|
|
Awards
|
|
|
Stock Awards
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
Compensation
|
|
|
|
|
Name
|
|
Year
|
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
Compensation ($)
|
|
|
Earnings
|
|
|
($)
|
|
|
Total ($)
|
|
|
David R. Bethune
|
|
|
2007
|
|
|
|
44,844
|
|
|
|
40,613
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85,457
|
|
J. Steven Garrett
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Leslie H. Green
|
|
|
2007
|
|
|
|
39,034
|
|
|
|
30,757
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,791
|
|
O.B. Parrish
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
George J. Vuturo
|
|
|
2007
|
|
|
|
9,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,391
|
|
Former
Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kurt R. Krauss
|
|
|
2007
|
|
|
|
36,726
|
|
|
|
34,602
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,328
|
|
Christopher D. Johnson
|
|
|
2007
|
|
|
|
26,717
|
|
|
|
24,279
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,996
|
|
Hazel L. Myer
|
|
|
2007
|
|
|
|
30,445
|
|
|
|
18,188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
48,633
|
|
David Sidransky
|
|
|
2007
|
|
|
|
29,631
|
|
|
|
20,599
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,230
|
|
Michael S. Lesser
|
|
|
2007
|
|
|
|
7,854
|
|
|
|
3,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,720
|
|
S. Timothy Rose
|
|
|
2007
|
|
|
|
2,213
|
|
|
|
9,213
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,426
|
|
|
|
|
(1)
|
|
This column includes annual retainer and meeting fees earned for
2007 regardless of when paid.
|
|
(2)
|
|
This column includes the compensation cost recognized for
financial statement reporting purposes under FAS 123R for
2006 with respect to awards of options (i.e., grant date fair
value amortized over the requisite service period). The amount
described includes the fiscal year compensation cost for awards
made in fiscal 2007 and in prior years, using the Black-Sholes
option-pricing model more fully described in Note 9 of the
Notes to the Consolidated Financial Statements in ZILAs
Form 10-K
for the year ended July 31, 2007.
|
|
(3)
|
|
No Stock Awards were granted in Fiscal 2007.
|
On August 16, 2007, David R. Bethune accepted an offer
letter to become the Executive Chairman of the Board. Under the
offer letter, which is effective until the earlier of
Mr. Bethunes departure from ZILAs Board or
July 31, 2008, Mr. Bethune is entitled to a base
salary of $255,000 per year, less applicable withholdings, to be
paid in accordance with ZILAs regular payroll practices.
In addition, Mr. Bethune is also entitled to stock option
grants based on individual performance or commensurate with
other executive-level employees and received, in each case as of
August 16, 2007:
|
|
|
|
|
an option to purchase 75,000 shares of ZILA common stock
under the 1997 Plan, which options vest quarterly over the next
12 months;
|
|
|
|
a grant of 100,000 shares of restricted stock, with the
restrictions on the stock lapsing quarterly over the next
12 months; and
|
|
|
|
in recognition of prior service to ZILA as Chairman of the
Board, a grant of 75,000 vested options to purchase ZILA common
stock under the Plan.
|
38
EQUITY
COMPENSATION PLAN INFORMATION
The following table summarizes options, warrants and securities
available for issuance under ZILAs equity compensation
plans as of July 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
Number of Securities
|
|
Weighted-Average
|
|
Remaining Available for
|
|
|
to be Issued Upon
|
|
Exercise Price of
|
|
Future Issuance Under Equity
|
|
|
Exercise of
|
|
Outstanding
|
|
Compensation Plans
|
|
|
Outstanding Options,
|
|
Options, Warrants
|
|
(Excluding Securities
|
|
|
Warrants and Rights
|
|
and Rights
|
|
Reflected in Column (a))
|
Plan Category
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders(1)
|
|
|
2,917,000
|
|
|
$
|
3.11
|
|
|
|
3,038,000
|
(3)
|
Equity compensation plans not approved by security holders(2)
|
|
|
12,924,000
|
|
|
$
|
2.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
15,841,000
|
|
|
|
|
|
|
|
3,038,000
|
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Includes the 1997 Plan and the ESPP.
|
|
(2)
|
|
Represents warrants issued to financial and medical advisors in
March 2003 and March 2006, and warrants issued in connection
with the November 2006 private placement financing more fully
described under the section entitled Certain Relationships
and Related Transactions.
|
|
(3)
|
|
Represents 1,411,000 shares of common stock available for
issuance under the 1997 Plan and 1,627,000 shares of common
stock available for issuance under the ESPP.
|
The following Compensation Committee Report does not
constitute soliciting material and should not be deemed filed or
incorporated by reference into any Company filing under the
Securities Act of 1933, as amended (the Securities
Act), or the Securities Exchange Act of 1934, as amended
(the Exchange Act), except to the extent the
intention to do so is expressly indicated.
COMPENSATION
COMMITTEE REPORT
The Compensation Committee has reviewed and discussed the
Compensation Discussion and Analysis required by
Item 402(b) of the Commissions
Regulation S-K
with management and, based on such review and discussions, the
Compensation Committee recommended to the Board of Directors
that the Compensation Discussion and Analysis be included in
this Proxy Statement.
O.B. Parrish (Chair)
J. Steven Garrett
Leslie H. Green
Members, Compensation Committee
The Board has adopted a Code of Ethical Conduct for
Financial Personnel, which applies solely to our finance
personnel. The Board has also adopted a Code of Business
Conduct, which applies to our Directors and employees
(including our principal executive officer, principal financial
officer and principal accounting officer). Both of these codes
are posted in the Corporate Governance section of
the Investor Relations portion of our website at
www.zila.com.
We intend to satisfy any disclosure
requirement under Item 5.05 of
Form 8-K
regarding an amendment to, or waiver from, a provision of these
codes relating to an executive officer by posting such
information on our website, unless otherwise required by NASDAQ
Marketplace Rules to disclose any such waiver on
Form 8-K.
39
The following table sets forth the total fees billed by BDO
Seidman, LLP for audit and other services for fiscal year 2006,
and the expected total fees billed for audit and other services
for fiscal year 2007:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
Audit Fees
|
|
$
|
874,464
|
|
|
$
|
574,525
|
|
Audit-Related Fees
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
|
|
|
|
|
|
All Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
874,464
|
|
|
$
|
574,525
|
|
Each year, the Audit Committee approves the annual audit
engagement in advance. The Audit Committee also has established
procedures to pre-approve all non-audit services provided by the
principal independent registered public accounting firm. All
2007 and 2006 non-audit services listed above were pre-approved.
Audit Fees:
This category includes the audit
of our annual financial statements and review of financial
statements included in our annual and period reports that are
filed with the Commission, the audit of internal control over
financial reporting and services that are normally provided by
the independent registered public accounting firm in connection
with regulatory filings or engagements for those fiscal years.
This category also includes advice on audit and accounting
matters that arose during, or as a result of, the audit or the
review of interim financial statements, and the preparation of
an annual management letter on internal control and
other matters.
Audit-Related Fees:
This category consists of
assurance and related services by BDO Seidman, LLP that are
reasonably related to the performance of the audit or review of
our financial statements and are not reported above under
Audit Fees.
Tax Fees:
This category consists of
professional services rendered by BDO Seidman LLP for tax
compliance and tax advice in fiscal years 2007 and 2006. The
services for the fees disclosed under this category include
technical tax advice.
All Other Fees:
There were no other
professional services rendered by BDO Seidman, LLP in fiscal
years 2007 or 2006.
40
The Board of Directors has appointed an Audit Committee,
consisting of three directors Dr. Vuturo
(Chair), Mr. Goldman and Ms. Green. Each of the
members is independent, as defined in NASDAQ
Marketplace Rule 4200(a)(15).
The purpose of the Audit Committee is to assist the oversight of
our Board in the integrity of the financial statements of ZILA,
ZILAs compliance with legal and regulatory matters, the
independent registered public accountants qualifications
and independence, and the performance of ZILAs independent
registered public accountant. The primary responsibilities of
the Audit Committee include overseeing ZILAs accounting
and financial reporting process and audits of the financial
statements of ZILA on behalf of the Board.
Management has the primary responsibility for the financial
statements and reporting process, including the systems of
internal controls. The independent registered public accountant
is responsible for auditing the financial statements and
expressing an opinion on the conformity of those audited
financial statements with accounting principles generally
accepted in the United States of America.
In fulfilling its oversight responsibilities, the Audit
Committee reviewed the audited financial statements with
management and the independent auditor. The Audit Committee
discussed with the independent registered public accountant the
matters required to be discussed by Statement of Accounting
Standards No. 61, as amended by SAS 89 and SAS 90,
Communications with Audit Committees, and
Rule 2-07
of
Regulation S-X
including the auditors judgments about the quality, not
just the acceptability, of ZILAs accounting principles and
such other matters as are required to be discussed with the
Audit Committee under the standards of the Public Company
Accounting Oversight Board. In addition, the Audit Committee
received from the independent registered public accountant the
written disclosures and the letter required by Independence
Standards Board Standard No. 1, Independence
Discussions with Audit Committees. The Audit Committee
also discussed with the independent registered public accountant
the auditors independence from management and our company,
including the matters covered by the written disclosures and
letter provided by the independent registered public accountant.
The Audit Committee discussed with the independent registered
public accountant the overall scope and plans for their audit.
The Audit Committee met with the independent registered public
accountant, with and without management present, to discuss the
results of the examinations, its evaluations of our company, the
internal controls, and the overall quality of the financial
reporting. The Audit Committee held 5 meetings during the fiscal
year ended July 31, 2007.
Based on the reviews and discussions referred to above, the
Audit Committee recommended to the Board, and the Board
approved, the inclusion of the audited financial statements in
the Annual Report on
Form 10-K
for the fiscal year ended July 31, 2007, for filing with
the Commission.
This report has been furnished by the Audit Committee of our
Board.
George J. Vuturo (Chair)
David Goldman
Leslie H. Green
Members, Audit Committee
41
COMPENSATION
COMMITTEE INTERLOCKS
AND INSIDER PARTICIPATION
No member of the Compensation Committee was at any time during
fiscal 2007 or at any other time an officer or employee of ZILA,
and no member had any relationship with ZILA requiring
disclosure under Item 404 of
Regulation S-K.
David R. Bethune, our Executive Chairman, formerly served on the
compensation committee of The Female Health Corporation, the
Chief Executive Officer for which is O.B. Parrish, one of our
directors and the Chair of our Compensation Committee. No other
executive officer of ZILA has served on the Board or
Compensation Committee of any other entity that has or has had
one or more executive officers who served as a member of the
Board or the Compensation Committee during the 2007 fiscal year.
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires our directors,
executive officers and our ten percent or greater shareholders
to file reports of ownership of our equity securities and
changes in such ownership with the Commission and NASDAQ and to
furnish copies of such reports to us.
Based solely on a review of the copies of such reports furnished
to us and written representations that no other reports were
required, all Section 16(a) filing requirements applicable
to our directors, executive officers and our ten percent or
greater shareholders were complied with during the fiscal year
ended July 31, 2007, other than each of the
Form 4s filed on September 28, 2007 for
Messrs. Bellizzi and Klinefelter.
The following tables list the ownership of our common stock for
the persons or the groups specified. Ownership includes direct
and indirect (beneficial) ownership, as defined by the
SECs rules. To our knowledge, each person, along with his
or her spouse, has sole voting and investment power over the
shares unless otherwise noted. The following tables set forth
information concerning the beneficial owners of our common stock
by (i) the directors, (ii) the named executive
officers (as such term is defined under the SECs
rules), (iii) the director nominees, (iv) any person
holding at least 5% of our shares and (v) all current
directors, director nominees and executive officers of ZILA as a
group. Beneficial ownership and percentage ownership of ZILA is
as of September 30, 2007 based on 61,575,879 shares of
ZILA common stock outstanding, except as indicated below.
CERTAIN
BENEFICIAL OWNERS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
|
|
Nature
|
|
|
|
|
|
|
|
|
of Beneficial
|
|
|
Percentage
|
|
Title of Class
|
|
Name and Address of Beneficial Owner
|
|
Ownership
|
|
|
of Class
|
|
|
Common Stock
|
|
MicroCapital LLC(1)
623 Fifth Avenue, Suite 2502
New York, NY 10022
|
|
|
7,414,207
|
|
|
|
12
|
%
|
Common Stock
|
|
Royce & Associates, LLC(2)
1414 Avenue of the Americas
New York, NY 10019
|
|
|
4,952,300
|
|
|
|
8
|
%
|
Common Stock
|
|
Visium Asset Management, LLC(3)
950 Third Avenue, 29th Floor
New York, NY 10022
|
|
|
4,953,284
|
|
|
|
8
|
%
|
Common Stock
|
|
William Blair & Company, L.L.C.(4)
222 W. Adams St.
Chicago, IL 60606
|
|
|
8,447,119
|
|
|
|
14
|
%
|
|
|
|
(1)
|
|
According to an Amendment to Schedule 13G filed with the
SEC on March 12, 2007, MicroCapital LLC shares voting and
investment power with respect to 7,414,207 shares of ZILA
common stock, and Ian P. Ellis and
|
42
|
|
|
|
|
MicroCapital Fund LP share voting and investment power with
respect to 5,361,073 shares of ZILA common stock.
|
|
(2)
|
|
Based on an Amendment to Schedule 13G filed with the SEC on
January 25, 2007.
|
|
(3)
|
|
According to an Amendment to Schedule 13G filed with the
SEC on January 31, 2007, Visium Balanced Fund, LP
(VBF) shares voting and investment power with
respect to 1,421,638 shares of ZILA common stock, Visium
Long Bias Fund, LP (VLBF) shares voting and
investment power with respect to 437,895 shares of ZILA
common stock, Visium Balanced Offshore Fund, Ltd.
(VBOF) shares voting and investment power with
respect to 2,367,371 shares of ZILA common stock, Visium
Long Bias Offshore Fund, Ltd. (VLBOF and together
with VBF, VLBF and VBOF, the Visium Funds) shares
voting and investment power with respect to
1,659,212 shares of ZILA common stock, Visium Capital
Management, LLC (VCM) shares voting and investment
power with respect to 1,859,533 shares of ZILA common
stock, and Jacob Gottlieb and Visium Asset Management, LLC
(VAM) possesses sole voting and investment power
with respect to 5,886,116 shares of ZILA common stock.
|
|
|
|
As part of the 2006 private placements described elsewhere in
ZILAs filings with the SEC, ZILA sold the following
securities to the Visium Funds: (i) $5,000,000.25 in
aggregate principal amount of 12% Unsecured Convertible Notes,
which converted into 2,857,143 shares of ZILA common stock,
(i) $7,500,000.20 in aggregate principal amount of
6% Senior Secured Convertible Notes, which could convert at
$2.21 per share into 3,409,091 shares of ZILA common stock,
and (iii) various series of warrants to acquire up to
2,907,461 shares of ZILA common stock. As described in the
Current Report on
Form 8-K
filed by ZILA on August 14, 2007, ZILA repurchased
876,246 shares of ZILA common stock and warrants to
purchase 171,304 shares of ZILA common stock from the
Visium Funds, leaving the Visium Funds with total, fully
diluted, holdings of ZILA common stock of 9,173,695 assuming the
Visium Funds have made no open market sales.
|
|
|
|
Each of the warrants issued to the Visium Funds contains a
provision that limits the number of shares that can be issued to
each such fund upon exercise such that the Visium Funds and
their affiliates can own no more than 9.99% of ZILA common
stock, and the Amendment to Schedule 13G for the Visium
Funds, VCM, VAM and Jacob Gottlieb do not include shares
issuable upon the exercise of warrants. The number of shares
reported as beneficially owned by the Visium Funds, VCM, VAM and
Jacob Gottlieb in the above table is the number reported in the
Amendment to Schedule 13G.
|
|
(4)
|
|
Based on an Amendment to Schedule 13G filed with the SEC on
May 10, 2007.
|
43
DIRECTORS
AND EXECUTIVE OFFICERS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(A)
|
|
|
(B)
|
|
|
|
|
|
|
|
|
|
|
|
Common
|
|
|
Options-
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
Stock-Beneficial
|
|
|
Beneficial
|
|
|
|
|
|
of Beneficial
|
|
Name
|
|
Position(s)
|
|
Ownership
|
|
|
Ownership
|
|
|
Total
|
|
|
Ownership
|
|
|
Frank J. Bellizzi
|
|
President of Zila Pharmaceuticals, Inc. and Executive Vice
President-Business Development of ZILA
|
|
|
137,565
|
|
|
|
269,231
|
|
|
|
406,796
|
|
|
|
*
|
|
Gary V. Klinefelter
|
|
Vice President, General Counsel and Secretary
|
|
|
94,659
|
|
|
|
183,335
|
|
|
|
277,994
|
|
|
|
*
|
|
Diane E. Klein
|
|
Vice President and Treasurer
|
|
|
276
|
|
|
|
92,667
|
|
|
|
92,943
|
|
|
|
*
|
|
David R. Bethune
|
|
Director & Executive Chairman
|
|
|
130,000
|
|
|
|
153,750
|
|
|
|
283,750
|
|
|
|
*
|
|
J. Steven Garrett
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
David Goldman
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Leslie H. Green
|
|
Director
|
|
|
3,000
|
|
|
|
103,333
|
|
|
|
106,333
|
|
|
|
*
|
|
O.B. Parrish
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
George J. Vuturo
|
|
Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Former Directors and Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Douglas D. Burkett, Ph.D.
|
|
Former Chairman, President & Chief Executive Officer
|
|
|
176,636
|
|
|
|
200,000
|
|
|
|
376,636
|
|
|
|
*
|
|
Andrew A. Stevens
|
|
Former Vice President and Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Lawrence A. Gyenes
|
|
Former Chief Financial Officer
|
|
|
65,500
|
|
|
|
|
|
|
|
65,500
|
|
|
|
*
|
|
Christopher D. Johnson
|
|
Former Director
|
|
|
7,500
|
|
|
|
104,067
|
|
|
|
111,567
|
|
|
|
*
|
|
Kurt R. Krauss
|
|
Former Director
|
|
|
20,000
|
|
|
|
46,223
|
|
|
|
66,223
|
|
|
|
*
|
|
Hazel L. Myer
|
|
Former Director
|
|
|
|
|
|
|
20,299
|
|
|
|
20,299
|
|
|
|
*
|
|
David Sidransky, M.D.
|
|
Former Director
|
|
|
|
|
|
|
29,573
|
|
|
|
29,573
|
(1)
|
|
|
*
|
|
Michael S. Lesser
|
|
Former Director
|
|
|
15,500
|
|
|
|
84,782
|
|
|
|
100,282
|
|
|
|
*
|
|
S. Timothy Rose
|
|
Former Director
|
|
|
21,000
|
|
|
|
73,333
|
|
|
|
94,333
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors and executive officers, as a group (17 persons)
|
|
|
|
|
671,636
|
|
|
|
1,360,593
|
|
|
|
2,048,229
|
|
|
|
3.3
|
%
|
|
|
|
*
|
|
Denotes ownership of less than one percent.
|
|
(A)
|
|
Direct Ownership
|
|
(B)
|
|
Exercisable options at September 30, 2007 or options
becoming exercisable within 60 days thereof.
|
|
(1)
|
|
Total amount indicated does not include a warrant granted to
Dr. Sidransky on March 14, 2003 for 16,000 shares
of ZILAs common stock at $.98. Such warrant has a term of
five years.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS
Policies and Procedures:
ZILA has established
policies and other procedures regarding approval of transactions
between our company and any employee, officer, director, and
certain of their family members and other related persons,
including those required to be reported under Item 404 of
Regulation S-K.
These policies and procedures are generally not in writing, but
are evidenced by long standing principles set forth in our Code
of Business Conduct or adhered to by our Board. As set forth in
the Audit Committee Charter, unless submitted to the
Compensation Committee by delegation from the Board, as and to
the extent required under applicable federal securities laws and
related rules and regulations,
and/or
the
NASDAQ listing standards, related party transactions
44
are submitted to the Audit Committee for ongoing review, and the
Audit Committee approves or disapproves such related party
transactions. Generally speaking, we enter into such
transactions only on terms that we believe are at least as
favorable to our company as those that we could obtain from an
unrelated third party.
Related Party Transactions:
In fiscal 2007, we
paid consulting fees of approximately $72,000 to David
Sidransky, M.D., for his work on ZILAs Medical
Advisory Board. Dr. Sidransky resigned as a member of
ZILAs Board in July 2007, but continues to be a member of
ZILAs Medical Advisory Board. We believe that the terms
and fees negotiated are no less favorable than those that could
be negotiated in an arms length transaction.
In November 2006, ZILA consummated two private placements (the
Private Placements) that collectively resulted in
the issuance of the following securities:
|
|
|
|
|
9,100,000 shares of Company common stock for $1.75 per
share (the Shares);
|
|
|
|
$12,075,000.25 in aggregate principal amount of the
Companys 12% Unsecured Convertible Notes (the
Unsecured Notes), which converted into
6,900,000 shares (the Unsecured Note Shares) of
Company common stock at a conversion price of $1.75 per share on
December 14, 2006, the date on which the Companys
shareholders approved, among other things, the Private
Placements;
|
|
|
|
Warrants to purchase approximately 5,403,000 shares of
Company common stock, which became exercisable starting in May
2007 for five years at an exercise price of $2.21 per share (the
Initial Warrants);
|
|
|
|
Warrants to purchase approximately 3,105,000 shares of
Company common stock, which became exercisable for five years at
an exercise price of $2.21 per share following approval by our
shareholders on December 14, 2006 (the Additional
Warrants);
|
|
|
|
$12,000,001.20 in aggregate principal amount of the
Companys 6% Senior Secured Convertible Notes (the
Secured Notes), which became convertible into
5,454,546 shares of our common stock at a conversion price
of $2.20 following approval by our shareholders on
December 14, 2006; and
|
|
|
|
Warrants to purchase approximately 1,909,091 shares of our
common stock, which became exercisable for five years at an
exercise price of $2.21 per share following approval by our
shareholders on December 14, 2006 (the Secured Note
Warrants).
|
ZILA agreed to provide certain registration rights with respect
to the Shares and Unsecured Note Shares, shares of Company
common stock issuable upon the exercise of the Initial Warrants,
Additional Warrants and Secured Note Warrants and upon
conversion of the Secured Notes. However, a dispute arose
regarding the extent of these registration rights with certain
investors who purchased Unsecured Notes, Initial Warrants,
Additional Warrants, Secured Notes, and Secured Note Warrants.
Separately, the Secured Notes contained financial and
non-financial covenants from which ZILA desired relief.
In an effort to resolve the aforementioned dispute and to obtain
covenant relief, ZILA and certain of the investors with whom
ZILA had the dispute agreed to take certain actions and
restructure the investors holdings (the
Restructuring). As part of the Restructuring, on
August 13, 2007, ZILA entered into an Amendment Agreement
(the Amendment Agreement) with Visium Balanced
Offshore Fund, Ltd., Visium Balanced Fund, LP, Visium Long Bias
Offshore Fund, Ltd., Visium Long Bias Fund, LP, and Atlas Master
Fund, Ltd. (collectively, the Investors), which
provides for, among other things, the following:
|
|
|
|
|
ZILA repurchased 932,832 Unsecured Note Shares from the
Investors for an aggregate of $1,249,994.88 in cash, at a price
based on the average closing bid price of ZILAs common
stock for the ten trading days prior to August 13, 2007, or
$1.34 per Unsecured Note Share;
|
|
|
|
ZILA repurchased 227,270 Secured Note Warrants from the
Investors for $149,998.20 in cash, at a price based on a
Black Scholes valuation for the Additional Warrants,
or $0.66 per Secured Note Warrant;
|
|
|
|
ZILA and Investors agreed to amend and restate the Secured Notes
(the Amended and Restated Secured Notes) on the
terms set forth below; and
|
|
|
|
ZILA paid the Investors a $600,000 amendment fee.
|
45
The Amendment Agreement contained a mutual release of claims.
The Amended and Restated Secured Notes are in the same aggregate
principal amount as the Secured Notes, or $12,000,001.20, but
are due July 31, 2010. Interest is payable on the Amended
and Restated Secured Notes quarterly at 7% in cash or, at the
option of ZILA, at 8% in shares of ZILA common stock at a price
equal to 90% of the average closing bid price of ZILA common
stock for the ten trading days immediately prior to the relevant
interest payment date. The Amended and Restated Secured Notes
are convertible into ZILA common stock at the option of the
holders thereof at a conversion rate $2.20 per share, which, if
fully converted and assuming no adjustments to the conversion
price, could result in the issuance of an additional
5,454,546 shares of ZILA common stock. In addition, the
Amended and Restated Secured Notes contain comprehensive
covenants that restrict the way in which ZILA can operate, and
contain covenants that require ZILA to:
|
|
|
|
|
maintain, at the end of each fiscal quarter commencing with the
fiscal quarter ending July 31, 2007, free cash in an amount
not less than $2,000,000; and
|
|
|
|
maintain, at the end of each of the fiscal quarters ending
July 31, 2008 and October 31, 2008, EBITDA of at least
$1.
|
In connection with the Restructuring and the issuance of the
Amended and Restated Notes, ZILA also received waivers from the
required majority of the holders of the Initial Warrants,
Additional Warrants and Secured Note Warrants waiving any
anti-dilution rights to which any holder of such warrants would
otherwise be entitled in connection with the issuance of any
shares as payment for interest on the Amended and Restated
Secured Notes.
In addition, on August 13, 2007, ZILA and Investors entered
into a Registration Rights Agreement (the Registration
Rights Agreement), under which ZILA agreed to cooperate
with the Investors to attempt to persuade the SEC to permit the
registration with the SEC of Unsecured Note Shares and shares
that are issuable upon exercise of Additional Warrants and
Secured Note Warrants and upon conversion of the Amended and
Restated Secured Notes, in each case to the extent not already
registered, and to file a resale registration statement covering
such shares within 30 days after the date, if ever, on
which the SEC indicates to the ZILA that the SEC would be
willing to declare such a registration statement effective. In
addition, in the event that shares of ZILA common stock have
been issued as payment for interest on the Amended and Restated
Secured Notes and the market value of such shares exceeds
$250,000, ZILA is required to file additional registration
statements promptly following the end of each of the
companys fiscal years, but no later than October 31 of
each year. After each filing deadline, ZILA is required to use
commercially reasonable efforts to have each registration
statement declared effective by the SEC 90 days after the
date on which the 30 day filing period began to run, or
120 days after such time if the SEC reviews the
registration statement.
ZILA will become obligated to pay liquidated damages equal to 1%
of the aggregate market value of the shares that should have
been included in any such registration statement if it fails to
file any such registration statement within the timeframes
described above, and will incur additional liquidated damages
equal to 1% of the aggregate market value of the shares that
should have been included in any such registration statement if
ZILA fails to cause any such registration statement to become
effective within the timeframes described above, up to an
aggregate cap of $3,000,000.
In connection with the Restructuring, those registration rights
agreements to which the Investors were a party were terminated
as to the Investors, but will remain in effect as to those other
investors in the Private Placements. In addition, a side letter
that imposed certain corporate governance obligations on ZILA,
the most notable of which that had not yet been fulfilled was to
appoint two additional directors to ZILAs Board, was
terminated.
HOUSEHOLDING
OF PROXY MATERIALS
The Commission has adopted rules that permit companies and
intermediaries (such as brokers) to satisfy the delivery
requirements for proxy statements and annual reports with
respect to two or more shareholders sharing the same address by
delivering a single proxy statement addressed to those
shareholders. This process, which is commonly referred to as
householding, potentially means extra convenience
for shareholders and cost savings for companies.
46
This year, a number of brokers with account holders who are our
shareholders will be householding our proxy
materials. A single proxy statement and one annual report will
be delivered to multiple shareholders sharing an address unless
contrary instructions have been received from the affected
shareholders. Once you have received notice from your broker
that they will be householding communications to
your address, householding will continue until you
are notified otherwise or until you revoke your consent. If, at
any time, you no longer wish to participate in
householding and would prefer to receive a separate
proxy statement and annual report, please notify your broker or
direct your written request to Vice President, General Counsel
and Secretary, Zila, Inc., 5227 North 7th Street, Phoenix,
Arizona
85014-2800,
or contact our Vice President, General Counsel and Secretary at
(800) 922-7887.
Shareholders who currently receive multiple copies of the proxy
statement at their address and would like to request
householding of their communications should contact
their broker.
SUBMISSION
OF SHAREHOLDER PROPOSALS
Pursuant to
Rule 14a-8
under the Exchange Act, shareholder proposals for the 2008
annual meeting must be received at our principal executive
offices by July 11, 2008 to be considered for inclusion in
our proxy materials relating to such meeting. Any notice of a
shareholder proposal submitted outside the process of
Rule 14a-8
of the Exchange Act after July 11, 2008 will be considered
untimely.
Direct any proposals, as well as related questions, to Gary V.
Klinefelter, Vice President, General Counsel and Secretary,
Zila, Inc., 5227 North 7th Street, Phoenix, Arizona
85014-2800.
Our Annual Report on
Form 10-K
with audited financial statements for the fiscal year ended
July 31, 2007 accompanies this Notice and Proxy Statement
and was mailed to all shareholders of record on or about
November 9, 2007. You may obtain our other Commission
filings through the internet at
www.sec.gov
or our
website,
www.zila.com.
Upon written request, we will provide, to each person
solicited, a copy of our
Form 10-K
for the fiscal year ending July 31, 2007, including the
financial statements and schedules thereto. Such requests should
be directed to Vice President, General Counsel and Secretary,
Zila, Inc., 5227 N. 7th Street, Phoenix, AZ
85014-2800.
The Board knows of no other matters for consideration at the
meeting. If any other business should properly arise, the
persons appointed in the enclosed proxy have discretionary
authority to vote in accordance with their best judgment.
By order of the Board of Directors,
David R. Bethune
Executive Chairman
47
Zila, Inc.
1997 Stock Award Plan
Amended and Restated as of November 6, 2007
A-1
Zila,
Inc.
1997
Stock Award Plan
(Amended
and Restated as of November 6, 2007)
1.
Purpose
.
The purpose of this
1997 Stock Award Plan (the Plan) is to assist Zila,
Inc., a Delaware corporation (the Company) and its
Related Entities in attracting, motivating, retaining and
rewarding high-quality executives and other Employees, officers,
Directors and Consultants by enabling such persons to acquire or
increase a proprietary interest in the Company in order to
strengthen the mutuality of interests between such persons and
the Companys shareholders, and providing such persons with
annual and long term performance incentives to expend their
maximum efforts in the creation of shareholder value. The Plan
is intended to qualify certain compensation awarded under the
Plan for tax deductibility under Section 162(m) of the Code
(as hereafter defined) to the extent deemed appropriate by the
Committee (or any successor committee) of the Board.
2.
Definitions
.
For purposes of
the Plan, the following terms shall be defined as set forth
below, in addition to such terms defined in Section 1
hereof.
(a)
Annual Meeting
means the
annual meeting of the shareholders of the Company.
(b)
Applicable Laws
means the
requirements relating to the administration of equity
compensation plans under U.S. state corporate laws,
U.S. federal and state securities laws, the Code, the rules
and regulations of any stock exchange upon which the Common
Stock is listed and the applicable laws of any foreign country
or jurisdiction where Awards are granted under the Plan.
(c)
Award
means any award granted
pursuant to the terms of this Plan including, an Option, Stock
Appreciation Right, Restricted Stock, Stock Units, Stock granted
as a bonus or in lieu of another award, Dividend Equivalent,
Other Stock-Based Award or Performance Award, together with any
other right or interest, granted to a Participant under the Plan.
(d)
Beneficiary
means the person,
persons, trust or trusts which have been designated by a
Participant in his or her most recent written beneficiary
designation filed with the Committee to receive the benefits
specified under the Plan upon such Participants death or
to which Awards or other rights are transferred if and to the
extent permitted under Section 11(b) hereof. If, upon a
Participants death, there is no designated Beneficiary or
surviving designated Beneficiary, then the term Beneficiary
means the person, persons, trust or trusts entitled by will or
the laws of descent and distribution to receive such benefits.
(e)
Beneficial Owner
,
Beneficially Owning
and
Beneficial Ownership
shall have the
meanings ascribed to such terms in Rule 13d3 under the
Exchange Act and any successor to such Rule.
(f)
Board
means the
Companys Board of Directors.
(g)
Cause
shall, with respect to
any Participant, have the equivalent meaning (or the same
meaning as cause or for cause) set forth
in any employment agreement between the Participant and the
Company or a Related Entity or, in the absence of any such
agreement, such term shall mean (i) the failure by the
Participant to perform his or her duties as assigned by the
Company (or a Related Entity) in a reasonable manner,
(ii) any violation or breach by the Participant of his or
her employment agreement with the Company (or a Related Entity),
if any, (iii) any violation or breach by the Participant of
his or her confidential information and invention assignment
agreement with the Company (or a Related Entity), if any,
(iv) any act by the Participant of dishonesty or bad faith
with respect to the Company (or a Related Entity), (iv) any
material violation or breach by the Participant of the
Companys or a Related Entitys policy for employee
conduct, if any, (iv) any act by the Participant of
dishonesty or bad faith with respect to the Company (or a
Related Entity), (v) use of alcohol, drugs or other similar
substances affecting the Participants work performance, or
(vi) the commission by the Participant of any act,
misdemeanor, or crime reflecting unfavorably upon the
Participant or the Company. The good faith determination by the
Committee of whether the Participants Continuous Service
was terminated by the Company for Cause shall be
final and binding for all purposes hereunder.
A-2
(h)
Change in Control
means and
shall be deemed to have occurred on the earliest of the
following dates:
(i) the date on which any person (as such term
is used in Sections 13(d) and 14(d) of the Exchange Act)
obtains beneficial ownership (as defined in
Rule 13d-3
of the Exchange Act) or a pecuniary interest in more than 20% of
the combined voting power of the Companys then outstanding
securities (
Voting Stock
);
(ii) the consummation of a merger, consolidation,
reorganization or similar transaction
other
than a
transaction: (1) (a) in which substantially all of the
holders of Companys Voting Stock hold or receive directly
or indirectly eighty percent (80%) or more of the voting stock
of the resulting entity or a parent company thereof, in
substantially the same proportions as their ownership of the
Company immediately prior to the transaction; or (2) in
which the holders of Companys capital stock immediately
before such transaction will, immediately after such
transaction, hold as a group on a fully diluted basis the
ability to elect at least a majority of the directors of the
surviving corporation (or a parent company);
(iii) there is consummated a sale, lease, exclusive license
or other disposition of all or substantially all of the
consolidated assets of the Company and its Subsidiaries, other
than a sale, lease, license or other disposition of all or
substantially all of the consolidated assets of the Company and
its Subsidiaries to an entity, more than eighty percent (80%) of
the combined voting power of the voting securities of which are
owned by shareholders of the Company in substantially the same
proportions as their ownership of the Company immediately prior
to such sale, lease, license or other disposition; or
(iv) individuals who, on the date this Plan is adopted by
the Board, are Directors (the
Incumbent
Board
) cease for any reason to constitute at least a
majority of the Directors; provided, however, that if the
appointment or election (or nomination for election) of any new
Director was approved or recommended by a majority vote of the
members of the Incumbent Board then still in office, such new
member shall, for purposes of this Plan, be considered as a
member of the Incumbent Board.
For purposes of determining whether a Change in Control has
occurred, a transaction includes all transactions in a series of
related transactions, and terms used in this definition but not
defined are used as defined in the Plan. The term Change in
Control shall not include a sale of assets, merger or other
transaction effected exclusively for the purpose of changing the
domicile of the Company.
Notwithstanding the foregoing or any other provision of this
Plan, the definition of Change in Control (or any analogous
term) in an individual written agreement between the Company and
the Participant shall supersede the foregoing definition with
respect to Awards subject to such agreement (it being
understood, however, that if no definition of Change in Control
or any analogous term is set forth in such an individual written
agreement, the foregoing definition shall apply).
(i)
Code
means the Internal
Revenue Code of 1986, as amended from time to time, including
regulations thereunder and successor provisions and regulations
thereto.
(j)
Committee
means a committee
designated by the Board to administer the Plan with respect to
at least a group of Employees, Directors or Consultants.
(k)
Consultant
means any person
(other than an Employee or a Director, solely with respect to
rendering services in such persons capacity as a director)
who is engaged by the Company or any Related Entity to render
consulting or advisory services to the Company or such Related
Entity.
(l)
Continuous Service
means
uninterrupted provision of services to the Company as an
Employee, a Director, or a Consultant. Continuous Service shall
not be considered to be interrupted in the case of (i) any
approved leave of absence, (ii) transfers among the
Company, any Related Entities, or any successor entities, as
either an Employee, a Director, or a Consultant, or
(iii) any change in status as long as the individual
remains in the service of the Company or a Related Entity as
either an Employee, a Director, or a Consultant (except as
otherwise provided in the Option Agreement). An approved leave
of absence shall include sick leave, military leave, or any
other authorized personal leave.
A-3
(m)
Corporate Transaction
means
the occurrence, in a single transaction or in a series of
related transactions, of any one or more of the following events:
(i) a sale, lease, exclusive license or other disposition
of all or substantially all, as determined by the Board in its
discretion, of the consolidated assets of the Company and its
Subsidiaries;
(ii) a sale or other disposition of more than twenty
percent (20%) of the outstanding securities of the
Company; or
(iii) a merger, consolidation, reorganization or similar
transaction, whether or not the Company is the surviving
corporation.
(n)
Covered Employee
means an
Eligible Person who is a Covered Employee as specified in
Section 7(d) of the Plan.
(o)
Director
means a member of
the Board or the board of directors of any Related Entity.
(p)
Directors Plan
means the
Zila, Inc. Non-Employee Directors Stock Option Plan.
(q)
Disability
means a permanent
and total disability (within the meaning of Section 22(e)
of the Code), as determined by a medical doctor satisfactory to
the Committee.
(r)
Dividend Equivalent
means a
right, granted to a Participant under Section 6(g) hereof,
to receive cash, Stock, other Awards or other property equal in
value to dividends paid with respect to a specified number of
shares of Stock, or other periodic payments.
(s)
Effective Date
means the
effective date of this amended and restated Plan, which shall be
December 16, 2004.
(t)
Eligible Person
means all
Employees (including officers), Directors and Consultants of the
Company or of any Related Entity. The foregoing notwithstanding,
only employees of the Company, the Parent, or any Subsidiary
shall be Eligible Persons for purposes of receiving any
Incentive Stock Options. An Employee on leave of absence may be
considered as still in the employ of the Company or a Related
Entity for purposes of eligibility for participation in the Plan.
(u)
Employee
means any person,
including an officer or Director, who is an employee of the
Company or any Related Entity. The Payment of a directors
fee by the Company or a Related Entity shall not be sufficient
to constitute employment by the Company.
(v)
Exchange Act
means the
Securities Exchange Act of 1934, as amended from time to time,
including rules thereunder and successor provisions and rules
thereto.
(w)
Executive Officer
means an
executive officer of the Company as defined under the Exchange
Act.
(x)
Fair Market Value
means the
fair market value of Stock, Awards or other property as
determined by the Plan Administrator, or under procedures
established by the Plan Administrator. Unless otherwise
determined by the Plan Administrator, the Fair Market Value of
Stock as of any given date, after which the Stock is publicly
traded on a stock exchange or market, shall be the closing sale
price per share reported on a consolidated basis for stock
listed on the principal stock exchange or market on which Stock
is traded on the date as of which such value is being determined
or, if there is no sale on that date, then on the last previous
day on which a sale was reported.
(y)
Good Reason
shall, with
respect to any Participant, have the equivalent meaning (or the
same meaning as good reason or for good
reason) set forth in any employment agreement between the
Participant and the Company or a Related Entity or, in the
absence of any such agreement, such term shall mean (i) the
assignment to the Participant of any duties inconsistent in any
respect with the Participants position (including status,
offices, titles and reporting requirements), authority, duties
or responsibilities as assigned by the Company (or a Related
Entity), or any other action by the Company (or a Related
Entity) which results in a diminution in such position,
authority, duties or responsibilities, excluding for this
purpose an isolated, insubstantial and inadvertent action not
taken in bad faith and which is remedied by the Company (or a
Related Entity) promptly after receipt of notice thereof given
by the Participant; (ii) any failure by the Company (or a
Related Entity) to comply with its obligations
A-4
to the Participant as agreed upon, other than an isolated,
insubstantial and inadvertent failure not occurring in bad faith
and which is remedied by the Company (or a Related Entity)
promptly after receipt of notice thereof given by the
Participant; (iii) the Companys (or Related
Entitys) requiring the Participant to be based at any
office or location more than fifty miles from the location of
employment as of the date of Award, except for travel reasonably
required in the performance of the Participants
responsibilities; (iv) any purported termination by the
Company (or a Related Entity) of the Participants
Continuous Service otherwise than for Cause as defined in
Section 2(g), or by reason of the Participants
Disability as defined in Section 2(q), prior to the
Expiration Date; or (v) any reduction in the
Participants base salary.
(z)
Incentive Stock Option
means
any Option intended to be designated as an incentive stock
option within the meaning of Section 422 of the Code or any
successor provision thereto.
(aa)
Non-Employee Director
means
a Director of the Company who is not an Employee.
(bb)
Option
means a right granted
to a Participant under Section 6(b) hereof, to purchase
Stock or other Awards at a specified price during specified time
periods.
(cc)
Other Stock-Based Awards
means Awards granted to a Participant pursuant to
Section 6(h) hereof.
(dd)
Parent
means any corporation
(other than the Company), whether now or hereafter existing, in
an unbroken chain of corporations ending with the Company, if
each of the corporations in the chain (other than the Company)
owns stock possessing 50 percent or more of the combined
voting power of all classes of stock in one of the other
corporations in the chain.
(ee)
Participant
means a person
who has been granted an Award under the Plan which remains
outstanding, including a person who is no longer an Eligible
Person.
(ff)
Performance Award
means a
right, granted to an Eligible Person under Section 7
hereof, to receive Awards based upon performance criteria
specified by the Plan Administrator.
(gg)
Person
has the meaning
ascribed to such term in Section 3(a)(9) of the Exchange
Act and used in Sections 13(d) and 14(d) thereof, and shall
include a group as defined in Section 13(d)
thereof.
(hh)
Plan Administrator
means the
Board or any Committee delegated by the Board to administer the
Plan.
(ii)
Related Entity
means any
Parent, Subsidiary and any business, corporation, partnership,
limited liability company or other entity in which the Company,
a Parent or a Subsidiary, directly or indirectly, holds a
substantial ownership interest.
(jj)
Restricted Stock
means Stock
granted to a Participant under Section 6(d) hereof, that is
subject to certain restrictions and to a risk of forfeiture.
(kk)
Rule 16b-3
and
Rule 16a-1(c)(3)
means
Rule 16b-3
and
Rule 16a-1(c)(3),
as from time to time in effect and applicable to the Plan and
Participants, promulgated by the Securities and Exchange
Commission under Section 16 of the Exchange Act.
(ll)
Stock
means the
Companys Common Stock, and such other securities as may be
substituted (or resubstituted) for Stock pursuant to
Section 11(c) hereof.
(mm)
Stock Appreciation Right
means a right granted to a Participant pursuant to
Section 6(c) hereof.
(nn)
Stock Unit
means a right,
granted to a Participant pursuant to Section 6(e) hereof,
to receive Stock, cash or a combination thereof at the end of a
specified period of time.
(oo)
Subsidiary
means any
corporation (other than the Company), whether now or hereafter
existing, in an unbroken chain of corporations beginning with
the Company, if each of the corporations other than the last
corporation in the unbroken chain owns stock possessing
50 percent or more of the total combined voting power of
all classes of stock in one of the other corporations in such
chain.
A-5
3.
Administration
.
(a)
Administration by Board
.
The
Board shall administer the Plan unless and until the Board
delegates administration to a Committee, as provided in
Section 3(c).
(b)
Powers of Board
.
The Board
shall have the power, subject to, and within the limitations of,
the express provisions of the Plan:
(i) To determine from time to time which of the persons
eligible under the Plan shall be granted Awards; when and how
each Award shall be granted; what type or combination of types
of Award shall be granted; the provisions of each Award granted
(which need not be identical), including the time or times when
a person shall be permitted to receive Stock pursuant to an
Award; and the number of shares of Stock with respect to which
an Award shall be granted to each such person.
(ii) To construe and interpret the Plan and Awards granted
under it, and to establish, amend and revoke rules and
regulations for its administration. The Board, in the exercise
of this power, may correct any defect, omission or inconsistency
in the Plan or in any Stock Award Agreement, in a manner and to
the extent it shall deem necessary or expedient to make the Plan
fully effective.
(iv) To amend the Plan or an Award as provided in
Section 11(e).
(v) To terminate or suspend the Plan as provided in
Section 11(e).
(vi) Generally, to exercise such powers and to perform such
acts as the Board deems necessary or expedient to promote the
best interests of the Company and that are not in conflict with
the provisions of the Plan.
(c)
Delegation to Committee
.
(i)
General
.
The Board may
delegate administration of the Plan to a Committee or Committees
of two (2) or more members of the Board, and the term
Committee shall apply to any person or persons to
whom such authority has been delegated. If administration is
delegated to a Committee, the Committee shall have, in
connection with the administration of the Plan, the powers
theretofore possessed by the Board, including the power to
delegate to a subcommittee any of the administrative powers the
Committee is authorized to exercise (and references in this Plan
to the Board shall thereafter be to the Committee or
subcommittee), subject, however, to such resolutions, not
inconsistent with the provisions of the Plan, as may be adopted
from time to time by the Board. The Board may abolish the
Committee at any time and revest in the Board the administration
of the Plan.
(ii)
Section 162(m) and
Rule 16b-3
Compliance
.
In the discretion of the Board,
the Committee may consist solely of two or more Outside
Directors, in accordance with Section 162(m) of the
Code,
and/or
solely of two or more Non-Employee Directors, in
accordance with
Rule 16b-3.
In addition, the Board or the Committee may delegate to a
committee of two or more members of the Board the authority to
grant Awards to eligible persons who are either (a) not
then Covered Employees and are not expected to be Covered
Employees at the time of recognition of income resulting from
such Award, (b) not persons with respect to whom the
Company wishes to comply with Section 162(m) of the Code,
or (c) not then subject to Section 16 of the Exchange
Act.
(d)
Effect of Boards
Decision
.
All determinations, interpretations
and constructions made by the Board in good faith shall not be
subject to review by any person and shall be final, binding and
conclusive on all persons.
(e)
Arbitration
.
Any dispute or
claim concerning any Award granted (or not granted) pursuant to
the Plan or any disputes or claims relating to or arising out of
the Plan shall be fully, finally and exclusively resolved by
binding and confidential arbitration conducted pursuant to the
rules of Judicial Arbitration and Mediation Services, Inc.
(JAMS) in Phoenix, Arizona. The Company shall pay
all arbitration fees. In addition to any other relief, the
arbitrator may award to the prevailing party recovery of its
attorneys fees and costs. By accepting an Award, the
Participant and the Company waive their respective rights to
have any such disputes or claims tried by a judge or jury.
A-6
(f)
Limitation of Liability
.
The
Committee and the Board, and each member thereof, shall be
entitled to, in good faith, rely or act upon any report or other
information furnished to him or her by any officer or Employee,
the Companys independent auditors, Consultants or any
other agents assisting in the administration of the Plan.
Members of the Committee and the Board, and any officer or
Employee acting at the direction or on behalf of the Plan
Administrator, shall not be personally liable for any action or
determination taken or made in good faith with respect to the
Plan, and shall, to the extent permitted by law, be fully
indemnified and protected by the Company with respect to any
such action or determination.
4.
Stock Subject to Plan
.
(a)
Limitation on Overall Number of Shares Subject to
Awards
.
Subject to adjustment as provided in
Section 11(c) hereof, the total number of shares of Stock
reserved and available for delivery in connection with Awards
under the Plan shall be (i) 8,000,000 plus (ii) any
share of Stock available under the Directors Plan as of the
Effective Date of this Plan. Any shares of Stock delivered under
the Plan may consist, in whole or in part, of authorized and
unissued shares or treasury shares.
(b)
Availability of Shares Not Delivered under
Awards
.
(i) If any Shares subject to an Award, or to an award under
the Directors Plan that is outstanding on the Effective Date of
the Plan, are forfeited, expire or otherwise terminate without
issuance of such Shares, or any Award, or award under the
Directors Plan that is outstanding on the Effective Date of the
Plan is settled for cash or otherwise does not result in the
issuance of all or a portion of the Shares subject to such Award
or award, the Shares shall, to the extent of such forfeiture,
expiration, termination, cash settlement or non-issuance, again
be available for Awards under the Plan, subject to
Section 4(b)(iv) below.
(ii) If any shares of Common Stock issued pursuant to an
Award, or to an award under the Directors Plan that is
outstanding on the Effective Date of the Plan, are forfeited
back to or repurchased by the Company, including, but not
limited to, any repurchase or forfeiture caused by the failure
to meet a contingency or condition required for the vesting of
such shares, then the shares of Common Stock not acquired under
such Award shall revert to and again become available for
issuance under the Plan.
(iii) In the event that any Option or other Award granted
hereunder is exercised through the tendering of Shares (either
actually or by attestation) or by the withholding of Shares by
the Company, or withholding tax liabilities arising from such
Option or other Award are satisfied by the tendering of Shares
(either actually or by attestation) or by the withholding of
Shares by the Company, then only the number of Shares issued net
of the Shares tendered or withheld shall be counted for purposes
of determining the maximum number of Shares available for grant
under the Plan. In the event that any option or award granted
under the Directors Plan that is outstanding on the Effective
Date of the Plan, is exercised through the tendering of Shares
(either actually or by attestation) or by the withholding of
Shares by the Company, or withholding tax liabilities arising
from such options or awards are satisfied by the tendering of
Shares (either actually or by attestation) or by the withholding
of Shares by the Company, then the Shares so tendered or
withheld shall again be available for Awards under the Plan.
(iv) Notwithstanding anything in this Section 4(b) to
the contrary and solely for purposes of determining whether
Shares are available for the grant of Incentive Stock Options,
the maximum aggregate number of shares that may be granted under
this Plan shall be determined without regard to any Shares
restored pursuant to this Section 4(b) that, if taken into
account, would cause the Plan to fail the requirement under Code
Section 422 that the Plan designate a maximum aggregate
number of shares that may be issued.
(c)
Application of
Limitations
.
The limitation contained in this
Section 4 shall apply not only to Awards that are settled
by the delivery of shares of Stock but also to Awards relating
to shares of Stock but settled only in cash (such as cash-only
Stock Appreciation Rights). The Plan Administrator may adopt
reasonable counting procedures to ensure appropriate counting,
avoid double counting (as, for example, in the case of tandem or
substitute awards) and make adjustments if the number of shares
of Stock actually delivered differs from the number of shares
previously counted in connection with an Award.
A-7
5.
Eligibility; Per-Person Award
Limitations
.
Awards may be granted under the
Plan only to Eligible Persons. In each fiscal year during any
part of which the Plan is in effect, an Eligible Person may not
be granted an Award under which more than 1,000,000 shares
of Stock could be received by the Participant, subject to
adjustment as provided in Section 11(c). In addition, the
maximum amount that may be earned as a Performance Award
(payable in cash) or other Award (payable or settled in cash)
for a performance period by any one Participant shall be
$5,000,000.
6.
Terms of Awards
.
(a)
General
.
Awards may be granted
on the terms and conditions set forth in this Section 6. In
addition, the Plan Administrator may impose on any Award or the
exercise thereof, at the date of grant or thereafter (subject to
Section 11(e)), such additional terms and conditions, not
inconsistent with the provisions of the Plan, as the Plan
Administrator shall determine, including terms requiring
forfeiture of Awards in the event of termination of Continuous
Service by the Participant and terms permitting a Participant to
make elections relating to his or her Award. The Plan
Administrator shall retain full power and discretion to
accelerate, waive or modify, at any time, any term or condition
of an Award that is not mandatory under the Plan.
(b)
Options
.
The Plan
Administrator is authorized to grant Options to Participants on
the following terms and conditions:
(i)
Stock Option Agreement
.
Each
grant of an Option shall be evidenced by a Stock Option
Agreement. Such Stock Option Agreement shall be subject to all
applicable terms and conditions of the Plan and may be subject
to any other terms and conditions which are not inconsistent
with the Plan and which the Plan Administrator deems appropriate
for inclusion in a Stock Option Agreement. The provisions of the
various Stock Option Agreements entered into under the Plan need
not be identical.
(ii)
Number of Shares
.
Each Stock
Option Agreement shall specify the number of shares of Stock
that are subject to the Option and shall provide for the
adjustment of such number in accordance with Section 11(c)
hereof. The Stock Option Agreement shall also specify whether
the Stock Option is an Incentive Stock Option or a Non-Qualified
Stock Option.
(iii)
Exercise Price
.
(A)
In General
.
Each Stock Option
Agreement shall state the price at which shares of Stock subject
to the Option may be purchased (the Exercise Price),
which shall be, with respect to Incentive Stock Options, not
less than 100% of the Fair Market Value of the Stock on the date
of grant. In the case of Non-Qualified Stock Options, the
Exercise Price shall be determined in the sole discretion of the
Plan Administrator.
(B)
Ten
Percent Shareholder
.
If a Participant
owns or is deemed to own (by reason of the attribution rules
applicable under Section 424(d) of the Code) more than 10%
of the combined voting power of all classes of stock of the
Company or any Related Entity, any Incentive Stock Option
granted to such Participant must have an Exercise Price per
share of at least 110% of the Fair Market Value of a share of
Stock on the date of grant.
(iv)
Time and Method of
Exercise
.
The Plan Administrator shall
determine the time or times at which or the circumstances under
which an Option may be exercised in whole or in part (including
based on achievement of performance goals
and/or
future service requirements). The Plan Administrator may also
determine the time or times at which Options shall cease to be
or become exercisable following termination of Continuous
Service or upon other conditions. The Board or the Committee may
determine the methods by which such exercise price may be paid
or deemed to be paid (including, in the discretion of the Plan
Administrator, a cashless exercise procedure), the form of such
payment, including, without limitation, cash, Stock, other
Awards or awards granted under other plans of the Company or a
Related Entity, or other property (including notes or other
contractual obligations of Participants to make payment on a
deferred basis), and the methods by or forms in which Stock will
be delivered or deemed to be delivered to Participants.
(v)
Incentive Stock Options
.
The
terms of any Incentive Stock Option granted under the Plan shall
comply in all respects with the provisions of Section 422
of the Code. Anything in the Plan to the contrary
A-8
notwithstanding, no term of the Plan relating to Incentive Stock
Options (including any Stock Appreciation Rights in tandem
therewith) shall be interpreted, amended or altered, nor shall
any discretion or authority granted under the Plan be exercised,
so as to disqualify either the Plan or any Incentive Stock
Option under Section 422 of the Code, unless the
Participant has consented in writing to the change that will
result in such disqualification. If and to the extent required
to comply with Section 422 of the Code, Options granted as
Incentive Stock Options shall be subject to the following
special terms and conditions:
(A) the Option shall not be exercisable more than ten years
after the date such Incentive Stock Option is granted; provided,
however, that if a Participant owns or is deemed to own (by
reason of the attribution rules of Section 424(d) of the
Code) more than 10% of the combined voting power of all classes
of stock of the Company or any Parent Corporation and the
Incentive Stock Option is granted to such Participant, the term
of the Incentive Stock Option shall be (to the extent required
by the Code at the time of the grant) for no more than five
years from the date of grant; and
(B) If the aggregate Fair Market Value (determined as of
the date the Incentive Stock Option is granted) of the shares of
stock with respect to which Incentive Stock Options granted
under the Plan and all other option plans of the Company, its
Parent or any Subsidiary are exercisable for the first time by a
Participant during any calendar year exceeds $100,000, then such
Participants Incentive Stock Option(s) or portions thereof
that exceed such $100,000 limit shall be treated as Nonstatutory
Stock Options (in the reverse order in which they were granted,
so that the last Incentive Stock Option will be the first
treated as a Nonstatutory Stock Option). This paragraph shall
only apply to the extent such limitation is applicable under the
Code at the time of the grant.
(vi)
Repurchase Rights
.
The
Committee and the Board shall have the discretion to grant
Options that are exercisable for unvested shares of Common
Stock. Should the Participants Continuous Service cease
while holding such unvested shares, the Company shall have the
right to repurchase any or all of those unvested shares, at
either (a) the exercise price paid per share, (b) the
fair market value or (c) the lower of the exercise price
paid per share and the fair market value. The terms upon which
such repurchase right shall be exercisable (including the period
and procedure for exercise and the appropriate vesting schedule
for the purchased shares) shall be established by the Plan
Administrator and set forth in the document evidencing such
repurchase right.
(c)
Stock Appreciation Rights
.
The
Plan Administrator is authorized to grant Stock Appreciation
Rights to Participants on the following terms and conditions:
(i)
Right to Payment
.
A Stock
Appreciation Right shall confer on the Participant to whom it is
granted a right to receive, upon exercise thereof, the excess of
(A) the Fair Market Value of one share of stock on the date
of exercise over (B) the grant price of the Stock
Appreciation Right as determined by the Plan Administrator.
(ii)
Other Terms
.
The Plan
Administrator shall determine at the date of grant or
thereafter, the time or times at which and the circumstances
under which a Stock Appreciation Right may be exercised in whole
or in part (including based on achievement of performance goals
and/or
future service requirements), the time or times at which Stock
Appreciation Rights shall cease to be or become exercisable
following termination of Continuous Service or upon other
conditions, the method of exercise, method of settlement, form
of consideration payable in settlement, method by or forms in
which Stock will be delivered or deemed to be delivered to
Participants, whether or not a Stock Appreciation Right shall be
in tandem or in combination with any other Award, and any other
terms and conditions of any Stock Appreciation Right. Stock
Appreciation Rights may be either freestanding or in tandem with
other Awards.
(d)
Restricted Stock
.
The Plan
Administrator is authorized to grant Restricted Stock to
Participants on the following terms and conditions:
(i)
Grant and
Restrictions
.
Restricted Stock shall be
subject to such restrictions on transferability, risk of
forfeiture and other restrictions, if any, as the Plan
Administrator may impose, or as otherwise provided in this Plan.
The restrictions may lapse separately or in combination at such
times, under such circumstances (including based on achievement
of performance goals
and/or
future service requirements), in such installments or otherwise,
as the Plan Administrator may determine at the date of grant or
thereafter. Except to the extent restricted under the terms of
the Plan and any Award agreement relating to the Restricted
Stock, a
A-9
Participant granted Restricted Stock shall have all of the
rights of a shareholder, including the right to vote the
Restricted Stock and the right to receive dividends thereon
(subject to any mandatory reinvestment or other requirement
imposed by the Plan Administrator). During the restricted period
applicable to the Restricted Stock, subject to
Section 11(b) below, the Restricted Stock may not be sold,
transferred, pledged, hypothecated, margined or otherwise
encumbered by the Participant.
(ii)
Forfeiture
.
Except as
otherwise determined by the Plan Administrator at the time of
the Award, upon termination of a Participants Continuous
Service during the applicable restriction period, the
Participants Restricted Stock that is at that time subject
to restrictions shall be forfeited and reacquired by the
Company; provided that the Plan Administrator may provide, by
rule or regulation or in any Award agreement, or may determine
in any individual case, that restrictions or forfeiture
conditions relating to Restricted Stock shall be waived in whole
or in part in the event of terminations resulting from specified
causes, and the Plan Administrator may in other cases waive in
whole or in part the forfeiture of Restricted Stock.
(iii)
Certificates for
Stock
.
Restricted Stock granted under the
Plan may be evidenced in such manner, as the Plan Administrator
shall determine. If certificates representing Restricted Stock
are registered in the name of the Participant, the Plan
Administrator may require that such certificates bear an
appropriate legend referring to the terms, conditions and
restrictions applicable to such Restricted Stock, that the
Company retain physical possession of the certificates, that the
certificates be kept with an escrow agent and that the
Participant deliver a stock power to the Company, endorsed in
blank, relating to the Restricted Stock.
(iv)
Dividends and Splits
.
As a
condition to the grant of an Award of Restricted Stock, the Plan
Administrator may require that any cash dividends paid on a
share of Restricted Stock be automatically reinvested in
additional shares of Restricted Stock or applied to the purchase
of additional Awards under the Plan. Unless otherwise determined
by the Plan Administrator, Stock distributed in connection with
a Stock split or Stock dividend, and other property distributed
as a dividend, shall be subject to restrictions and a risk of
forfeiture to the same extent as the Restricted Stock with
respect to which such Stock or other property has been
distributed.
(e)
Stock Units
.
The Plan
Administrator is authorized to grant Stock Units to
Participants, which are rights to receive Stock, cash, or a
combination thereof at the end of a specified time period,
subject to the following terms and conditions:
(i)
Award and
Restrictions
.
Satisfaction of an Award of
Stock Units shall occur upon expiration of the time period
specified for such Stock Units by the Plan Administrator (or, if
permitted by the Plan Administrator, as elected by the
Participant). In addition, Stock Units shall be subject to such
restrictions (which may include a risk of forfeiture) as the
Plan Administrator may impose, if any, which restrictions may
lapse at the expiration of the time period or at earlier
specified times (including based on achievement of performance
goals
and/or
future service requirements), separately or in combination, in
installments or otherwise, as the Plan Administrator may
determine. Stock Units may be satisfied by delivery of Stock,
cash equal to the Fair Market Value of the specified number of
shares of Stock covered by the Stock Units, or a combination
thereof, as determined by the Plan Administrator at the date of
grant or thereafter. Prior to satisfaction of an Award of Stock
Units, an Award of Stock Units carries no voting or dividend or
other rights associated with share ownership.
(ii)
Forfeiture
.
Except as
otherwise determined by the Plan Administrator, upon termination
of a Participants Continuous Service during the applicable
time period thereof to which forfeiture conditions apply (as
provided in the Award agreement evidencing the Stock Units), the
Participants Stock Units (other than those Stock Units
subject to deferral at the election of the Participant) shall be
forfeited; provided that the Plan Administrator may provide, by
rule or regulation or in any Award agreement, or may determine
in any individual case, that restrictions or forfeiture
conditions relating to Stock Units shall be waived in whole or
in part in the event of terminations resulting from specified
causes, and the Plan Administrator may in other cases waive in
whole or in part the forfeiture of Stock Units.
(iii)
Dividend Equivalents
.
Unless
otherwise determined by the Plan Administrator at date of grant,
any Dividend Equivalents that are granted with respect to any
Award of Stock Units shall be either (A) paid
A-10
with respect to such Stock Units at the dividend payment date in
cash or in shares of unrestricted Stock having a Fair Market
Value equal to the amount of such dividends, or
(B) deferred with respect to such Stock Units and the
amount or value thereof automatically deemed reinvested in
additional Stock Units, other Awards or other investment
vehicles, as the Plan Administrator shall determine or permit
the Participant to elect.
(f)
Bonus Stock and Awards in Lieu of
Obligations
.
The Plan Administrator is
authorized to grant Stock as a bonus, or to grant Stock or other
Awards in lieu of Company obligations to pay cash or deliver
other property under the Plan or under other plans or
compensatory arrangements, provided that, in the case of
Participants subject to Section 16 of the Exchange Act, the
amount of such grants remains within the discretion of the
Committee to the extent necessary to ensure that acquisitions of
Stock or other Awards are exempt from liability under
Section 16(b) of the Exchange Act. Stock or Awards granted
hereunder shall be subject to such other terms as shall be
determined by the Plan Administrator.
(g)
Dividend Equivalents
.
The Plan
Administrator is authorized to grant Dividend Equivalents to a
Participant entitling the Participant to receive cash, Stock,
other Awards, or other property equal in value to dividends paid
with respect to a specified number of shares of Stock, or other
periodic payments. Dividend Equivalents may be awarded on a
free-standing basis or in connection with another Award. The
Plan Administrator may provide that Dividend Equivalents shall
be paid or distributed when accrued or shall be deemed to have
been reinvested in additional Stock, Awards, or other investment
vehicles, and subject to such restrictions on transferability
and risks of forfeiture, as the Plan Administrator may specify.
(h)
Other Stock-Based Awards
.
The
Plan Administrator is authorized, subject to limitations under
applicable law, to grant to Participants such other Awards that
may be denominated or payable in, valued in whole or in part by
reference to, or otherwise based on, or related to, Stock, as
deemed by the Plan Administrator to be consistent with the
purposes of the Plan, including, without limitation, convertible
or exchangeable debt securities, other rights convertible or
exchangeable into Stock, purchase rights for Stock, Awards with
value and payment contingent upon performance of the Company or
any other factors designated by the Plan Administrator, and
Awards valued by reference to the book value of Stock or the
value of securities of or the performance of specified Related
Entities or business units. The Plan Administrator shall
determine the terms and conditions of such Awards. Stock
delivered pursuant to an Award in the nature of a purchase right
granted under this Section 6(h) shall be purchased for such
consideration (including without limitation loans from the
Company or a Related Entity), paid for at such times, by such
methods, and in such forms, including, without limitation, cash,
Stock, other Awards or other property, as the Plan Administrator
shall determine. The Plan Administrator shall have the
discretion to grant such other Awards which are exercisable for
unvested shares of Common Stock. Should the Participants
Continuous Service cease while holding such unvested shares, the
Company shall have the right to repurchase, at a price
determined by the Administrator at the time of grant, any or all
of those unvested shares. The terms upon which such repurchase
right shall be exercisable (including the period and procedure
for exercise and the appropriate vesting schedule for the
purchased shares) shall be established by the Plan Administrator
and set forth in the document evidencing such repurchase right.
Cash awards, as an element of or supplement to any other Award
under the Plan, may also be granted pursuant to this
Section 6(h).
7.
Performance Awards
.
(a)
Performance Conditions
.
The
right of a Participant to exercise or receive a grant or
settlement of any Award, and the timing thereof, may be subject
to such performance conditions as may be specified by the Plan
Administrator. The Plan Administrator may use such business
criteria and other measures of performance as it may deem
appropriate in establishing any performance conditions, and may
exercise its discretion to reduce the amounts payable under any
Award subject to performance conditions, except as limited under
Section 7(b) hereof in the case of a Performance Award
intended to qualify under Code Section 162(m). If and to
the extent required under Code Section 162(m), any power or
authority relating to a Performance Award intended to qualify
under Code Section 162(m), shall be exercised by the
Committee as the Plan Administrator and not the Board.
(b)
Performance Awards Granted to Designated Covered
Employees
.
If and to the extent that the
Committee determines that a Performance Award to be granted to
an Eligible Person who is designated by the Committee as likely
to be a Covered Employee should qualify as
performance-based compensation for purposes of Code
A-11
Section 162(m), the grant, exercise
and/or
settlement of such Performance Award shall be contingent upon
achievement of pre-established performance goals and other terms
set forth in this Section 7(b).
(i)
Performance Goals
Generally
.
The performance goals for such
Performance Awards shall consist of one or more business
criteria and a targeted level or levels of performance with
respect to each of such criteria, as specified by the Committee
consistent with this Section 7(b). Performance goals shall
be objective and shall otherwise meet the requirements of Code
Section 162(m) and regulations thereunder including the
requirement that the level or levels of performance targeted by
the Committee result in the achievement of performance goals
being substantially uncertain. The Committee may
determine that such Performance Awards shall be granted,
exercised
and/or
settled upon achievement of any one performance goal or that two
or more of the performance goals must be achieved as a condition
to grant, exercise
and/or
settlement of such Performance Awards. Performance goals may
differ for Performance Awards granted to any one Participant or
to different Participants.
(ii)
Business Criteria
.
One or
more of the following business criteria for the Company, on a
consolidated basis,
and/or
specified Related Entities or business units of the Company
(except with respect to the total shareholder return and
earnings per share criteria), shall be used exclusively by the
Committee in establishing performance goals for such Performance
Awards: (1) total shareholder return; (2) such total
shareholder return as compared to total return (on a comparable
basis) of a publicly available index such as, but not limited
to, the Standard & Poors 500 Stock Index or the
S&P Specialty Retailer Index; (3) net income;
(4) pretax earnings; (5) earnings before interest
expense, taxes, depreciation and amortization; (6) pretax
operating earnings after interest expense and before bonuses,
service fees, and extraordinary or special items;
(7) operating margin; (8) earnings per share;
(9) return on equity; (10) return on capital;
(11) return on investment; (12) operating earnings;
(13) working capital or inventory; and (14) ratio of
debt to shareholders equity.
(iii)
Performance Period;
Timing
For Establishing Performance Goals. Achievement of performance
goals in respect of such Performance Awards shall be measured
over a performance period of up to ten years, as specified by
the Committee. Performance goals shall be established not later
than ninety (90) days after the beginning of any
performance period applicable to such Performance Awards, or at
such other date as may be required or permitted for
performance-based compensation under Code
Section 162(m).
(iv)
Performance Award Pool
.
The
Committee may establish a Performance Award pool, which shall be
an unfunded pool, for purposes of measuring Company performance
in connection with Performance Awards. The amount of such
Performance Award pool shall be based upon the achievement of a
performance goal or goals based on one or more of the business
criteria set forth in Section 7(b)(ii) hereof during the
given performance period, as specified by the Committee in
accordance with Section 7(b)(iii) hereof. The Committee may
specify the amount of the Performance Award pool as a percentage
of any of such business criteria, a percentage thereof in excess
of a threshold amount, or as another amount which need not bear
a strictly mathematical relationship to such business criteria.
(v)
Settlement of Performance Awards; Other
Terms
.
Settlement of such Performance Awards
shall be in cash, Stock, other Awards or other property, in the
discretion of the Committee. The Committee may, in its
discretion, reduce the amount of a settlement otherwise to be
made in connection with such Performance Awards. The Committee
shall specify the circumstances in which such Performance Awards
shall be paid or forfeited in the event of termination of
Continuous Service by the Participant prior to the end of a
performance period or settlement of Performance Awards.
(c)
Written Determinations
.
All
determinations by the Committee as to the establishment of
performance goals, the amount of any Performance Award pool or
potential individual Performance Awards and as to the
achievement of performance goals relating to Performance Awards
under Section 7(b), shall be made in writing in the case of
any Award intended to qualify under Code Section 162(m).
The Committee may not delegate any responsibility relating to
such Performance Awards if and to the extent required to comply
with Code Section 162(m).
(d)
Status of Performance Awards Under Code
Section 162(m)
.
It is the intent of the
Company that Performance Awards under this Section 7 hereof
granted to persons who are designated by the Committee as likely
A-12
to be Covered Employees within the meaning of Code
Section 162(m) and regulations thereunder shall, if so
designated by the Committee, constitute qualified
performance-based compensation within the meaning of Code
Section 162(m) and regulations thereunder. Accordingly, the
terms of Sections 7(b), (c) and (d), including the
definitions of Covered Employee and other terms used therein,
shall be interpreted in a manner consistent with Code
Section 162(m) and regulations thereunder. The foregoing
notwithstanding, because the Committee cannot determine with
certainty whether a given Participant will be a Covered Employee
with respect to a fiscal year that has not yet been completed,
the term Covered Employee as used herein shall mean only a
person designated by the Committee, at the time of grant of
Performance Awards, as likely to be a Covered Employee with
respect to that fiscal year. If any provision of the Plan or any
agreement relating to such Performance Awards does not comply or
is inconsistent with the requirements of Code
Section 162(m) or regulations thereunder, such provision
shall be construed or deemed amended to the extent necessary to
conform to such requirements.
8.
[Intentionally omitted]
9.
Certain Provisions Applicable to Awards or
Sales
.
(a)
Stand-Alone, Additional, Tandem, and Substitute
Awards
.
Awards granted under the Plan may, in
the discretion of the Plan Administrator, be granted either
alone or in addition to, in tandem with, or in substitution or
exchange for, any other Award or any award granted under another
plan of the Company, any Related Entity, or any business entity
to be acquired by the Company or a Related Entity, or any other
right of a Participant to receive payment from the Company or
any Related Entity. Such additional, tandem, and substitute or
exchange Awards may be granted at any time. If an Award is
granted in substitution or exchange for another Award or award,
the Plan Administrator shall require the surrender of such other
Award or award in consideration for the grant of the new Award.
In addition, Awards may be granted in lieu of cash compensation,
including in lieu of cash amounts payable under other plans of
the Company or any Related Entity.
(b)
Award Repricing
Prohibited
.
Except in connection with a
Corporate Transaction (for purposes of this Section 9(b),
including, without limitation, any stock dividend, stock split,
extraordinary cash dividend, recapitalization, reorganization,
merger, consolidation,
split-up,
spin-off, combination or exchange of shares), the terms of
outstanding Awards may not be amended to (i) reduce the
exercise price of such Awards or (ii) cancel such Awards in
exchange for cash or other Awards with an exercise price that is
less than the exercise price of the original Awards without
shareholder approval.
(c)
Form and Timing of Payment Under Awards;
Deferrals
.
Subject to the terms of the Plan
and any applicable Award agreement, payments to be made by the
Company or a Related Entity upon the exercise of an Option or
other Award or settlement of an Award may be made in such forms
as the Plan Administrator shall determine, including, without
limitation, cash, other Awards or other property, and may be
made in a single payment or transfer, in installments, or on a
deferred basis. The settlement of any Award may be accelerated,
and cash paid in lieu of Stock in connection with such
settlement, in the discretion of the Plan Administrator or upon
occurrence of one or more specified events (in addition to a
Change in Control). Installment or deferred payments may be
required by the Plan Administrator (subject to
Section 11(g) of the Plan) or permitted at the election of
the Participant on terms and conditions established by the Plan
Administrator. Payments may include, without limitation,
provisions for the payment or crediting of a reasonable interest
rate on installment or deferred payments or the grant or
crediting of Dividend Equivalents or other amounts in respect of
installment or deferred payments denominated in Stock.
(d)
Exemptions from Section 16(b)
Liability
.
It is the intent of the Company
that this Plan comply in all respects with applicable provisions
of
Rule 16b-3
or
Rule 16a-1(c)(3)
to the extent necessary to ensure that neither the grant of any
Awards to nor other transaction by a Participant who is subject
to Section 16 of the Exchange Act is subject to liability
under Section 16(b) thereof (except for transactions
acknowledged in writing to be non-exempt by such Participant).
Accordingly, if any provision of this Plan or any Award
agreement does not comply with the requirements of
Rule 16b-3
or
Rule 16a-1(c)(3)
as then applicable to any such transaction, such provision will
be construed or deemed amended to the extent necessary to
conform to the applicable requirements of
Rule 16b-3
or
Rule 16a-1(c)(3)
so that such Participant shall avoid liability under
Section 16(b).
A-13
10.
Change in Control; Corporate Transaction
.
(a)
Change in Control
.
(i) If a Change in Control occurs and as of, or within
twelve (12) months after, the effective time of such Change
in Control, (i) a Participants Continuous Service is
terminated without Cause (including a termination due to death
or Disability) by the Company, its successor or the
successors parent or (ii) a Participants
Continuous Service is terminated by the Participant with Good
Reason, then, as of the date of termination of Continuous
Service, the Award shall become fully vested and exercisable.
(ii) The Plan Administrator may, in its discretion,
accelerate the vesting, exercisability, lapsing of restrictions,
or expiration of deferral of any Award, including if we undergo
a Change in Control. In addition, the Plan Administrator may
provide in an Award agreement that the performance goals
relating to any Performance Award will be deemed to have been
met upon the occurrence of any Change in control.
(iii) In addition to the terms of Sections 10(a)(i)
and 10(a)(ii) above, the effect of a Change in
Control, may be provided (1) in an employment,
compensation, or severance agreement, if any, between the
Company or any Related Entity and the Participant, relating to
the Participants employment, compensation, or severance
with or from the Company or such Related Entity, or (2) in
the agreement evidencing the Award.
(b)
Corporate Transactions
.
In the
event of a Corporate Transaction, any surviving corporation or
acquiring corporation shall either (i) assume or continue
any or all Awards outstanding under the Plan or
(ii) substitute similar stock awards for outstanding Awards
(it being understood that similar awards include, but are not
limited to, awards to acquire the same consideration paid to the
shareholders or the Company, as the case may be, pursuant to the
Corporate Transaction). The Administrator, in its discretion and
without the consent of any Participant, may (but is not
obligated to) either (i) accelerate the vesting of all
Awards (and, if applicable, the time at which such Awards may be
exercised) in full or as to some percentage of the Award to a
date prior to the effective time of such Corporate Transaction
as the Administrator shall determine (contingent upon the
effectiveness of each Corporate Transaction) or
(ii) provide for a cash payment in exchange for the
termination of an Award or any portion thereof where such cash
payment is equal to the Fair Market Value of the Shares that the
Participant would receive if the Award were fully vested and
exercised (if applicable) as of such date (less any applicable
exercise price). The Administrator, in its sole discretion,
shall determine whether each Award is assumed, continued or
substituted.
Notwithstanding the foregoing, with respect to Restricted Stock
and any other Award granted under the Plan that the Company has
any reacquisition or repurchase rights, the reacquisition or
repurchase rights for such Awards may be assigned by the Company
to the successor of the Company (or the successors parent
company) in connection with such Corporate Transaction. In
addition, the Administrator, in its discretion, may (but is not
obligated to) provide that any reacquisition or repurchase
rights held by the Company with respect to such Awards shall
lapse in whole or in part (contingent upon the effectiveness of
the Corporate Transaction).
(c)
Dissolution or Liquidation
.
In
the event of a dissolution or liquidation of the Company, then
all outstanding Awards shall terminate immediately prior to the
completion of such dissolution or liquidation, and shares of
Common Stock subject to the Companys repurchase option may
be repurchased by the Company notwithstanding the fact that the
holder of such stock is still in Continuous Service.
11.
General Provisions
.
(a)
Compliance With Legal and Other
Requirements
.
The Company may, to the extent
deemed necessary or advisable by the Plan Administrator,
postpone the issuance or delivery of Stock or payment of other
benefits under any Award until completion of such registration
or qualification of such Stock or other required action under
any federal or state law, rule or regulation, listing or other
required action with respect to any stock exchange or automated
quotation system upon which the Stock or other Company
securities are listed or quoted, or compliance with any other
obligation of the Company, as the Plan Administrator, may
consider appropriate, and may require any Participant to make
such representations, furnish such information and comply with
or be subject to such other conditions as it may consider
appropriate in connection with the issuance or delivery of Stock
or payment of other benefits in compliance with applicable laws,
rules, and regulations, listing requirements, or other
obligations. The foregoing notwithstanding, in connection with a
Change in Control, the Company shall take or cause to be taken
no
A-14
action, and shall undertake or permit to arise no legal or
contractual obligation, that results or would result in any
postponement of the issuance or delivery of Stock or payment of
benefits under any Award or the imposition of any other
conditions on such issuance, delivery or payment, to the extent
that such postponement or other condition would represent a
greater burden on a Participant than existed on the
90th day preceding the Change in Control.
(b)
Limits on Transferability; Beneficiaries.
(i)
General
.
Except as
provided in the Award agreement, a Participant may not assign,
sell, transfer, or otherwise encumber or subject to any lien any
Award or other right or interest granted under this Plan, in
whole or in part, other than by will or by operation of the laws
of descent and distribution, and such Awards or rights that may
be exercisable shall be exercised during the lifetime of the
Participant only by the Participant or his or her guardian or
legal representative.
(ii)
Permitted Transfer of
Option
.
The Plan Administrator, in its sole
discretion, may permit the transfer of an Option (but not an
Incentive Stock Option, or any other right to purchase Stock
other than an Option) as follows: (A) by gift to a member
of the Participants Immediate Family or (B) by
transfer by instrument to a trust providing that the Option is
to be passed to beneficiaries upon death of the Participant. For
purposes of this Section 11(b)(ii), Immediate
Family shall mean the Participants spouse (including
a former spouse subject to terms of a domestic relations order);
child, stepchild, grandchild,
child-in-law;
parent, stepparent, grandparent,
parent-in-law;
sibling and
sibling-in-law,
and shall include adoptive relationships. If a determination is
made by counsel for the Company that the restrictions contained
in this Section 11(b)(ii) are not required by applicable
federal or state securities laws under the circumstances, then
the Committee or Board, in its sole discretion, may permit the
transfer of Awards (other than Incentive Stock Options and Stock
Appreciation Rights in tandem therewith) to one or more
Beneficiaries or other transferees during the lifetime of the
Participant, which may be exercised by such transferees in
accordance with the terms of such Award, but only if and to the
extent permitted by the Plan Administrator pursuant to the
express terms of an Award agreement (subject to any terms and
conditions which the Plan Administrator may impose thereon, and
further subject to any prohibitions and restrictions on such
transfers pursuant to
Rule 16b-3).
A Beneficiary, transferee, or other person claiming any rights
under the Plan from or through any Participant shall be subject
to all terms and conditions of the Plan and any Award agreement
applicable to such Participant, except as otherwise determined
by the Plan Administrator, and to any additional terms and
conditions deemed necessary or appropriate by the Plan
Administrator.
(c)
Adjustments.
(i)
Adjustments to
Awards
.
In the event that any dividend
or other distribution (whether in the form of cash, Stock, or
other property), recapitalization, forward or reverse split,
reorganization, merger, consolidation, spin-off, combination,
repurchase, share exchange, liquidation, dissolution or other
similar corporate transaction or event affects the Stock
and/or
such
other securities of the Company or any other issuer such that a
substitution, exchange, or adjustment is determined by the Plan
Administrator to be appropriate, then the Plan Administrator
shall, in such manner as it may deem equitable, substitute,
exchange, or adjust any or all of (A) the number and kind
of shares of Stock which may be delivered in connection with
Awards granted thereafter, (B) the number and kind of
shares of Stock by which annual per-person Award limitations are
measured under Section 5 hereof, (C) the number and
kind of shares of Stock subject to or deliverable in respect of
outstanding Awards, (D) the exercise price, grant price or
purchase price relating to any Award
and/or
make
provision for payment of cash or other property in respect of
any outstanding Award, and (E) any other aspect of any
Award that the Plan Administrator determines to be appropriate.
(ii)
Other Adjustments
.
The
Committee (and the Board if and only to the extent such
authority is not required to be exercised by the Committee to
comply with Code Section 162(m)) is authorized to make
adjustments in the terms and conditions of, and the criteria
included in, Awards (including Performance Awards and
performance goals and performance goals relating thereto) in
recognition of unusual or nonrecurring events (including,
without limitation, acquisitions and dispositions of businesses
and assets) affecting the Company, any Related Entity or any
business unit, or the financial statements of the Company or any
Related Entity, or in response to changes in applicable laws,
regulations, accounting principles, tax rates and regulations or
business conditions or in view of the Committees
assessment of the business strategy of the
A-15
Company, any Related Entity or business unit thereof,
performance of comparable organizations, economic and business
conditions, personal performance of a Participant, and any other
circumstances deemed relevant; provided that no such adjustment
shall be authorized or made if and to the extent that such
authority or the making of such adjustment would cause Options,
Stock Appreciation Rights, Performance Awards granted under
Section 7(b) hereof to Participants designated by the
Committee as Covered Employees and intended to qualify as
performance-based compensation under Code
Section 162(m) and the regulations thereunder to otherwise
fail to qualify as performance-based compensation
under Code Section 162(m) and regulations thereunder.
(d)
Taxes
.
The Company and any
Related Entity are authorized to withhold from any Award
granted, any payment relating to an Award under the Plan,
including from a distribution of Stock, or any payroll or other
payment to a Participant, amounts of withholding and other taxes
due or potentially payable in connection with any transaction
involving an Award, and to take such other action as the Plan
Administrator may deem advisable to enable the Company and
Participants to satisfy obligations for the payment of
withholding taxes and other tax obligations relating to any
Award. This authority shall include authority to withhold or
receive Stock or other property and to make cash payments in
respect thereof in satisfaction of a Participants tax
obligations, either on a mandatory or elective basis in the
discretion of the Committee.
(e)
Changes to the Plan and
Awards
.
The Board may amend, alter, suspend,
discontinue or terminate the Plan, or the Committees
authority to grant Awards under the Plan, without the consent of
shareholders or Participants. Any amendment or alteration to the
Plan shall be subject to the approval of the Companys
shareholders if such shareholder approval is deemed necessary
and advisable by the Board. However, without the consent of an
affected Participant, no such amendment, alteration, suspension,
discontinuance or termination of the Plan may materially and
adversely affect the rights of such Participant under any
previously granted and outstanding Award. The Plan Administrator
may waive any conditions or rights under, or amend, alter,
suspend, discontinue or terminate any Award theretofore granted
and any Award agreement relating thereto, except as otherwise
provided in the Plan; provided that, without the consent of an
affected Participant, no such action may materially and
adversely affect the rights of such Participant under such Award.
(f)
Limitation on Rights Conferred Under
Plan
.
Neither the Plan nor any action taken
hereunder shall be construed as (i) giving any Eligible
Person or Participant the right to continue as an Eligible
Person or Participant or in the employ of the Company or a
Related Entity; (ii) interfering in any way with the right
of the Company or a Related Entity to terminate any Eligible
Persons or Participants Continuous Service at any
time, (iii) giving an Eligible Person or Participant any
claim to be granted any Award under the Plan or to be treated
uniformly with other Participants and Employees, or
(iv) conferring on a Participant any of the rights of a
shareholder of the Company unless and until the Participant is
duly issued or transferred shares of Stock in accordance with
the terms of an Award.
(g)
Unfunded Status of Awards; Creation of
Trusts
.
The Plan is intended to constitute an
unfunded plan for incentive and deferred
compensation. With respect to any payments not yet made to a
Participant or obligations to deliver Stock pursuant to an
Award, nothing contained in the Plan or any Award shall give any
such Participant any rights that are greater than those of a
general creditor of the Company; provided that the Committee may
authorize the creation of trusts and deposit therein cash,
Stock, other Awards or other property, or make other
arrangements to meet the Companys obligations under the
Plan. Such trusts or other arrangements shall be consistent with
the unfunded status of the Plan unless the Committee
otherwise determines with the consent of each affected
Participant. The trustee of such trusts may be authorized to
dispose of trust assets and reinvest the proceeds in alternative
investments, subject to such terms and conditions as the Plan
Administrator may specify and in accordance with applicable law.
(h)
Nonexclusivity of the
Plan
.
Neither the adoption of the Plan by the
Board nor its submission to the shareholders of the Company for
approval shall be construed as creating any limitations on the
power of the Board or a committee thereof to adopt such other
incentive arrangements as it may deem desirable including
incentive arrangements and awards which do not qualify under
Code Section 162(m).
(i)
Fractional Shares
.
No
fractional shares of Stock shall be issued or delivered pursuant
to the Plan or any Award. The Plan Administrator shall determine
whether cash, other Awards or other property shall be issued or
paid
A-16
in lieu of such fractional shares or whether such fractional
shares or any rights thereto shall be forfeited or otherwise
eliminated.
(j)
Governing Law
.
The validity,
construction and effect of the Plan, any rules and regulations
under the Plan, and any Award agreement shall be determined in
accordance with the laws of the State of Arizona without giving
effect to principles of conflicts of laws, and applicable
federal law.
(k)
Plan Effective Date and Shareholder Approval;
Termination of Plan
.
The Plan shall become
effective on the Effective Date, subject to subsequent approval
within 12 months of its adoption by the Board by
shareholders of the Company eligible to vote in the election of
directors, by a vote sufficient to meet the requirements of Code
Sections 162(m) (if applicable) and 422,
Rule 16b-3
under the Exchange Act (if applicable), applicable Nasdaq
requirements, and other laws, regulations, and obligations of
the Company applicable to the Plan. Awards may be granted
subject to shareholder approval, but may not be exercised or
otherwise settled in the event shareholder approval is not
obtained. The Plan shall terminate no later than 10 years
from the date of the later of (x) the Effective Date and
(y) the date an increase in the number of shares reserved
for issuance under the Plan is approved by the Board (so long as
such increase is also approved by the shareholders).
A-17
. NNNNNNNNNNNN NNNNNNNNNNNNNNN C123456789 000004 000000000.000000 ext 000000000.000000 ext
000000000.000000 ext 000000000.000000 ext MR A SAMPLE DESIGNATION (IF ANY) 000000000.000000 ext
000000000.000000 ext ADD 1 Electronic Voting Instructions ADD 2 ADD 3 You can vote by Internet or
telephone! ADD 4 Available 24 hours a day, 7 days a week! ADD 5 Instead of mailing your proxy, you
may choose one of the two voting ADD 6 methods outlined below to vote your proxy. NNNNNNNNN
VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR. Proxies submitted by the Internet or
telephone must be received by 5:30 p.m., Central Standard Time, on December 12, 2007. Vote by
Internet
Log on to the Internet and go to www.investorvote.com
Follow the steps outlined on
the secured website. Vote by telephone
Call toll free 1-800-652-VOTE (8683) within the United
States, Canada & Puerto Rico any time on a touch tone telephone. There is NO CHARGE to you for the
call. Using a black ink pen, mark your votes with an X as shown in X
Follow the instructions
provided by the recorded message. this example. Please do not write outside the designated areas.
Annual Meeting Proxy Card 123456 C0123456789 12345 3 IF YOU HAVE NOT VOTED VIA THE INTERNET OR
TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED
ENVELOPE. 3 A Proposals The Board of Directors recommends a vote FOR all the nominees listed and
FOR Proposals 2 3. 1. Election of Directors: For Withhold For Withhold For Withhold + 01 David
R. Bethune 02 J. Steven Garrett 03 David Goldman 04 Leslie H. Green 05 O.B. Parrish 06 -
George J. Vuturo For Against Abstain For Against Abstain 2. To approve an amendment to the 1997
Stock Option Plan to 3. To ratify the appointment of BDO Seidman, LLP, as increase the total number
of shares authorized for issuance Zila, Inc.s independent registered public accounting from five
million (5,000,000) to eight million (8,000,000) shares. firm for the fiscal year ending July 31,
2008. 4. In their discretion, the proxies are authorized to vote upon such other business as may
properly come before the meeting. B Non-Voting Items Change of Address Please print new address
below. C Authorized Signatures This section must be completed for your vote to be counted.
Date and Sign Below NOTE: Please sign your name(s) EXACTLY as your name(s) appear(s) on this
proxy. All joint holders must sign. When signing as attorney, trustee, executor, administrator,
guardian or corporate officer, please provide your FULL title. Date (mm/dd/yyyy) Please print
date below. Signature 1 Please keep signature within the box. Signature 2 Please keep
signature within the box. C 1234567890 J N T MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140
CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND
NNNNNNN6 2 A V 0 1 5 6 0 2 1 MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND +
|
3 IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND
RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. 3 Proxy ZILA, INC. Notice of 2007 Annual
Meeting of Shareholders The undersigned hereby appoints David R. Bethune and George J. Vuturo, and
each of them, proxy for the undersigned, with power of substitution to vote all the shares of
common stock of Zila, Inc. held of record by the undersigned on October 18, 2007 at the annual
meeting of shareholders to be held at the Arizona Biltmore Resort & Spa, located at 2400 East
Missouri, Phoenix, AZ 85016 on December 13, 2007 at 8:00 a.m. Arizona time, and at any adjournment
thereof, upon the matters designated below and as more fully set forth in the Proxy Statement and
for the transaction of such business as may properly come before the meeting. THIS PROXY IS
SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS. WHEN PROPERLY EXECUTED, THIS PROXY WILL BE VOTED IN
THE MANNER DIRECTED BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE
VOTED FOR PROPOSALS 1, 2, 3 and 4. (Please date and sign on the reverse side)
|
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024